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Abstract: 
Parkinson's disease in reality arises as a result of a complex series of events, however it is 
strongly linked to the loss of a specific cellular population of midbrain dopaminergic neurons 
making it a candidate for stem cell based research. Stem cells can be cultured in vitro and via 
asymmetric cell division possess the capacity for both self renewal and the production of 
differentiated derivatives. The use of specific molecules and culture conditions can be 
applied to promote the differentiation of them towards particular cellular fates, in turn 
facilitating the possibility of producing enriched populations of cells displaying 
characteristics of a certain phenotype of interest. 
There has been much research focussed on the in vitro generation of dopaminergic neurons 
from various stem cell types. In this work the Tera2.cl.SP12 embryonal carcinoma stem cell 
line was the primary vehicle investigated for its ability to produce cells that were reflective of 
a dopaminergic phenotype. Retinoic acid was found to be able to up regulate the expression 
of a range of dopaminergic markers in the Tera2.cl.SP12 cell line over time. However it was 
clear that lowered oxygen culture, a method known to promote the production of neurons 
reflective of a dopaminergic phenotype in mesencephalic cultures, had no effect on the 
dopaminergic differentiation capacity of the embryonal carcinoma stem cells. 
The glycoprotein Wntl when applied to Tera2.cl.SP12 cultures in concert with retinoic acid 
was shown to increase the number and percentage of cells positive for the neuronal marker 
Beta I I I tubulin approximately 1.5 fold. This was accompanied by a concomitant rise in the 
mRNA expression of this marker, thus suggesting that the use of Wntl may be a means to 
produce cultures derived from embryonal carcinoma cells that are more neuronal, based on 
marker expression data. Other established methods to achieve dopaminergic differentiation 
such as suspension culture, stromal cell co-culture and the application of Sonic hedgehog and 
Fibroblast growth factor 8 are also able to induce a degree of neuronal and dopaminergic 
marker expression in Tera2.cl.SP12 cultures. Overall these results suggest that the 
Tera2.cl.SP12 cell line might be one vehicle for the study of dopaminergic neurogenesis in 
vitro, in particular when Wntl and retinoic acid are used as a means to favourably enrich the 
population of cells displaying neuronal characteristics. 
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Chapter 1 
Literature Review 
1.1 Introduction 
The primary aim of this thesis is to try to assess the potential o f the human embryonal 
carcinoma stem cell line Tera2.cl.SP12 as a model for the study o f dopaminergic 
differentiation in vitro. This cellular system in itself is of value mainly as a tool for 
basic research that may help extend our knowledge o f the processes specifying a 
dopaminergic fate and potentially i f deemed viable, it may be suitable for applied 
usage in the context of toxicological and pharmacological screening assays. However 
the study of dopaminergic neurogenesis is of broader significance due to the 
substantial loss o f midbrain dopaminergic neurons from the substantia nigra pars 
compacta that are associated with and recognised as one o f the major traits o f 
Parkinson's disease. It is the direct relevance to this condition that drives the body of 
research focussed upon the generation o f dopaminergic neurons in vitro. As such the 
introduction to this work starts with a brief appraisal and background to Parkinson's 
disease, prior to considering the role o f stem cells as a research tool particularly in 
relation to neurogenesis, before finally concentrating in greater depth on the current 
understanding o f dopaminergic differentiation in vitro as this essentially forms the 
heart o f this disquisition. 
1.2 Overview of Parkinson's disease 
The hallmark o f Parkinson's disease is the loss o f dopaminergic neurons from the 
substantia nigra pars compacta and the concomitant depigmentation o f it (Devine & 
Lewis, 2008). The condition affects roughly 100 - 180/100,000 o f the population, 
although estimates vary significantly, and becomes increasingly prevalent with the 
onset o f old age. It presents a considerable economic burden o f around £6 bil l ion a 
year in the United Kingdom alone (Findley et al., 2003) which is only likely to 
increase given the demographic trend towards an increasingly elderly population. 
However the condition is not just linked to the dopaminergic system of the substantia 
nigra pars compacta, with the earliest changes taking place in the medulla 
oblongata/pontine tegmentum as well as the olfactory bulb (Braak et al., 2006). In the 
initial steps, Braak stages 1 and 2 sufferers do not display any symptoms, subsequent 
to this though in Braak stages 3 and 4 the more well known areas such as the 
substantia nigra pars compacta become implicated, along with sections o f the 
midbrain and basal forebrain, prior to the neocortex displaying pathological changes 
(Davie, 2008). 
At present Parkinson's disease is typically thought o f as being idiopathic, in other 
words it may arise without a known cause (Di Monte et al., 2002); however there may 
be genetic elements and envirormiental exposures that increase the risk, on balance 
though it is likely to occur as a result o f a range of factors, such as ageing, exposure to 
toxins in the environment and potential genetic susceptibility (Samii et al., 2004). 
Alongside loss o f dopaminergic neurons another key pathological trait seen in many 
cases o f Parkinson's disease is the detection o f a-synuclein rich Lewy bodies 
(Spillantini et al., 1998). It has been proposed that exposure to toxins could affect not 
only the structure of a-synuclein but also its ability to bind ubiquitin and be processed 
by the 26S proteasome (Figure 1.1). In turn this may further enhance its aggregation 
and subsequently add to the impairment o f the process o f abnormal protein 
degradation (Di Monte et al., 2002). In work by Uversky et al., 2001 it was 
demonstrated that when certain pesticides were incubated in the presence of a-
synuclein its rate of fibrillation in vitro was accelerated. Like wise similar findings 
were presented in work carried out in vivo (Manning-Bog et al., 2002). These studies 
give support to the concept that environmental exposure to particular toxins may have 
a direct role in the pathogenesis of Parkinson's disease via a mechanism involving a-
synuclein (Di Monte et al., 2002). 
Figure 1.1: Potential Interactions of a-Synuclein with environmental toxins 
(redrawn from Di Monte et al, 2002) 
TOXIC Insult 
a-synuclein 
Key: 
^ a-synuclein 
O Ubiquitin 
B Proteasome 
Ubiquitinisation 
Proteasomal 
Degradation 
Figure 1.1: a-synuclein could be directly damaged by a toxic insult; such an 
event could alter the covalent binding of it with ubiquitin; and in turn hamper its 
degradation by the 268 proteasome (Di Monte et al., 2002). 
However this molecule may not only play a role in forms of Parkinson's disease that 
may be attributable to envirormiental exposures, as the gene encoding it was the first 
site to be identified as possessing a mutation in it (an alanine to threonine substitution) 
that could cause the condition (Polymeropoulos et al., 1997). Two additional point 
mutations of this gene, along with gene duplications and triplications give rise to a 
rare, autosomal dominant type o f Parkinson's disease (Kruger et al., 1998; Zarranz et 
al., 2004; Singleton et al., 2003; Nishioka et al., 2006). It is of interest that sufferers 
with duplications o f the gene display a later age o f onset and less severe phenotype 
than their counterparts possessing triplications, suggesting that disease severity may 
be linked to a-synuclein expression (Nishioka et al., 2006; Eriksen et al., 2005; Savitt 
et al., 2006). 
The importance o f this phosphoprotein is further underlined by the observation that 
polymorphisms in the promoter for a-synuclein are accompanied by an increase in the 
risk o f developing Parkinson's disease (Pals et al., 2004; Hadjigeorgiou et al., 2005; 
Tan et al., 2004). In addition a-synuclein null mice display resistance to the toxin 
MPTP that is often used to induce Parkinsonism in models o f the disease (Dauer et 
al., 2002). This relates neatly to the concept defined earlier whereby exposure to 
certain toxins may via a mechanism involving a-synuclein lead to the pathogenesis o f 
Parkinson's disease. 
There have though been mutations identified such as those in the protein known as 
Parkin that give rise to a form of Parkinsonism independent o f Lewy body formation 
in juvenile cases, indicating that this protein may play a role in the development o f 
such structures (reviewed in Davie, 2008). Parkin is an E3 ligase that is involved in 
the attachment o f ubiquitin molecules to target proteins that are as such marked for 
degradation by the proteasome (Zhang et al., 2000). One protein that Parkin may add 
ubiquitin to is the a-synuclein interacting protein Synphilin-1 in turn facilitating the 
production o f Lewy bodies (Chung et al., 2001). Thus supporting the above concept 
that Parkin may be involved in the process o f Lewy body formation which would 
explain why mutations in it that often lead to the early onset forms of Parkinson's 
disease usually, with rare exception, display an absence of such structures (Mori et al., 
1998; Farrer et al., 2001; Sasaki et al., 2004; Savitt et al., 2006). 
Despite most cases o f Parkinson's disease being sporadic in nature other mutations in 
single genes have been observed that may enhance our understanding o f the 
mechanisms responsible for the condition. Mutations in the DJ-1 gene are somewhat 
akin to those in Parkin and give rise to an autosomal recessive, early onset form of the 
disease (Bonifati et al., 2003). The function o f DJ-1 protein is not precisely defined at 
present but it can prevent via its interaction with a-synuclein, when in a specific 
oxidised state, the formation o f fibrils (Zhou et al., 2006). Thus suggesting that it acts 
as a redox sensitive chaperone that can shield cells exposed to oxidative stress from 
the potentially detrimental effects of a-synuclein misfolding (Savitt et al., 2006). 
In a similar fashion to DJ-1, mutations in PINK-1 result in an autosomal recessive, 
early onset form of Parkinson's disease (Valente et al., 2004). Both factors are also 
present in the mitochondria; given that abnormalities, in Complex 1 o f the oxidative 
phosphorylation enzyme pathway are a regular trait of sporadic forms of the disease 
(Abou-Sleiman et al., 2006) and have been described in other complexes (Schapira, 
2008), as well as the susceptibility o f neurons in the substantia nigra pars compacta to 
oxidative damage, it would appear that malfunction o f this organelle may have a role 
in the pathogenesis o f Parkinson's disease (Savitt et al., 2006; Davie, 2008). 
One final set o f mutations o f relevance were identified in the gene for leucine rich 
repeat kinase 2 (LRRK2) (Zimprich et al., 2004; Paisan-Ruiz et al., 2004). These are 
the most frequent genetic cause of Parkinson's disease with one mutation involving a 
glycine to serine substitution being responsible for between 2 and 40%, depending on 
the study population, o f all cases of this condition (Bonifati, 2006; Devine & Lewis, 
2008). At present the role o f LRRK2 is unknown but work in rat neurons suggests it 
may have a function in regulating the morphology o f neuritic processes (Macleod et 
al., 2006). In addition when a mutant form of it is expressed in SH-SY5Y cells the 
result is a shortening o f neurites that is linked to increased autophagic vacuole content 
(Plowey et al., 2008). It may also interact with Parkin in vitro (Smith et al., 2005), as 
well as possessing a ROC (Ras o f complex proteins) domain that can similarly relate 
to (3-tubulin a component of microtubules and Moesin (Gandhi et al., 2008; Jaleel et 
al., 2007). These findings together suggest that LRRK2 may interact with pathways 
that could themselves form part o f the mechanism o f the onset of Parkinson's disease 
(Devine & Lewis, 2008). 
After this brief consideration o f the possible causes of Parkinson's disease the 
question is raised o f what therapeutic interventions have been used to try and 
ameliorate the symptoms of it? The initial link between Parkinson's disease and 
dopamine deficiency lead to early efforts to rectify this, via the use o f the dopamine 
precursor levodopa (Cotzias et al., 1969). This was then utilised in conjunction with a 
peripheral decarboxylase inhibitor, for example carbidopa or benserazide (Rinne & 
Sonninen, 1973; Rinne et al., 1972) that facilitated the entry of more o f it into the 
brain (Savitt et al., 2006). In a comparable fashion catechol-o-methyl transferase 
inhibitors that act to elongate the half life o f levodopa and dopamine were found to 
augment the effects o f levodopa administration (Ericsson, 1971; Myl ly la et al., 1993; 
Roberts etal., 1993). 
In contrast to trying to increase the availability o f dopamine precursors, efforts were 
also made to curb the decrease in endogenous levels o f the neurotransmitter. 
Monoamine oxidase type B inhibitors such as Selegiline act in such a manner (Chrisp 
et al., 1991). Elsewhere other efforts have focussed on producing dopamine agonists 
that bypass the need for synthesis o f this compound, by acting directly on 
postsynaptic dopamine receptors (Gopinathan et al., 1981; Calne et al., 1974). 
Before the arrival o f levodopa treatment, surgical therapies had also been used to 
reduce the tremor and rigidity seen in patients with the disease, but their usage 
became less common as administration of the drug became more widespread (Brophy, 
1998). However more recently still there has been a resurgence towards surgical 
based strategies, founded on the use o f deep brain stimulation (Benabid et al., 2000; 
Stefani et al., 2007). 
Although all o f the treatments outlined are of value their capacity to provide a 
satisfactory quality o f l iving for Parkinson's disease sufferers tends to diminish with 
time. In addition they are unable to address the problem of the continual degeneration 
evident in both the dopaminergic and non dopaminergic systems. As such a 
significant amount o f recent research has concentrated on identifying the reasons 
underlying the loss o f dopaminergic cells. In addition to investigating the potential 
for neuroprotective, restorative or possibly cell replacement based strategies (Savitt et 
al., 2006). These approaches may well involve the use o f stem cells which are the 
focus of the next section o f this Chapter. 
1.3 Stem cells as a tool to study neurogenesis 
There are a wide variety o f stem cell types that may be o f use both as research tools to 
further our understanding o f development or as potential sources of cells for use in 
therapeutic strategies such as cell transplantation that may help in the treatment of 
certain diseases. Like wise they may also provide a supply o f cells for in vitro assays 
to screen for example novel compounds for a specific activity that may help in drug 
based remedies for known conditions. Individual areas o f research tend to have 
associated with them, varieties of stem cell that are particularly pertinent for use in the 
context o f the topic being studied. This thesis is primarily focussed on the use of 
embryonal carcinoma stem cells as a model to study the formation o f dopaminergic 
neurons. However there are additional cell types that are often generally utilised for 
the study o f neurogenesis and these are discussed briefly along with embryonal 
carcinoma cells in this Section. 
When studying neurogenesis it is unsurprising to find multipotent neural stem cells 
that exist in both the developing as well as the adult mammalian brain are often used. 
Broadly speaking these cell types are derived f rom the nervous system and/or can 
generate neural tissue, possess some degree o f ability for self renewal and can give 
rise to cells that differ f rom them via asymmetric cell division. It is also possible to 
derive such cells f rom other more primitive cell types that are capable o f generating 
neural stem cells as well as those o f alternative tissues (Figure 1.2) (Gage, 2000). The 
distinction between multipotent stem cells and neural progenitors as identified in 
Figure 1.2 is still somewhat hazy as there are instances where cells described as 
neural progenitors are obtained from; for example embryonic brain that are 
proliferated post isolation, prior to differentiation in a manner analogous to that 
utilised for neural stem cells (Gage, 2000). I t is always advisable therefore to try and 
assess any effects on such cells relative to the specific developmental stage they were 
isolated at and in relation to the species from which they were obtained. 
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Figure 1.2: Stem cells from which neurons may be derived (based on Gage, 2000) 
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Figure 1.2: A hierarchy of mammalian stem cells that may give rise to neurons. The 
least restricted cells are at the top with the degree of restriction increasing going down 
the page. The small arrows pointing up the page allow for the potential of stem cells 
to dedifferentiate (Gage, 2000). 
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Mesenchymal stem cells are another type o f multipotent stem cell that have been 
evaluated as a source f rom which neurons may be generated in vitro. However there 
utilisation is less widespread and would require them to possess the capacity to trans 
differentiate given their mesodermal origins. This process has been brought into 
question and is an area o f some controversy (Hardy et al., 2008), which perhaps 
accounts for their limited employment in this context. 
Also in widespread usage for the study o f neurogenesis in vitro are the pluripotent 
embryonic stem cells derived f rom the blastocyst inner cell mass, which have now 
been isolated from a number o f species such as mouse (Evans & Kaufman, 1981) and 
human (Thomson et al., 1998). Embryonal carcinoma stem cells arise from germ cell 
tumours and given their resemblance to the pluripotent embryonic stem cells o f the 
inner cell mass are considered an apposite model system to them. Both systems 
possess certain advantages and these often dictate the choice o f cell decided upon for 
use. There are a number of human embryonal carcinoma cell types such as the 
Ntera2.Dl (Andrews et al., 1984) and Tera2.cl.SP12 cell lines (Przyborski, 2001) that 
can grow independently o f feeder layers associated with embryonic stem cell culture, 
that provide a possible model o f human development. This was seen as an advantage 
of such cells, however there are now protocols that facilitate the culture o f human 
embryonic stem cells in the absence of feeder layers (Amit & Itskovitz Eldor, 2006), 
which promote the embryonic stem cell cause. In the context o f the embryonal 
carcinoma versus embryonic stem cell dichotomy, embryonal carcinoma cells were 
also seen as a more ethical option, although once again new methods were developed 
for the extraction of human embryonic stem cells that left the embryo f rom which 
they were derived intact (Klimanskaya et al., 2006). In turn promoting still further the 
case for using embryonic stem cells, which also possess a greater more diversified 
differentiation capacity and are not o f cancerous origin, which is an undeniable 
drawback of embryonal carcinoma cells that limits their potential usage particularly in 
regard to transplantation based approaches. However embryonal carcinoma cells are 
robust, easy to manipulate and relatively inexpensive to culture and are thus attractive 
in vitro tools. In addition they can be rapidly expanded to give large numbers of cells 
and indeed given their more restricted differentiation capability, might be better 
viewed as a source o f cells with a strong propensity for neural differentiation. To this 
end eariy indications using the Tera2.cl.SP12 line obtained via immunomagnetic 
sorting (Przyborski, 2001) were that it may possess a greater disposition than its 
counterpart Ntera2 for such neural development (Przyborski et al., 2000; Przyborski 
et al., 2004). 
Both Embryonal carcinoma and embryonic stem cell models may be valuable tools for 
studying neurogenesis, embryonic stem cells appear more regularly in the literature 
but when embryonal carcinoma cells are used they tend to react similarly to their 
embryonic stem cell counterparts in response to many dopaminergic phenotype 
inducing agents in some of the widely used protocols aimed at generating 
dopaminergic neurons in vitro (Schwartz et al., 2005; Ravindran & Rao, 2006). It is 
such procedures that are focussed on in the final section o f this Chapter as they unite 
the use of stem cells with the desire to produce dopaminergic neurons for application 
in developing improved therapies for Parkinson's disease. 
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1.4 In Vitro Methods to Generate Dopaminergic Neurons 
Introduction 
Dopamine although originally thought to merely be a precursor in the synthesis o f 
noradrenaline and adrenaline was after the discovery o f it in the mammalian brain 
(Montagu, 1957) shown to be a significant catecholaminergic neurotransmitter of the 
vertebrate central nervous system. Many populations o f dopaminergic cells exist for 
example in the retina, olfactory bulb, retrorubral field and those o f the ventral 
tegmental area that are implicated in obsessive compulsive disorder and schizophrenia 
(Lin & Rosenthal, 2003). These mesencephalic ventral tegmental area dopaminergic 
neurons that form the mesolimbic system are one o f the two most significant groups 
of this neuronal subtype. The other being the nigrostriatal dopaminergic neurons o f 
the substantia nigra pars compacta. 
The discovery o f dopamine deficiency in the substantia nigra and corpus striatum of 
brains from Parkinson's disease patients (Ehringer & Homykiewicz, 1960) and 
subsequent link between the striatum and substantia nigra lead to the understanding 
that loss o f the dopamine producing cells there, lead to a loss o f dopaminergic 
innervation to the corpus striatum and thus a deficit of the chemical was observed in 
this location (Poirier & Sourkes, 1965). Parkinson's disease can therefore be linked 
to a specific brain region and to a specific abnormality in one neurotransmitter. 
Although the disease is in fact more complex with many stages, o f which the loss of 
midbrain substantia nigra dopaminergic neurons is just one, it does make the 
condifion a suitable target for cell based therapies, i f an enriched populafion of the 
phenotype of interest can be produced. Though the primary focus o f such strategies 
tends to be on cell replacement, there are many obstacles to this. For example 
survival o f grafted cells, the location o f the graft which is generally into the striatum 
not the substantia nigra itself, loss o f transplanted cells due to immune rejection or 
toxic factors that have already caused loss of the native dopaminergic neurons having 
the same effect on their grafted counterparts (Svendsen, 2008). There is also the 
possibility o f aberrant cells that could give rise to teratomas being transplanted, and 
the process o f transplantation itself may physically damage the relatively delicate 
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neuronal cells, in particular any neuritic extensions. Some of these hurdles may be 
overcome through studies in cell based systems utilising the variety o f currently 
available and developing technologies. However in vitro methods also have potential 
not only as basic tools for furthering our understanding o f the developmental 
mechanisms o f specific cellular phenotypes, but may provide a range of models for 
pharmacological screening. In addition such approaches may afford an understanding 
that facilitates the design of novel compounds that can stimulate endogenous repair 
mechanisms in the brain. This is exemplified by work using neural stem cells from 
the sub ventricular zone o f adult rats where dopamine D3 receptors are known to be 
expressed. When cultures of these cells were treated with a dopamine D3 receptor 
selective agonist 7-hydroxy-dipropylaminotetralin there was an increase in cell 
number (Coronas et al., 2004), which gives support to the concept that it may be 
possible to influence the inherent ability of certain cellular populations in the brain to 
assist in the self repair o f this organ. 
The demographic trend towards an increasingly elderly population in much of society, 
issues with current methods for treating Parkinson's disease particularly in the later 
stages, the specificity o f the neuronal subtype affected and the array o f potential 
therapeutic options they may offer have lead to much investigation into the possible 
methods to generate dopaminergic neurons in vitro, it is these that form the main basis 
o f this section. However a brief description o f the work on the developmental 
processes that specify midbrain dopaminergic neurons in vivo is first given, as this has 
provided the foundation for many of the in vitro studies. 
Specification of Mesencephalic Dopaminergic Precursors 
A myriad o f intricate interactions between a host of transcription factors and a 
cascade of signalling events give rise to the induction o f midbrain dopaminergic 
neurons. Principally though they form from interacting signals provided by two 
different organising centres. Sonic hedgehog arising f rom the floor plate and 
Fibroblast growth factor 8 arising from the isthmic organiser, which acts as a 
boundary between the mid and hindbrain. Sonic hedgehog is the primary soluble 
signalling molecule along the dorsoventral axis and can induce the formation of 
dopaminergic neurons in explants from the fore and midbrain (Hynes et al., 1995; 
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Wang et al., 1995), whilst Fibroblast growth factor 8 is produced in a discrete region 
that corresponds to the midbrain hindbrain boundary (Crossley et al., 1996; Lee et al., 
1997; Ye et al., 1998). The intersection and combination o f signals provided by these 
two molecules gives rise to the induction o f dopaminergic precursors rostrally to the 
isthmic organiser (Figure 1.3), (reviewed in Wallen & Perlmann, 2003; Arenas, 2002; 
Maxwell & L i , 2005). 
The strength o f the developmental influence o f these two factors on the production o f 
a midbrain dopaminergic cell fate is also recognised in the widespread usage o f them 
in a variety o f cell based methods and as such approaches founded on their usage 
offer a suitable starting point when considering dopaminergic differentiation in vitro. 
Figure 1.3: Dopaminergic development in the mouse embryo (based on Simon et 
ah 2003 
Figure 1.3: The intersection of Sonic hedgehog and Fibroblast growth factor 8 
causes the induction of midbrain dopaminergic neurons in the mouse embryo at E8 to 
E9. FP = Floor Plate, is = isthmus, F = forebrain, H =hindbrain, M = midbrain, mDA 
= midbrain dopaminergic neurons (Simon et al., 2003). 
15 
The use of Sonic Hedgehog and Fibroblast Growth Factor 8 as tools to promote 
dopaminergic differentiation in vitro 
These two key signalling molecules have been a part o f many protocols aimed at 
generating dopaminergic neurons in vitro. Many of these methods have attempted to 
make use o f these factors in synergy with other approaches or molecules known to 
have favourable effects on the induction o f a dopaminergic cell fate and as such their 
use w i l l also be referred to in later sections. However there are some key issues to 
their successful application which are to be focussed on here. Early work in mouse 
embryonic stem cells showed that neural differentiation could be achieved via 
formation o f 3D aggregates in suspension culture, known as embryoid bodies, either 
in the presence o f retinoic acid (Bain et al., 1995), or absence o f it in serum free 
conditions (Okabe et al., 1996). Subsequently Lee et al., 2000 used a sequenfial 
protocol beginning with embryoid body formation f rom an expanded population o f 
undifferentiated murine embryonic stem cells to act as a starting point to generate an 
enriched population o f dopaminergic neurons. After the embryoid body stage nestin 
positive neural precursors were obtained via a medium based selection process, these 
cells were then expanded prior to a final differentiation step (Lee et al., 2000). The 
combined administration o f Sonic hedgehog and Fibroblast growth factor 8 during the 
expansion phase (Stage 4 in Lee et al., 2000) gave rise to a more than twofold 
increase in the number o f cells that were positive for tyrosine hydroxylase the rate 
limiting enzyme in dopamine biosynthesis. Interestingly treatment with either factor 
alone at this point showed a less significant effect than when both molecules were 
applied in a concerted manner. This is strongly indicative that as is the case in vivo, 
the presence of both signals is required to induce a dopaminergic phenotype. Another 
critical finding was that the collective application o f these two molecules at other 
preceding or latter steps o f the process had no effect on the yield o f tyrosine 
hydroxylase positive cells obtained (Lee et al., 2000). 
Further work in human embryonic stem and embryonal carcinoma cells further 
substantiated the importance o f temporal factors when trying to elicit dopaminergic 
differenfiation in vitro. Firstly using the human embryonal carcinoma stem cell line 
Ntera2, i t was shown that Sonic hedgehog and Fibroblast growth factor 8 were not 
able to induce tyrosine hydroxylase expression. However this was in Ntera2 
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embryonal carcinoma cells pre treated with retinoic acid. Such culture o f Ntera2 cells 
with retinoic acid results in the production o f neurons with various neurotransmitter 
phenotypes and it is these hNT neurons that were the subject o f investigation. Only 
small percentages (2%) o f neurons were tyrosine hydroxylase immunopositive 
fol lowing application o f Sonic hedgehog and fibroblast growth factor 8. Again 
highlighting the importance o f developmental stage on the ability o f cells in culture to 
respond to the cues provided (Stull & lacovitti, 2001). Given that Sonic hedgehog 
and Fibroblast growth factor 8 are thought to act in the earlier stages o f dopaminergic 
neuron development an approach involving their use to manipulate the embryonal 
carcinoma stem cell system towards a dopaminergic fate cannot be discounted i f the 
exogenous application o f them can be optimised to an appropriate temporal window. 
Indeed in a similar protocol to that o f Lee et al., 2000, the Ntera2.Dl cell line was 
used to first generate aggregates in suspension that appeared akin to embryoid bodies. 
Medium based selection for nestin positive precursors followed, prior to expansion 
and then sorting using neuronal cell adhesion molecule to enrich the neuroprogenitor 
pool. Finally differentiation was induced using a cocktail containing glial cell line 
derived neurotrophic factor and interleukin-ip both agents being known to promote a 
dopaminergic phenotype (Ravindran & Rao, 2006). Interestingly unlike most other 
protocols involving experimentation using the embryonal carcinoma cell system, 
refinoic acid treatment is not involved. Although retinoic acid may possess a role in 
the specification of a dopaminergic phenotype it is also implicated in specifying other 
cellular fates and indeed can cause formation o f both neurons and glia f rom certain 
embryonal carcinoma cell lines such as Tera2.cl.SP12 (Stewart et al., 2003). 
Therefore its use could be brought into question; however Sonic hedgehog itself is 
known to have a role in the formation o f serotonergic hindbrain neurons. In 
conjunction with Fibroblast growth factor 8 in the protocol o f Lee et al., 2000, it 
causes a fourteen fold increase in the number o f serotonin positive cells when applied 
during the expansion phase. Even when Sonic hedgehog is applied alone a similar 
effect is observed (Lee et al., 2000). Therefore although it may be seen as desirable to 
avoid the use o f certain molecules like retinoic acid, it is probably more important to 
control when and how they are used. Sonic hedgehog is regularly a constituent o f 
procedures trying to induce dopaminergic neurons but it still has the ability to help 
generate alternative neuronal fates. 
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It is, though, noteworthy that embryonal carcinoma stem cells can be used in the 
absence of retinoic acid to generate dopaminergic neurons. It also demonstrates that 
Fibroblast growth factor 8 and Sonic hedgehog can be used effectively in the Ntera2 
embryonal carcinoma cell system, and that using this embryoid body based method 
they do act in a similar fashion to the embryonic stem cells, for which they act as a 
model (reviewed in Przyborski et al., 2004). 
In addition to their use in mouse embryonic stem and human embryonal carcinoma 
cells. Sonic hedgehog and Fibroblast growth factor 8 have also been utilised in human 
embryonic stem cells. This work highlighted the importance o f the correct timing o f 
application of exogenous compounds (Figure 1.4). When Fibroblast growth factor 8 
was applied alongside Sonic hedgehog to Soxl positive neuroepithelial cells, the 
output was a set o f tyrosine hydroxylase positive, y-aminobutyric acid co-expressing, 
bipolar cells that lacked expression o f the midbrain marker Engrailed 1. However i f 
Fibroblast growth factor 8 was administered to Soxl negative precursors, followed by 
combined Sonic Hedgehog/Fibroblast growth factor 8 treatment then a distinctly 
different population o f tyrosine hydroxylase positive. Engrailed 1 co-expressing 
midbrain type dopaminergic neurons, with complex processes and large cell bodies 
were produced (Yan et al., 2005). 
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Figure 1.4; The temporal effects of Shh and F G F 8 on the acquisition of a 
dopaminergic phenotype (based on Yan et al, 2005) 
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Figure 1.4: The effect of timing of administration of certain molecules is key in influencing 
the specification of particular cellular phenotypes, as exemplified here for Fibroblast growth 
factor 8 and Sonic hedgehog. When human embryonic stem cell derived neural precursors are 
given an early dose of Fibroblast growth factor 8 prior to Soxl expression they are capable of 
generating midbrain type dopaminergic neurons, when this molecule is applied in conjunction 
with Sonic hedgehog after Soxl expression is detectable, the resultant output is dopaminergic 
neurons characteristic of a forebrain identity (based on Yan et al., 2005). 
In another protocol based on that o f Lee et al., 2000, Sonic hedgehog and Fibroblast 
growth factor 8 were used to try and influence murine adult neural stem cells o f the 
sub ventricular zone to produce midbrain phenotype dopaminergic neurons. The two 
factors were able to induce expression o f midbrain markers but the adult neural stem 
cells still maintained a forebrain identity, giving rise to mixed phenotype neurons. 
However in their absence no tyrosine hydroxylase positive neurons were found, 
indicating that Sonic hedgehog/Fibroblast growth factor 8 were responsible for the 
induction o f T H posifive neurons and that aduft neural stem cells do not default to, or 
show no predisposition to produce dopaminergic neurons. High performance liquid 
chromatography also showed that although adult neural stem cells could release 
dopamine, depolarisation with potassium ions (K"^) did not significantly increase this 
effect. In contrast neurons positive for tyrosine hydroxylase derived from embryonic 
stem cells displayed an evoked release o f dopamine upon depolarisation 
(Papanikolaou et al., 2008). 
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Functional testing such as that carried out by high performance liquid 
chromatography is key i f the dopaminergic neurons generated are to be validated for 
use in applications such as toxicological and pharmacological screens or i f they are to 
be used in any kind o f potential cell transplantation based strategy in the future. To 
this end dopaminergic neurons derived using Sonic hedgehog/Fibroblast growth 
factor 8 based approaches f rom a variety o f sources do tend to display biological 
function. For example dopamine production, an ability to respond to 
neurotransmitters and spontaneous synaptic activity are all seen in mouse embryonic 
stem cell derived tyrosine hydroxylase positive neurons (Lee et al., 2000). Likewise 
human embryonic stem cell derived neurons exhibit activity dependent release o f 
dopamine and electrophysiological properties, although the in vitro dopaminergic 
neurons derived in this human embryonic stem cell system convey the notion o f a 
slow process o f maturation as evidenced by atypical electrophysiology and poor 
uptake activity o f dopamine. This may be due to a lack o f signals and targets for the 
human cells in the culture conditions used (Yan et al., 2005). 
Beyond the level o f functional testing transplantation o f enriched human Ntera2 
derived neural cell adhesion molecule positive cells into the substantia nigra of a 6-
hydroxydopamine treated rat model o f Parkinson's disease resulted in behavioural 
improvement. Although the sample size was small, neural cell adhesion molecule 
positive sorted cells did not give rise to any tumours. Transplanted cells were both 
able to survive in the substantia nigra and differentiate as shown by expression o f 
tyrosine hydroxylase and anti human nuclei, the presence of tyrosine hydroxylase 
being indicative o f the dopaminergic differentiation o f the transplanted cells. Though 
tyrosine hydroxylase could also be a marker o f other neuronal phenotypes, the locality 
of the graft and procedure used to derive the transplanted cells would suggest a 
dopaminergic identity. Ideally as in any study a panel o f dopaminergic markers 
would be used as supporting evidence. In vitro however neural cell adhesion 
molecule positive neuroprogenitors when differentiated did not express dopamine p 
hydroxylase as would be expected of non dopaminergic tyrosine hydroxylase positive 
neurons and did express Engrailed 1, N u r r l , and a range o f other dopaminergic 
neuron associated elements. Therefore there is promise in this technique which 
underlines the importance of cell sorting prior to transplantation (Ravindran & Rao, 
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2006), to avoid the problem of teratoma formation as was found with mouse 
embryonic stem cell derived transplanted dopaminergic neurons. In this study one 
animal was found to have a teratoma in its brain post transplantation (Nishimura et al., 
2003). Overcoming this safety issue is one o f the many challenges facing the 
successful use o f embryonic stem cells. Given the malignant nature o f embryonal 
carcinoma stem cells their role is more realistically confined to more basic 
fundamental research to refine the procedures that could then be applied elsewhere. 
Co-culture Methods to Achieve Dopaminergic Differentiation 
For all the variety o f strategies used to generate dopaminergic neurons in vitro, most 
of them at their core i f not based on Sonic hedgehog and Fibroblast growth factor 8 
are founded on co-culture approaches. In particular involving the use o f bone marrow 
derived murine PA6 cells. Although alternative stromal cells, for example MS5 
(Perrier et al., 2004), in addition to other cell types such as glia o f the ventral 
midbrain (Castelo-Branco et al., 2006) and Sertoli (Yue et al., 2006) as well as 
meningeal (Hayashi et al., 2008) cells have been used. The general advantages o f 
such protocols are the relative ease of the technique and usually short time course 
needed to achieve induction o f dopaminergic differentiation. The main drawback is 
in the use of animal cells that are coming into contact with or are in close proximity 
( i f a membrane is used) to the cells o f interest. This would need to be addressed 
before application in a clinical setting, and is prohibitive in the context o f any kind o f 
screening assay as the cellular population in direct co-culture approaches is 
heterogenous. Another key question that remains is what is the identity o f the 
inductive molecules in such approaches in particular with PA6 cells what constitutes 
the Stromal Derived Inducing Activity known as SDIA? 
In early work using mouse embryonic stem cells the nature o f the stromal derived 
inducing activity was investigated. It was found that even after fixation with 
paraformaldehyde, PA6 cells could still cause neural differentiation. Similariy other 
stromal cell types also exhibited a comparable activity fol lowing fixation but prior to 
it only exerted a weak or intangible neural inducing effect, where as PA6 cells pre or 
post fixation displayed posifive effects on neural cell specification. The speculation 
in this work was that other stromal cells produce a mixture o f inductive and inhibitory 
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factors. PA6 cells lack the latter component that is lost upon fixation o f alternative 
stromal cell types. Hence why PA6 cells can exert an effect in both conditions not 
just post fixation as is the case for their counterparts. The other important aspect of 
this work was it highlighted that at least in part the inductive activity arose from or 
was mediated by something on the cell surface, as fixed cells lack the capacity to 
secrete soluble factors. 
However when a 0.4^M filter membrane was used to alleviate any physical contact 
between the embryonic stem and PA6 cells significant neural induction was observed. 
This is indicative that there is also a soluble constituent to the PA6 stromal derived 
inducing activity. Interestingly though media conditioned by PA6 cells was unable to 
exert a similar effect. Overall the initial suggestions were that the stromal derived 
inducing activity possessed two components, a membrane bound and soluble factor, 
or that there was an initial secretion o f a product that then subsequently had an 
interaction at the cell surface. Although the identity o f the stromal derived inducing 
activity is unknown, one intriguing aspect o f this protocol is that detection o f tyrosine 
hydroxylase occurs between day six to day eight o f induction. Embryonic stem cells 
are equivalent to E4 cells o f the inner cell mass and in foetal mouse midbrain tyrosine 
hydroxylase is first expressed at E l 1.5 (Foster et al., 1988). Therefore there is a 
seemingly comparable temporal schedule in vitro to that seen in vivo (Kawasaki et al., 
2000). 
Similar PA6 based protocols have also been investigated in embryonic stem cells 
from other species and in alternative cell types. From this there have arisen some 
consistent but also some contradictory findings. This may not only be accounted for 
by species specific differences but by the stromal derived inducing activity consisting 
of a number o f factors, possibly more than the two identified using murine embryonic 
stem cells, however it may be that there are multiple activities that can either be 
classified as soluble or membrane bound. Different aspects o f the stromal derived 
inducing activity may be crifical depending on the system used. 
Firstly in primate embryonic stem cells a similar ability was shown by PA6 cells to 
induce a broadly neuronal and more specifically a dopaminergic fate. There was a 
slightly longer period o f induction required before the appearance of expression of 
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dopaminergic markers like tyrosine hydroxylase, and the efficiency o f neural 
differentiation was approximately 50% of that found using mouse cells. However the 
process did work and was more rapid in its time course in vitro than might have been 
predicted f rom the in vivo setting, this rapidity is one advantage o f the method 
(Kawasaki et al., 2002). 
The PA6 based approach has also been tested in human embryonic stem cells, in 
addition to human embryonal carcinoma stem cells. Zeng et al., 2004 used the BGOl 
human embryonic stem cell line in conjunction with PA6 cells to generate tyrosine 
hydroxylase positive cells in just under 90% of embryonic stem cell colonies over a 
time course o f three weeks. The differentiated cells expressed a range of 
dopaminergic markers such as dopamine transporter, N u r r l , and aromatic amino acid 
decarboxylase. They were dopamine (3 hydroxylase negative indicating that they were 
not noradrenergic and could release dopamine upon depolarisation by potassium ions 
(Zeng et al., 2004). Park et al., 2005 tested three other human embryonic stem cell 
lines in the PA6 co-culture system, only one o f the three displayed neural precursor 
differentiation. After one week nestin and p I I I - tubulin expression were present in 
more than 90% o f the HSF-6 derived cells, but given the same conditions the other 
two lines tested (SNU-hES3 and Miz-hESl) showed less than 10% of cells to be 
comparable in the expression o f these markers (Park et al., 2005, reviewed in Taylor 
& Minger, 2005). 
Given the variability in outcomes using human embryonic stem cells, at around the 
same period the observation was made that PA6 cells could influence the 
dopaminergic differentiation o f the Ntera2 human embryonal carcinoma stem cell line 
(Schwartz et al., 2005). The efficiency and time course o f this generation mirrored 
closely that in human embryonic stem cells, which is not dissimilar to the scenario 
found when using Sonic hedgehog/Fibroblast growth factor 8 based protocols. This 
offers promise in that the robust nature and relatively basic inexpensive methods for 
human embryonal carcinoma stem cell culture, combined with a clear likeness to the 
human embryonic stem cell system in relation to dopaminergic differentiation, could 
make embryonal carcinoma cells a useful tool to study dopaminergic neurogenesis 
whilst greater control and charcterisation of human embryonic stem cell systems is 
developed. The findings could then be translated from one system into the other, 
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although subtle differences may be found, there are still advantages to be gained from 
the tandem use o f both human cell systems; especially given the species specific 
differences that are observed between human and animal neuronal progenitor cells 
(Jin et al., 2006) that really underline the need for balanced experimentation across a 
range o f models. 
The work by Schwartz et al., 2005 using the Ntera2 cell line epitomised this, as PA6 
driven differentiation occurred over a similar period to a comparable level and 
showed a sequence o f marker expression resembling that in human embryonic stem 
cells (Zeng et al., 2004). However subtle variations were seen, for example the 
embryonal carcinoma cells developed as packed colonies upon seeding and remained 
as such during differentiation on a monolayer o f confluent PA6 cells (Schwartz et al., 
2005). Human embryonic stem cells in comparison normally migrate out o f the 
colonies as differentiation proceeds (Zeng et al., 2004). In addition fewer tyrosine 
hydroxylase positive processes were seen after three weeks of Ntera2-PA6 co-culture 
(Schwartz et al., 2005) further highlighting the minor but noticeable disparity between 
the two systems. 
The investigations in the Ntera2 embryonal carcinoma cell system though provided 
some interesting findings. First o f all to reduce the stress on the cells in culture when 
differentiating, mitomycin C treated mitotically inactivated PA6 cells were used. 
These treated cells could produce dopaminergic differentiation in a manner analogous 
to their untreated counterparts. It was also possible to achieve dopaminergic neuron 
generation using media conditioned by PA6 cells exposed to mitomycin C, however 
more tyrosine hydroxylase positive cells were formed using standard co-culture than 
with conditioned medium (Schwartz et al., 2005). The observed effects with 
conditioned medium are though in contrast to the findings using murine embryonic 
stem cells where conditioned medium did not markedly induce tyrosine hydroxylase 
expression (Kawasaki et al., 2000). 
This could be due to poor protein solubility (Kawasaki et al., 2002) or Ntera2 cells 
possessing a greater sensitivity to insoluble glyco or lipoglycoproteins for example 
Wnts, it may also reflect a species specific divergence in terms o f responsiveness to 
stromal derived inducing activity as Schwartz et al in an unpublished observation. 
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2005 found a comparable result using human embryonic stem cells. It does however 
add support to the notion that secreted factors are a part o f the dopaminergic 
differentiation enhancing ability o f the stromal derived inducing activity o f PA6 cells 
(Schwartz et al., 2005). 
In a recent paper utilising human embryonic stem cells there was the suggestion that it 
is the secreted factors provided by the PA6 cells that are required to define a specific 
dopaminergic cell fate. In this work they found that fixed PA6 cells although in 
possession of a cell surface neural differentiation capacity lacked the ability to induce 
a significant number o f tyrosine hydroxylase positive cells. This was recognised by a 
three fold decrease in tyrosine hydroxylase expression relative to co-culture with 
untreated PA6 cells. Irradiation and mitomycin C treatment also had strong effects in 
a congruous manner. However mitomycin C exposure had only a minor and fixation 
an extremely minimal effect on the neural inducing activity, assessed by P-III-tubulin 
expression. Irradiation though decreased it by 50%, thus indicating that the neural 
inducing ability was linked to the cell surface. Conditioned medium alone was 
ineffective as for mouse embryonic stem cells (Kawasaki et al., 2000) but in contrast 
to human embryonal carcinoma stem cells (Schwartz et al., 2005) in generating 
positive tyrosine hydroxylase expression. However when combined wi th heparin 
and/or fixed PA6 cells differenfiation o f tyrosine hydroxylase positive cells could be 
achieved, the extent o f this though was still not as great as for untreated PA6 co-
culture. In addition conditioned medium was also able to elicit two other effects, 
firstly it promoted the survival o f human embryonic stem cells and secondly it was 
able to preserve Oct3/4 expression (Vazin et al., 2008). Other evidence has 
previously suggested that sustained Oct3/4 expression could be implicated in early 
neuronal differentiation (Shimozaki et al., 2003; Burgess et al., 2002). Together these 
findings reinforce the concept that the stromal derived inducing activity may be a 
compilation o f multiple factors (Figure 1.5) that can exert an assortment o f effects that 
may elicit varied responses in different experimental systems. 
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Figure 1.5: A summary of the elements of the stromal derived inducing activity 
Soluble 
secreted 
factor 
Wnt 5a or other 
Wnt family 
members (?) 
Specifc 
dopaminergic 
inducing 
activity 
Cell 
surface 
activity 
Stromal Derived 
Inducing Activity 
Neural 
differentiation 
capacity 
Secreted factor 
that interacts 
with cell 
surface 
Fibroblast growth 
factor 8 (7) or an 
associated family 
member 
Temporal 
aspect 
Figure 1.5: The different aspects of the stromal derived inducing activity that may have an effect on its 
neural or dopaminergic differentiation ability are shown in blue. Possible candidates that may comprise 
part of the SDIA are shown in red. It may be that factors such as Wnts or Fibroblast growth factor family 
members are involved in more than one of the aspects outlined in blue, for example Wnt 5a could 
potentially be a soluble factor, interact with the cell surface and have a specific effect on promoting the 
acquisition of a dopaminergic phenotype. 
In fact the stromal derived inducing activity may have a temporal component to its 
action. It appears that the stromal derived inducing activity can instruct a 
dopaminergic fate in embryonic stem cell derived neural progenitors before or at the 
point o f expression o f Soxl . However it does not seem to exert an effect during the 
latter stages o f neuronal differentiation (Parmar & L i , 2007). This is comparable to 
the situation where early Fibroblast growth factor 8 application prior to Soxl 
expression is critical to the specification o f a midbrain dopaminergic neuronal fate 
(Yan et al., 2005). Members o f the Fibroblast growth factor family may be secreted 
then subsequently interact wi th the cell surface (Bemfield et al., 1999; lozzo et al., 
1998). This being one o f the possible mechanisms o f the stromal derived inducing 
activity identified by Kawasaki et al., 2000, who like Parmar & L i , 2007 carried out 
their work on murine embryonic stem cells. Therefore there is a strong suggestion 
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that Fibroblast growth factor 8 or an associated molecule could be a part o f the 
instructive activity o f the stromal derived inducing activity when using this embryonic 
stem cell system. However one would speculate that i f Fibroblast growth factor 8 or a 
relation o f it is involved, then it w i l l most probably be acting in concert with at least 
one other factor, as when applied alone its effect was significantly less than when 
added in conjunction with Sonic hedgehog at stage four in the protocol o f Lee et al., 
2000. 
Regardless o f the molecular nature o f the PA6 stromal derived inducing activity, any 
dopaminergic type cells derived using this approach must be able to show functional 
properties i f they are ever to be able to be utilised in any relevant application. To this 
end the neuronal derivatives o f mouse embryonic stem cells co-cultured with PA6 
cells showed secretion o f dopamine, assessed by high performance liquid 
chromatography and could upon transplantation maintain a tyrosine hydroxylase 
positive phenotype as well as integrate into the mouse striatum. There was around a 
22% survival rate o f such tyrosine hydroxylase positive cells in this 6-
hydroxydopamine model after two weeks. In a similar 6-hydroxydopamine model the 
transplantation o f neural precursors derived from a range of mouse and somatic cell 
nuclear transfer derived embryonic stem cells cultured on primary stromal cells or 
stromal cell lines, was able to show reasonable numbers o f tyrosine hydroxylase 
positive cells surviving eight weeks after transplantation. In this model administration 
of 6-hydroxydopamine into the striatum causes a selective loss o f dopaminergic 
neurons in the midbrain and a resulting deinnervation o f the striatum. Apomorphine 
or amphetamine is then given to cause motor disturbances that lead to fu l l body 
rotations depending on the drug used. Any measure that involves replacement o f 
dopamine w i l l give a recognisable decrease in the rotational behaviour. Within eight 
weeks o f transplantation more than 70% of animals showed significantly diminished 
apomorphine or amphetamine induced rotational asymmetry (Barberi et al., 2003, 
reviewed in Taylor & Minger, 2005). 
Like their murine counterparts primate embryonic stem cells showed dopamine 
release fol lowing potassium ion induced depolarisation. Again in a 6-
hydroxydopamine mouse model two weeks post implantation there were some 
(approximately 8%)) surviving tyrosine hydroxylase positive neurons (Kawasaki et al.. 
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2002). The PA6 method has also been utilised to create progenitors with the capacity 
to differentiate into dopaminergic neurons. l-methyl-4-phenyl-l,2,3,6-
tetrahydropyridine (MPTP) lesioned primates acting as a Parkinsonian model, upon 
receipt o f transplants o f these populations o f cells, showed significantly reduced 
lesion related neurological defects and augmented fluorodopa uptake assessed by 
positron emission tomography relative to controls (Takagi et al., 2005). The 
percentage o f dopaminergic cells surviving fourteen weeks post transplantation was 
also significantly increased over the levels observed using grafts o f tissue from the 
post mitotic foetal midbrain (Taylor & Minger, 2005). 
Finally when using human embryonic stem cell derived neurons for transplantation in 
a 6-hydroxydopamine model only small numbers (approximately 8 - 9%) o f tyrosine 
hydroxylase positive cells survived five weeks post implantation (Zeng et al., 2004). 
Similarly HSF-6 derived cells although able to show funcfional signs and molecular 
markers o f a dopaminergic phenotype, survived poorly upon transplantation; with few 
tyrosine hydroxylase positive cells remaining six weeks post implantation (Park et al., 
2005; reviewed in Taylor & Minger). Therefore there are still clearly a large number 
of obstacles to overcome before cell transplantation can ever be effectively and safely 
used. However there have been attempts to address some of the issues. 
Dopaminergic neurons are particularly sensitive to enzymatic treatment and physical 
dissociation procedures. This means that loss of some of the cells o f interest is likely 
in any protocol based on their derivation from a stem or progenitor cell population 
growTi in standard adherent conditions, as the cells prior to transplantation have to be 
removed by some method from the culture surface used. By growing mouse 
embryonic stem cells in hollow fibres using PA6 conditioned medium for sixteen days 
Yamazoe & Iwata, 2006, were able to generate P-III-tubulin and tyrosine hydroxylase 
positive cells that could release dopamine upon depolarisation with potassium ions. 
This method allowed the formation o f dopaminergic neurons without loss o f cells as 
the fibres act to protect the neurons from mechanical pressures. Such fibres may also 
serve an additional role in protecting cells from the host immune system i f they were 
to be transplanted (Yamazoe & Iwata, 2006). Such strategies offer a starting point for 
improvements in cell transplantation procedures. 
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Ultimately though for cell transplantation therapy and ideally for screening based 
assays it is both essential and desirable to remove the need for co-culture by 
elucidating the molecular nature o f the stromal derived inducing activity of PA6 cells. 
This would eliminate possible transfer o f murine pathogens which at present makes 
PA6 based approaches unviable in a clinical setting. To this end a comparison o f PA6 
and meningeal cells was made. Meningeal cells are able to induce dopaminergic 
differentiation in mouse and human embryonic stem cells, the derivatives express 
markers o f a dopaminergic phenotype and potassium ion evoked dopamine release. 
Interestingly the developmental stage o f the meningeal cells affects their 
dopaminergic neuron inducing activity wi th E l 8 cells displaying the greatest effect on 
the acquisition o f a dopaminergic phenotype in comparison to their E14 and P4 
counterparts. When expression o f six soluble factors implicated in the differentiation 
of dopaminergic neurons (Fibroblast growth factor 8, Sonic hedgehog, W n t l , Wnt3a, 
Wnt5a and transforming growth factor-p3) was assessed only Wnt5a and 
transforming growth factor-pS mRNA were found to be expressed. Real time RT-
PCR showed that transforming growth factor-P3 expression increased with 
developmental stage and was greater in meningeal than PA6 cells; whilst E l8 
meningeal cells, which possessed the greatest inducing activity shared a similar level 
of Wnt5a expression to their PA6 counterparts, where as the less potent E l 4 and P4 
stage meningeal cells expressed lower levels of this particular component. 
The effects o f Wnt5a as a soluble aspect of the stromal derived inducing activity were 
investigated further. PA6 conditioned medium could induce dopaminergic 
differentiation o f mouse embryonic stem cells grown on matrigel relative to a control 
differentiation medium. I f a Wnt5a neutralising antibody was added to the 
conditioned medium the levels o f dopaminergic induction were decreased to control 
levels. However addition o f recombinant Wnt5a to the differentiation medium could 
elicit an increase in the percentage of cells acquiring a dopaminergic phenotype. 
Therefore it appears that Wnt5a is an important part o f the mechanism of the stromal 
derived inducing activity (Hayashi et al., 2008). 
These findings are also consistent with other work that demonstrates that ventral 
midbrain glia express region specific transcription factors such as Engrailed 1 and 
Otx2 as well as secreting Wnt5a. In turn they are able to amplify the differentiation 
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of both mesencephalic and cortical Nur r l positive precursors into tyrosine 
hydroxylase positive cells. Again using a Wnt5a neutralising antibody it was shown 
that at least part o f the effect o f ventral midbrain glia on Nur r l positive precursors 
was attributable to the effects o f Wnt5a (Castelo-Branco et al., 2006). Likewise 
earlier work had indicated that Wnt5a had a specific instructive role in driving Nurr l 
positive precursors towards the acquisition of a dopaminergic phenotype (Castelo-
Branco et al., 2003). When using human embryonic stem cells as described earlier it 
was observed that the specific dopaminergic inducing activity appeared to lie in the 
soluble factors produced by PA6 cells. When heparin was used to try and increase the 
activity o f any secreted factors using conditioned medium there was a noticeable 
effect on dopaminergic differentiation (Vazin et al., 2008). Similarly in the study o f 
Hayashi et al., 2008, condifioned medium was collected fol lowing incubation o f PA6 
cells for twenty four hours in a differentiation medium containing heparin. In this 
work Wnt5a was highlighted as one possible heparin binding soluble factor capable o f 
causing dopaminergic differentiafion (Hayashi et al., 2008). By analogy one might 
suspect that Wnt5a exerts a similar effect in human as well as mouse embryonic stem 
cells. Perhaps when considering possible constituents o f the stromal derived inducing 
activity it may be worth examining dopaminergic inducing elements that share a high 
degree o f conservation between species, as the stromal derived inducing activity can 
have an effect in murine, primate and human cell systems, despite there being 
evidence that there are species specific differences. Therefore it is logical that at least 
some o f the aspects o f the stromal derived inducing activity might be highly 
conserved. In addition the PA6 mediated stromal derived inducing activity i f multi 
factorial as it appears to be opens up the question o f whether a cell can be engineered 
to express in a spatially and temporally controlled manner, neurotrophic factors 
following implantation that could sfimulate endogenous repair in a disease model. 
Beyond the methods considered thus far, dopaminergic differentiation has also been 
achieved f rom primate embryonic stem cells in co-culture with Sertoli cells. This 
protocol showed temporal efficiency and produced cells expressing a range of 
dopaminergic markers that could release dopamine upon potassium ion 
depolarisation. After transplantation into a 6-hydroxydopamine model tyrosine 
hydroxylase positive neurons were observed to survive for at least two months. When 
a filter membrane was used significant neural differentiation facilitated by the Sertoli 
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cells was seen. This is indicative o f soluble factors being responsible for the 
inductive effect. Interestingly though Sertoli cell conditioned medium did not cause a 
significant level o f differentiation. This could be indicative o f two different 
components, one at the cell surface and one a labile soluble factor (Yue et al., 2006), 
this is analogous to the situation found with PA6 stromal derived inducing activity. 
However the neural inducing activity o f Sertoli cells could be highly attributable to 
glial cell line derived neurotrophic factor. Not only was it found in Sertoli cell 
conditioned medium but fol lowing a weak dose o f anti-glial cell line derived 
neurotrophic factor antibody, to act as a blocker o f its activity, neural differentiation 
was reduced. Glial cell line derived neurotrophic factor may therefore act to assist or 
augment the efficiency o f other factors in promoting differentiation (Yue et al., 2006). 
This is reflected in its usage in a number o f protocols aimed at optimising the 
synergistic interactions between different known inducers o f a dopaminergic 
phenotype. It is also worthy o f note that a rapid differentiation o f the human 
embryonal carcinoma cell line Ntera2.Dl can be achieved by growing tissue 
constructs o f Sertoli cells in conjunction with Ntera2 in a rotating wall bioreactor 
(Saporta et al., 2004). This is again analogous to the PA6 method in that the inductive 
factors may be highly conserved so as to be able to exert an effect on cell lines from 
different species. It also shows that retinoic acid is not necessarily an essential 
requirement when working with embryonal carcinoma stem cells, as was also the case 
in the work o f Ravindran & Rao, 2006. 
The role of Wnts in dopaminergic neurogenesis 
This family o f lipoglycoproteins consists o f nineteen members, some of which have 
been shown to have effects on the development o f dopaminergic neurons (for review 
see Arenas, 2005) and as such they are an area o f great interest in the context o f this 
thesis. Wnt5a as has been discussed may form part o f the stromal derived inducing 
activity o f PA6 cells and is secreted by ventral midbrain glia. However other Wnt 
family members may also play critical roles in the specification of a dopaminergic 
cell fate. In mice W n t l causes an increase in the expression o f Otx2 which acts as a 
repressor o f Nkx2-2, down regulating its activity. This then limits the acquisition of 
alternative neuronal fates and as such creates a permissive environment for other 
dopaminergic inducing agents such as Fibroblast growth factor 8 and Sonic hedgehog 
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to act (Prakash et al., 2006, reviewed in Burbach & Smidt, 2006). Wnt l has also been 
shown to increase the number o f Tuj 1 positive cells in rat ventral midbrain precursor 
cultures (Castelo-Branco et al., 2003). Such an effect would be highly desirable to 
reproduce in other systems where mixed cell populations could be increasingly driven 
towards a neuronal fate to enrich them prior to their guidance towards a specific 
neurotransmitter phenotype. The same molecule is also capable o f increasing the 
number o f Nur r l positive precursors in the rat E14.5 ventral midbrain cellular model. 
In addition it can have an effect on the differentiation o f precursors into more mature 
dopaminergic neurons. This implies that it possesses a dual role controlling both the 
proliferation and differentiation o f dopaminergic precursor cells (Castelo-Branco et 
al., 2003). 
Another family member Wnt3a actually caused the number o f dopaminergic neurons 
to decrease but increased the proliferation and helped to maintain the Nur r l positive 
precursor pool. This was in contrast to Wnt5a which had little effect on the 
proliferation o f the N u r r l positive precursors but drove the differentiation o f them 
towards a dopaminergic phenotype (Figure 1.6). Interestingly Wnt5a promoted the 
levels o f the glial cell line derived neurotrophic factor receptor cRET mRNA in these 
cultures and maintained the expression o f the m R N A for two glial cell line derived 
neurotrophic factor co receptors neural cell adhesion molecule and glial cell line 
derived neurotrophic factor family receptor a l (Castelo-Branco et al., 2003). Glial 
cell line derived neurotrophic factor is involved in the post natal stages o f 
development o f dopaminergic neurons (Granholm et al., 2000). This is indicative 
therefore that as is the case in vivo it may be possible to carefully control the 
acquisition and maintenance o f a dopaminergic phenotype in vitro i f the correct 
combination o f molecules can be utilised in concert or at least more optimally than 
has been achieved at present. 
The assessment o f patterns o f receptor expression may help provide a better 
understanding o f how and when molecules known to influence dopaminergic 
differentiation act. In turn this may aid the design o f new or adapted experimental 
protocols to achieve enriched populations o f dopaminergic neurons in vitro. This is in 
principle neatly demonstrated in work using human embryonic stem cells 
differentiated towards a dopaminergic fate using co-culture with astrocytes or PA6 
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cells. First o f all it was shown that co-culture o f astrocytes f rom the embryonic 
striatum resulted in the production of more tyrosine hydroxylase positive cells in 
comparison to co-culture wi th astrocytes f rom the embryonic mesencephalon, 
indicating that there are region specific differences between cell types, at least in 
relation to their dopaminergic inducing activity. Secondly though co-culture wi th 
PA6 cells that may possess Wnt5a as a part o f their stromal derived inducing activity 
(Hayashi et al., 2008) i f carried out in the presence o f glial cell line derived 
neurotrophic factor causes the number o f tyrosine hydroxylase positive cells obtained 
to double. It also increased the size and survival o f embryonic stem cell colonies 
containing the enhanced levels o f tyrosine hydroxylase positive cells (Buytaert-
Hoefen et al., 2004). Thus i f Wnt5a is part o f the stromal derived inducing activity i t 
is possible in theory that it may be up regulating glial cell line derived neurotrophic 
factor receptor expression, and as such i f the cells are primed to receive glial cell line 
derived neurotrophic factor then this would provide a plausible reason for the 
increased dopaminergic differentiation. 
Figure 1.6: The roles of Wnt family members in specifying a dopaminergic fate 
(redrawn from Castelo-Branco et al, 2003) 
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precursor 
Wnt 3a 
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Figure 1.6: Specific Wnt proteins display different effects on the proliferation of Nurrl 
positive precursors and their differentiation towards a more mature tyrosine hydroxylase 
positive neuronal phenotype. The greater the size of the arrow head the stronger the 
observed effect (based on Castelo-Branco et al., 2003). 
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Recently it has also been shown that Wnts may help in cell replacement strategies. 
Over expression o f W n t l and WntSa in murine ventral midbrain cultures enhanced 
Nur r l expression, and in the case o f Wnt5a also increased the levels o f tyrosine 
hydroxylase. This is indicative o f W n t l up regulafing the number o f dopaminergic 
precursors but would suggest that Wnt5a plays a greater role in the specific 
differentiation of dopaminergic neurons, which is similar to the findings of Castelo-
Branco et al., 2003. The effect o f Wnt5a over expression is matched by exogenous 
application o f the molecule and can be blocked by an antibody to it. Inhibitor 
experiments showed the effects o f Wnt5a to be mediated by a non canonical 
signalling pathway, which is supported by other work in a dopaminergic cell line 
(Schulte et al., 2005; Parish et al., 2008). In addition to displaying markers o f and an 
electrophysiological profile akin to midbrain dopaminergic neurons, WntSa treated 
cells upon transplantation into a 6-hydroxydopamine mouse model resulted in a 
marked recovery. They also showed enhanced integration and differentiation and 
could therefore be a highly efficient source of dopaminergic neurons for use in cell 
based replacement strategies (Parish et al., 2008). 
Similarly posidve effects were seen when Wnt5a in conjunction with Fibroblast 
growth factor 2 and 20 were used in the final stage o f the in vitro dopaminergic 
differentiation o f a parthenogenetic non human primate embryonic stem cell line. The 
stem cell derived neurons when transplanted into a 6-hydroxydopamine model 
displayed improved survival and enhanced the degree o f motor recovery. In this and 
the work o f Parish et al., 2008 there was no detectable tumour formation which is o f 
great importance i f this is to be developed further for clinical use (Sanchez-Pernaute 
et al., 2008). 
Suspension and Lowered Oxygen Culture as mediators in the acquisition of a 
dopaminergic phenotype in vitro 
Both the use o f a physiological oxygen culture environment and growth o f cells in 
suspension have provided a means of producing or even enhancing the generation o f 
dopaminergic neurons in vitro. At the core o f many protocols using embryonic stem 
cells is embryoid body formation. This has been extended to the generation o f 
34 
homogenous structures referred to as spherical neural masses (Cho et al., 2008). 
These can subsequently be rapidly and efficiently differentiated into dopaminergic 
neurons using a protocol involving Fibroblast growth factor 8/Sonic hedgehog and 
ascorbic acid. In addition to this no feeder cells are required during the differentiation 
process and long term passaging is possible without the spherical neural masses losing 
their capacity for dopaminergic differentiation. When transplanted into a 6-
hydroxydopamine model behavioural recovery is apparent and no tumour formation is 
observed. No Oct 4 positive cells were detected suggesting the efficient 
differentiation protocol eliminates any residual undifferentiated embryonic stem cells, 
thus providing a solid foundation for future development (Cho et al., 2008). 
In an earlier study also using human embryonic stem cells dopaminergic 
differentiation was achieved in a serum free suspension culture system without 
addition o f any dopaminergic phenotype inducing agents. This would suggest that 
there was sufficient signalling within the cellular aggregates to drive the process o f 
differentiation. In addition bone morphogenetic protein 4 could be used to manipulate 
the system, demonstrating the potential for use of other exogenous factors to drive the 
system towards specific cellular fates (Schulz et al., 2004). 
This highlights the flexibility o f the suspension culture model. By mimicking the 3D 
environment in vivo, 3D cell growth in vitro not only allows for more cell-cell 
interactions but also creates a more complex microenvironment whereby diffusible 
factors may more readily access their targets; in turn creating a situation that may 
more closely resemble the scenario in vivo. The fact that the determination o f cell fate 
in this system though can still be orchestrated by the application o f exogenous 
compounds, adds to the potential benefits o f it. A case may be made that suspension 
cultures are due to the more complex intrinsic interactions o f which they may be 
capable subsequently more able to respond to external stimuli. However the opposite 
may also be true as gaining control o f an increasingly intricate system might not so 
easily be achieved. 
In the context o f dopaminergic differentiation suspension culture may not only be 
advantageous in that it provides an in vitro representation o f 3D cell growth but in 
doing so it creates a physical variable, oxygen pressure, known to have an effect on 
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the acquisition o f a dopaminergic phenotype. When cells are grown as aggregates 
they are likely to be subjected to different ambient conditions depending on their local 
position. Cells at the edge o f a sphere are likely to receive a greater oxygen pressure 
than those in the centre (Figure 1.7), (Gassmann et al., 1996). It is therefore possible 
that at least in part suspension culture favours production o f neural cell types as 
oxygen pressures in the brain are typically lower (Silver & Erecinska, 1998) than 
those used in standard in vitro culture, and this situation may be to some degree 
recapitulated in the centre o f a cellular aggregate. 
Figure 1.7: The variation in oxygen pressure within a spherical cellular 
aggregate (based on Gassmann et al, 1996) 
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Figure 1.7: Oxygen tension is greatest at the periphery and decreases towards the 
centre of a spherical cellular aggregate (based on Gassmann et al., 1996) 
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There has indeed been evidence that may be indicative o f this in E12 rat ventral 
midbrain cultures. In this work a mix of growth factors and a fusion protein TAT-
Pax6 were used to promote dopaminergic differentiation of either intact neurospheres 
or dissociated neurosphere derived cells. Intact neurospheres treated with a 
combination o f growth factors and TAT-Pax6 yielded a significantly higher 
percentage o f tyrosine hydroxylase positive neurons than their dissociated 
neurosphere derived cell counterparts. Interestingly the tyrosine hydroxylase positive 
neurons were concentrated in the central region of the neurospheres with long axonal 
tyrosine hydroxylase positive projections protruding away from them. In contrast 
more limited axonal projections and a random distribution o f tyrosine hydroxylase 
positive neurons were observed in the dissociated cell cultures (Spitere et al., 2008). 
This suggests there to be some advantageous effects on dopaminergic differentiation 
that are attributable to the growth of cells in 3D and the seemingly favourable 
environment that this provides. It is possible that these effects may be at least in part 
due to oxygen pressure as the centre o f a sphere where dopaminergic differentiation 
was most pronounced in the work o f Spitere et al., 2008 is also the region that would 
be predicted to receive the lowest partial pressure o f oxygen. Other earlier work 
carried out in an essentially comparable rat E l 2 mesencephalic precursor model 
demonstrated a substantially increased capacity for dopaminergic differentiation in 
3±2% oxygen in comparison to standard 20% oxygen culture. Thus although there 
may be an array o f other factors involved the notion that 3D growth supports 
dopaminergic differentiation through a mechanism involving oxygen pressure is 
feasible, at least in the rat E l 2 midbrain precursor cell model. 
In fact lowered oxygen has a number o f favourable effects in the rat E l 2 
mesencephalic cell system. These include increased proliferation o f progenitors and a 
reduction in apoptosis, both o f which lead to an increase in total cell number. There 
was also an increase in the percentage o f cells specifically acquiring a dopaminergic 
phenotype (56% in 3±2% oxygen versus 18% in 20% oxygen). The combined effect 
o f all these factors being a highly desirable nine fold increase in the yield of 
dopaminergic neurons produced. Progress towards a differentiated state was also 
hastened (Studer et al., 2000), which is in itself valuable in the context o f temporal 
efficiency, which may be a key requisite in the design o f any type of assay system. 
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It has also been shown that lowered (3%) oxygen can facilitate long term human 
mesencephalic precursor cell proliferation giving rise to a larger yield o f cells that can 
be subsequently differentiated (Storch et al., 2001). Similarly murine mesencephalic 
neurospheres were viable and able to proliferate in 3% oxygen for a number o f weeks. 
Contrastingly a 2 1 % oxygen culture environment was prohibitive to long term 
expansion. It appears f rom microarray data that a range o f genes implicated in cell 
maturation, the cell cycle and apoptosis are regulated in a differential manner in 
precursors exposed to 3 as against 2 1 % oxygen over a one to two month period 
(Milosevic et al., 2005). Differential gene expression was also seen in lowered 
oxygen cultures in the work o f Studer et al., 2000. In particular there was an up 
regulation o f the erythropoietin transcript in 3±2% oxygen, as well as that o f 
Fibroblast growth factor 8. When recombinant Fibroblast growth factor 8b and 
erythropoietin were applied to the system under 20% oxygen it was found that 
Fibroblast growth factor 8b increased proliferation in the precursors and that 
erythropoietin caused a notable dose dependent increase in the number o f tyrosine 
hydroxylase positive cells. A blocking antibody to erythropoietin markedly reduced 
the dopaminergic neuron yield in both oxygen environments suggesting that 
application o f erythropoietin can mimic the effects o f lowered oxygen on the 
production o f dopaminergic neurons (Studer et al., 2000) 
The higher oxygen tensions in standard culture conditions are likely to cause the 
production o f reactive oxygen species which may be damaging to sensitive midbrain 
cell types. Thus it is unsurprising that the survival o f embryonic rat mesencephalic 
neurons is enhanced when they are protected f rom oxidative stress. Survival of 
tyrosine hydroxylase positive neurons was increased approximately twofold in 5% 
oxygen culture conditions. In addition in the presence of three different antioxidants 
there was also a favourable effect in terms of the number o f tyrosine hydroxylase 
positive cells. The combination o f 5% oxygen culture and one o f the three 
antioxidants N-acetyl cysteine promoted tyrosine hydroxylase positive cell numbers 
further giving a four fo ld increase (Colton et al., 1995). Therefore it would appear 
that when dealing wi th mesencephalic cultures, the use o f lowered oxygen is likely to 
assist in the production o f dopaminergic neurons via a range o f possible mechanisms. 
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The employment o f lowered oxygen has also recently been applied to mouse 
embryonic stem cell derived neural precursors in a bid to elicit dopaminergic 
differentiation. In this work 3.5% oxygen culture resulted in a 1.34 fold increase in 
tyrosine hydroxylase positive cells; there was an increase in the number o f colonies 
positive for tyrosine hydroxylase expression; however colony size was reduced in 
comparison to 20% oxygen. In addition expression o f tyrosine hydroxylase mRNA 
was up regulated 1.68 fold in lowered oxygen conditions ( K i m et al., 2008). 
Therefore it would appear that the use o f more physiologically matched oxygen 
culture environments may be o f use in other cell systems, which may in turn justify a 
more widespread usage o f the technology. 
Engineering a Dopaminergic Phenotype in vitro 
There are many factors involved in the specification of a dopaminergic fate (Figure 
1.8), some o f which have been successfully utilised to engineer a dopaminergic 
phenotype in vitro. The transcription factor N u r r l a member o f the orphan nuclear 
receptor family exemplifies this and has been employed in conjunction with a number 
of other methods to elicit doparriinergic differentiation. Firstly using the protocol o f 
Lee et al., 2000 involving Sonic hedgehog/Fibroblast growth factor 8 and ascorbic 
acid, it was possible to increase the production of tyrosine hydroxylase positive 
neurons via over expression o f N u r r l . This was also reflected by a greater ability to 
produce and release dopamine in Nur r l transduced cells (Chung et al., 2002). A 
similar study again in mouse embryonic stem cells demonstrated a consistent 
enhancement in dopamine release in stage five cultures o f Nur r l transfected 
embryonic stem cells relative to their wi ld type counterparts. In this study the 
percentage o f tyrosine hydroxylase positive neurons was increased from 5 to 50%) by 
over expression o f N u r r l alone and this effect was augmented in the presence of 
Sonic hedgehog and Fibroblast growth factor 8 (Kim et al., 2002). Such positive 
synergistic effects were built upon in subsequent work involving PA6 co-culture of 
murine embryonic stem cells in tandem with Nur r l over expression. This procedure 
led to an approximately twofold rise in the number o f neurons in relation to wi ld type 
controls, as well as increasing the proportion o f these neurons that were tyrosine 
hydroxylase positive to more than 50%. When Sonic hedgehog/Fibroblast growth 
factor 8 and ascorbic acid were added to further facilitate this differentiation around 
39 
90% o f T u j l positive neurons were found to be tyrosine hydroxylase positive, 
indicating not only that PA6 stromal derived inducing activity and Nur r l can act 
synergistically but that the addition o f other dopaminergic inducing agents can 
supplement this effect ( K i m et al., 2006a). 
Investigations in a mouse neural stem cell model using N u r r l over expression were 
also able to show that Fibroblast growth factor 8 and Sonic hedgehog could act in 
concert with Nur r l to yield a large number of cells displaying positive 
immunoreactivity for tyrosine hydroxylase. In the same study human foetal 
astrocytes could elicit a smaller but significant effect which could be slightly 
amplified by addition o f forskolin and retinoic acid. These two molecules alone 
though could not exert any tangible effects in this system. The observations with 
Sonic hedgehog and Fibroblast growth factor 8 intimate that Nur r l may not act down 
stream of these molecules, but rather it may operate independently o f or in synergy 
with them to stipulate a dopaminergic phenotype ( K i m et al., 2003). 
The use o f N u r r l over expression has in addition been coupled to that o f other known 
determinants o f a mesencephalic dopaminergic cell fate. The use o f retroviral gene 
delivery to express neurogenin 2 in foetal mouse ventral midbrain progenitors caused 
increased neuronal differentiation, but did not in itself boost formation of 
dopaminergic neurons. Generation of cells expressing tyrosine hydroxylase but with 
an immature morphology and a lack of dopaminergic marker co-marker expression 
was mediated by expression o f Nur r l alone; however when combined, neurogenin 2 
and N u r r l over expression produce mature tyrosine hydroxylase positive neurons that 
express a range o f other markers (Andersson et al., 2007). These two factors have 
also been investigated in rat as well as mouse neural precursors. In rat cultures Nur r l 
over expression could efficiently yield tyrosine hydroxylase positive cells. However 
in the murine system generation o f tyrosine hydroxylase positive cells was diminished 
and showed a large disparity dependent upon the embryonic age and brain regions 
from which the precursors were derived. The variability between the two systems 
was sustained upon co-expression with neurogenin 2. In rat cultures the production of 
tyrosine hydroxylase positive cells induced by Nur r l was curbed in the presence of 
neurogenin 2. The opposite was true in murine cultures where the dual action 
enhanced the output o f dopaminergic cells (Park et al., 2008), which is similar to the 
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findings of Andersson et al., 2007; the critical aspect of the work o f Park et al., 2008, 
being to identify clear species specific differences in the development o f midbrain 
dopaminergic neurons. This again highlights the necessity o f a range o f experimental 
systems to provide a broad and balanced overview of the process of dopaminergic 
differenfiation in different models. 
On this theme Nur r l over expression has also been utilised to induce a dopaminergic 
phenotype in rodent adult neural precursor cells from the subventricular zone and 
white matter. The use o f adult cells carries not only ethical advantages but practical 
ones such as a lack o f problems with tumour formation. The diff icul ty though lies in 
having the ability to instruct such cells towards specific neurotransmitter phenotypes. 
Therefore N u r r l over expression in this instance is to be favoured, especially given 
that it can be combined with co-expression o f Mashl as well as brain derived 
neurotrophic factor and neurotrophin 3 treatment to increase the yield o f 
dopaminergic neurons which display functional properties. Although to a limited 
extent Nur r l and Nur r l plus Mashl engineered subventricular zone adult neural 
precursor cells were also able to help reverse the behavioural deficit in a Parkinsonian 
rat model having shown an ability to survive, integrate and differentiate into tyrosine 
hydroxylase positive neurons in vivo. This study gives support to the notion that 
autologous cell transplantation may in the future be possible (Shim et al., 2007). 
Furthermore in both murine and human embryonic stem cell models Nur r l has been 
shown to cooperate wi th Pitx3, a homeodomain transcription factor, in promoting the 
terminal maturation o f such cultures to a midbrain dopaminergic phenotype (Martinat 
et al., 2006). Moreover these components were investigated in work using neural 
stem cells f rom rat, where neither N u r r l nor Pitx3 expression alone was capable of 
initiating the production of dopaminergic neurons, indicating that they are both 
necessary but not sufficient to cause dopaminergic differentiation in this model. 
When cultured in the presence o f E l 1 ventral midbrain explants, Pitx3 but not N u r r l 
transduced neurospheres displayed a clear increase in the number o f dopaminergic 
neurons present. O f these neurons in the explant cultures over half were attributable 
to the Pitx3 expressing neurospheres (O'Keeffe et al., 2008). This is one case where 
Nurr l seems to exhibit little effect, in contrast to what has been found elsewhere, 
although it reinforces the usage o f Pitx3 to achieve acquisition o f a dopaminergic 
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phenotype. A Pitx3-eGFP knock in mouse embryonic stem cell line united with 
fluorescence activated cell sorting has also been successfully used to purify out an 
enriched population o f dopaminergic neurons f rom a mixed population o f the in vitro 
differentiated embryonic stem cells. This type o f selection holds future promise in 
helping to produce refined populations o f cells for use in transplantation strategies 
(Hedlund et al., 2008). 
Figure 1.8: Factors and Signals involved in the specification of a dopaminergic fate (redrawn from Arenas, 2008) 
Specification 
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En1 Nkx 2-2 Wnt1 Lmx1a 
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Figure 1.8: Some of the myriad of factors that may play a role in defining a dopaminergic phenotype. This scheme is a reflection of 
the current understanding of the process and will most probably change with time as new developments continue to arise (redrawn 
from Arenas, 2008). 
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Another key determinant o f a dopaminergic phenotype L m x l a was successfully over 
expressed in mouse embryonic stem cells in an expression vector driven by a nestin 
enhancer that is active in neuronal progenitor cells. The undifferentiated mouse 
embryonic stem cells were differentiated into nestin positive neuroprogenitors by 
culturing them on gelatin coated culture ware in the presence of Fibroblast growth 
factor 2, Fibroblast growth factor 8 and a 1.7mM dose o f Sonic hedgehog. The 
concomitant use o f this differentiation protocol and L m x l a over expression lead to a 
strong inducfion o f M s x l , an accompanying reducfion in Nkx 6-1 and the production 
o f a substantial number o f T u j l positive neurons that also expressed tyrosine 
hydroxylase. More importantly these neurons co expressed a panel o f other markers 
that together give a signature unique to dopaminergic neurons. It was also o f interest 
that ventralisation by Sonic hedgehog was essential for L m x l a to induce the 
formation o f dopaminergic neurons, as mouse embryonic stem cells cultured in 
conditions where this signalling molecule was omitted expressed the dorsal marker 
Pax7 the expression o f which was absent in Sonic hedgehog treated samples, the 
result o f this absence being an induction in M s x l expression but not in tyrosine 
hydroxylase positive neurons (Andersson et al., 2006). In the same study L m x l b and 
M s x l were also over expressed. L m x l b transfection gave rise to only a small number 
of tyrosine hydroxylase posifive neurons, indicating that it is not as potent an inducer 
of them as Lmxla . M s x l in a comparable fashion to that observed m vivo was able to 
induce neurogenin2 but not dopaminergic neurons when used alone, but when co-
transfected with L m x l a was capable o f causing a noficeable induction in tyrosine 
hydroxylase positive neurons after only 6 days o f culture, suggesting it may possess a 
temporal effect on the dopaminergic differentiation process (Andersson et al., 2006). 
When L m x l a had its expression reduced by siRNA in human embryonic stem cell 
derived neural precursors, there was a congruous decline in the expression o f a range 
of other dopaminergic markers, suggesting that this particular transcription factor is 
essential for the acquisition o f a mature dopaminergic phenotype in human embryonic 
stem cell derived neural precursors (Cai et al., 2008). This evidence is not only 
consistent with that detailed previously in defining L m x l a as an important 
determinant o f a dopaminergic fate but also indicates that it plays a role in both 
murine and human systems, although its activity may be slightly different between 
species. In the work o f Cai et al., 2008 the lack o f efficient methods for the 
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transfection o f L m x l a expression vectors into human embryonic stem cell colonies 
leads to a situation whereby it is still at present unclear i f L m x l a is able to induce a 
dopaminergic phenotype in human embryonic stem cell derived neural precursors. 
Therefore in the same study monolayers o f a human neuroblastoma cell line and 
primary human neural precursor cells were used to investigate the effects of L m x l a 
over expression. In contrast to the findings in mouse embryonic stem cells 
(Andersson et al., 2006), transfected cells did not display an induction in 
dopaminergic marker expression. This may be due to the human neuroblastoma cell 
line used being derived from post natal tissue and the primary cultures from 
midgestational foetal brain. Given the importance o f using/applying dopaminergic 
inducing agents at the optimal temporal window, usually early in development it is 
possible the cell types used were too far progressed in their development to be 
responsive to the effects o f L m x l a over expression. Alternatively it may be there is a 
species specific difference with other inductive partners being required for L m x l a to 
exert an effect in the human system (Cai et al., 2008). 
In other work using retroviral mediated transgene delivery, the over expression of 
L m x l a and M s x l was investigated in the human embryonic derived progenitor cell 
line NGC-407. L m x l a , but not M s x l , was able to cause a threefold increase in the 
yield o f tyrosine hydroxylase immunopositive cells, although this rise represented 3% 
as opposed to 1% o f the population, in essence meaning the quantity o f such cells was 
too minimal to be o f value in the context o f any potential applied usage. These two 
factors along with Pitx3 and neurogenin2 were also over expressed in neurospheres 
obtained f rom El4.5 rat ventral mesencephalic progenitor cells. Neurogenin2 in 
accordance with it possessing a proneural function exhibited a strong effect on 
neuronal induction. Pitx3 was able to reduce expression o f Sox2 and nestin, markers 
of more immature neural cells, but displayed no clear effect on neuronal or glial 
differentiation. O f further interest were the observations that L m x l a caused very few 
cells to form neurons and over expression o f Msx l resulted in increased 
oligodendrocytic rather than neuronal differentiation. In addition over expression of 
any o f these four factors either alone or in concert with each other had no effect on the 
ability o f the rat neural stem cells to acquire a dopaminergic phenotype (Roybon et 
al., 2008). This work along with that described previously again reinforces the 
concept o f the need for awareness o f species specific differences, the methods of over 
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expression used and the developmental stage o f the cell type chosen for 
experimentation. It also highlights that certain factors are more optimal in some 
model systems than others, even so such work is important in helping to highlight 
idiosyncrasies, such as L m x l a over expression having effects on cell proliferation that 
are not easy to predict (Roybon et al., 2008). In turn this may temper the usage of 
comparable approaches in other cell types where this factor exerts a greater effect, i f 
for example the aim was to produce neurons for transplantation, as such cells may 
have a propensity for tumour formation based on the findings o f Roybon et al., 2008. 
That is not to say though in other models this would be the case but given the 
potentially large number o f unknown variables, it is perhaps still advantageous to try 
and gain as broad an understanding as possible across the entire range o f available 
experimental systems. 
One other possible component o f the pathway(s) specifying a dopaminergic fate that 
has successfully been over expressed to help engineer such a phenotype in vitro is 
Foxa2. An expression plasmid containing it was transferred into cultured murine 
E10.5 mesencephalic explants, resulting in a 4 fold increase in the ratio o f tyrosine 
hydroxylase positive cells. In a similar manner a mouse embryonic stem cell line that 
had been designed to inducibly express a Foxa2 transgene was able to show a 7 fold 
enhancement in the production of tyrosine hydroxylase positive cells (Kittappa et al., 
2007). 
In an alternative spin on the over expression strategy method, human neural 
progenitor cells were produced that could release either glial cell line derived 
neurotrophic factor or insulin like growth factor 1 which may both have 
neuroprotective effects. These cells were then implanted into a rat 6-
hydroxydopamine Parkinsonian model. The cells secreting these two factors upon 
transplantation were shown relative to human neural precursor or sham controls to 
help diminish the loss of dopaminergic neurons (Ebert et al., 2008). This approach 
gives support to the concept that when transplanting cells that possess properties of 
dopaminergic neurons to try and directly combat the loss o f them in models of 
Parkinson's disease, you could also transfer some supporting cells that express neuro 
protective or neurotrophic factors. It may even be possible to engineer dopaminergic 
type cells to f u l f i l this role, eradicating the need for a secondary cell population. In 
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turn such approaches may offer synergy with the capacity for endogenous repair 
within the brain. 
Overall therefore efforts to engineer a dopaminergic phenotype in vitro or even to 
support or protect one in vivo hold some potential. It may be seen as undesirable to 
transplant cells that are genetically engineered, but this is debateable and does not 
restrict the value o f such approaches in broadening our understanding o f the 
mechanisms of dopaminergic differentiation in a variety o f cellular models. 
Alternative means to achieve or augment dopaminergic differentiation 
Although for the purposes o f this work the procedures used to attempt to achieve a 
dopaminergic phenotype in vitro have been classified into distinct sections, the 
complexity o f the process o f dopaminergic differentiation and the myriad o f factors 
involved, mean the vast majority o f such methods fall into more than one category. 
There are also some studies that do not discretely fit into any such banding and these 
are to be focussed upon here. 
First of all ascorbic acid can restore the dopaminergic differentiation efficiency of 
mesencephalic precursors that is lost when such cells are proliferated or passaged over 
an extended duration in vitro. It also gives rise to a more than 10 fold increase in 
tyrosine hydroxylase positive cells relative to untreated controls (Yan et al,, 2001). 
As such the use o f this molecule is often associated with other protocols for example 
that o f Cho et al., 2008 who used it alongside Sonic hedgehog and Fibroblast growth 
factor 8 as part o f a highly efficient procedure to generate dopaminergic neurons. 
Like wise it was used in conjunction with these two molecules, along with a cocktail 
o f other dopaminergic inducing agents, including glial cell line derived neurotrophic 
factor, brain derived neurotrophic factor, transforming growth factor type p3 and 
dibutyryl cAMP as well as an initial stromal cell co-culture step in the work of Perrier 
et al., 2004. The transgenic MS5-Wnt l stromal cell line used as part o f the Perrier et 
al., 2004 study was also utilised in concert with the bone morphogenetic protein 
antagonist noggin to enhance the differentiation o f two human embryonic stem cell 
lines into neuroepithelial progenitors which were subsequently driven towards a 
dopaminergic phenotype in conditions similar to those described in Perrier et al., 
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2004, that favour such differentiation (Sonntag et al., 2007). In a comparable fashion 
formation o f dopaminergic neurons f rom mouse and human embryonic stem cells via 
co-culture wi th PA6 cells was enhanced in the presence of noggin (Chiba et al., 
2008). The production o f tyrosine hydroxylase positive neurons f rom human 
embryonic stem cells grown in co-culture with PA6 cells can also be enhanced 5 fold, 
f rom 3 to 15% when the culture medium is supplemented with Fibroblast growth 
factor 20 (Correia et al., 2008). One possible advantage o f the use o f molecules like 
Fibroblast growth factor 20 and noggin is that they can be exogenously applied or 
withdrawn at key points in a differentiation protocol to try and optimise their effect, 
where as co-culture based methods are far less controlled in that there may be any 
number o f unknown factors being secreted but there is no means to try and control 
their action to achieve the maximal desired output. There have though quite recently 
been efforts to reduce or remove the need for the use o f co-culture, conditioned media 
and the often complex culture media containing undefined components that are often 
associated with dopaminergic differentiation procedures. lacovitti et al., 2007 used a 
range o f human embryonic stem cell lines to produce neurons expressing markers o f a 
dopaminergic phenotype in just three weeks in vitro using a sequential method that 
involves only the use o f chemically defined media additives and substrata that are 
derived f rom human sources. Molecules such as noggin and dibutyryl cAMP used in 
the work outlined previously feature in this strategy, as does a suspension culture step. 
Although it was not possible to successfully harvest the more mature cells exhibiting 
a dopaminergic phenotype at the terminus o f the differentiation protocol, earlier stage 
neuronal progenitor cells were able to be collected for transplantation into a 6-
hydroxydopamine rat model and after two to three weeks in vivo exhibited attributes 
associated with a dopaminergic phenotype (lacovitfi et al., 2007). 
This work by lacovitti et al., 2007, also highlights the need for an adequate number o f 
neurons or neuroprogenitors for use in transplantation strategies. However cell 
number may be important in terms o f the seeding density used when setting up 
cultures for differentiation in vitro as well. This was exemplified in the work of Ko et 
al., 2005 using rat mesencephalic precursors, which gave rise to an enhanced yield o f 
neurons displaying dopaminergic characteristics when the cells were plated out at 
higher densities. 
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Cell seeding density is just one factor that may influence the dopaminergic 
differentiation o f cells in vitro, the substratum on which they grow may also have an 
effect and this is reflected in a wide number of protocols. O f interest though is the 
work o f Yu et al., 2007 who showed using rat neural stem cells that in the presence o f 
basic Fibroblast growth factor. Heparin and Laminin there was greater dopaminergic 
differentiation than when the adherent substrate Laminin was omitted. In addition in 
the work o f lacovitti et al., 2007 the human embryonic stem cell derived embryoid 
bodies were plated out onto collagen IV coated flasks as opposed to gelatin coated 
dishes as is the case in many published protocols. This alteration strongly enhanced 
the number o f embryoid bodies that became adherent meaning there was less o f a loss 
of neural progenitors at this stage, essentially enhancing overall cell number (lacovitti 
et al., 2007). 
In other recent work a range o f factors have been identified that may be o f value in 
promoting dopaminergic differentiation in vitro. The a-chemokines C X C L l , 6 and 8 
have been shown via a range o f mechanisms to promote the number o f dopaminergic 
neurons formed in rodent ventral midbrain precursor and neurosphere cultures 
(Edman et al., 2008a). In a similar fashion the P-chemokines CCL2 and CCL7 appear 
able to promote the dopaminergic differentiation o f rat ventral midbrain precursors. 
These molecules also demonstrated the capacity to enhance neuritogenesis in both the 
rat ventral midbrain precursor model and in neurosphere cultures o f murine origin 
(Edman et al., 2008b). 
Another possible determinant o f a dopaminergic phenotype is the Delta/Notch protein 
family member Delta like 1. Treatment with this agent during the expansion o f 
murine ventral midbrain progenitors was able to increase the proliferation o f such 
cells and the amount o f N u r r l positive neurons that expressed tyrosine hydroxylase 
following subsequent differentiation. However when Delta like 1 was applied during 
this differentiation phase it had no effect on the number o f tyrosine hydroxylase 
positive neurons. When endogenous levels o f this molecule were down regulated 
there was some concomitant loss of dopaminergic marker expression, supporting the 
concept that it may play a role in or have a permissive effect on the process of 
dopaminergic differentiation (Bauer et al., 2008). 
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An additional group of factors that may also possess a role and be o f use in driving 
future attempts to achieve dopaminergic differentiation in vitro are the glial cell line 
derived neurotrophic factor family ligands. In a murine model neurturin and 
persephin in the presence o f endogenous Transforming Growth Factor - p are able to 
induce dopaminergic neurons, notably when Transforming Growth Factor - P was 
utilised alongside persephin tyrosine hydroxylase positive cells were produced that 
appeared less susceptible to the effects o f MPP+ (l-methyl-4-phenyl pyridinium ion) 
toxicity (Roussa et al., 2008). 
One final distinctly different approach has been based on endeavours to produce cells 
displaying a dopaminergic phenotype from mesenchymal stem cells. Bone marrow 
derived adult human mesenchymal stem cells were induced over 12 days in vitro 
using a differentiation procedure that involved the use of Sonic hedgehog and 
Fibroblast growth factor 8 to form cells reflective o f a dopaminergic phenotype based 
on their marker expression profile. In addition such cells demonstrated an ability to 
produce and release dopamine in a depolarisation independent fashion, suggesting 
they are relatively developmentally immature (Trzaska et al., 2007). When RE-1 
silencing factor a suppressor o f mature neuronal genes in neuronal progenitors was 
silenced in mesenchymal stem cells which were then differentiated using the Sonic 
hedgehog/Fibroblast growth factor 8 based approach, more functionally mature cells 
exhibiting properties o f dopaminergic neurons were produced (Trzaska et al., 2008). 
Like wise using a differentiation cocktail including an array o f dopaminergic 
phenotype inducing agents, Barzilay et al., 2008 were able to produce derivatives 
from mesenchymal stem cells that expressed markers indicative o f a neuronal and 
more specifically a dopaminergic fate. In this work the cells produced were also able 
to secrete dopamine upon depolarisation (Barzilay et al., 2008). Such approaches 
however rely on the ability o f mesenchymal stem cells to trans differentiate, this 
competence o f such cells is an area o f some controversy and therefore at present these 
findings though promising need to be viewed in the light o f other evidence on this 
contentious issue (for a broader review see for example Hardy et al., 2008). It may 
even be that mesenchymal stem cells are capable o f acting in a similar manner to 
stromal cell lines such as PA6 and MS5 whereby they can exert an effect through the 
secretion o f neurotrophic factors. When combined with Sonic hedgehog and 
Fibroblast growth factor 8 application bone marrow stromal cells f rom adult mice 
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were able to help influence embryonic stem cells to form tyrosine hydroxylase 
positive neurons that were most probably dopaminergic given that they were negative 
in their expression for the noradrenergic and adrenergic marker dopamine (3 
hydroxylase (Shintani et al., 2008). Overall therefore it can be seen that although 
some procedures to produce dopaminergic neurons in vitro can be classified into 
generalised categories, many of them rely on the interplay o f a number o f factors, 
reflecting the possible diversity between species and universal complexity o f the 
process o f dopaminergic differentiation. This is neatly exemplified in two recent 
papers, one o f which combines the use o f PA6 co-culture, growth of cells as 
aggregates and Fibroblast growth factor 20 application (Shimada et al., 2009). Whilst 
the other is based upon L m x l a over expression in conjunction with Sonic hedgehog 
and Fibroblast growth factor 8 administration as a means to influence the 
differentiation o f murine and human embryonic stem cells towards a dopaminergic 
fate (Friling et al., 2009). 
Concluding Remarks 
There has been a wide array o f strategies employed to achieve the production of 
dopaminergic neurons f rom a variety o f cell types in vitro, many o f which have been 
reviewed in this Chapter. There may still be a range o f obstacles to overcome in 
recognising the potential o f such in vitro derived dopaminergic neurons to act as 
possible therapeutic agents in transplantation based treatments for Parkinson's 
disease. However the diversity o f cellular based models gives a broad foundation for 
furthering our understanding o f the process o f dopaminergic differentiation. They 
also often neatly complement much of the in vivo work that has been carried out 
elsewhere. I f the various means available to promote dopaminergic differentiation 
and the currently available technologies such as cell sorting are optimised in their 
usage, i t is not too hard to envisage that in vitro stem cell derived dopaminergic 
neurons could be produced, that i f shown to be functional may be suitable for use in 
pharmacological screening o f test compounds, that may be o f benefit in developing 
novel drug based therapies for Parkinson's disease in the not inconceivable future. In 
turn this may help reduce the number o f animals used in research and as such this is a 
highly desirable goal. In addition the process o f refining the current protocols and 
where possible maximising any potential synergistic interactions may help further our 
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understanding o f the underlying developmental process, which may again result in 
even more productive methods being designed to enhance the yields o f dopaminergic 
neurons it is possible to obtain in vitro. There are also as described in the previous 
section, different factors being identified which themselves may offer fresh insights 
into the specification o f a dopaminergic fate that may subsequently be able to be 
translated into new protocols aimed at producing more enriched populations o f 
dopaminergic neurons in vitro. This area due to its direct relevance to Parkinson's 
disease is one o f active research and may well remain so for the coming years, 
especially given the many avenues for potential investigation on offer. Some of these 
routes are pursued experimentally in the remainder o f this thesis which is primarily 
focussed on furthering our current understanding o f the process o f dopaminergic 
differentiation in vitro. The Tera2.cl.SP12 cell line is the primary vehicle for these 
studies as it may both help elucidate further details about the pathways involved in the 
specification o f this particular neurotransmitter phenotype and in addition give further 
insight into embryonal carcinoma cells as a means to study dopaminergic 
differentiation for those who have ethical objections to the use o f human embryonic 
stem cells. 
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Chapter 2 
Materials and Methods 
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2.1 Cell Culture 
Maintenance of Tera2.cl.SP12 and Ntera2 Embryonal Carcinoma cell cultures 
Embryonal carcinoma cells (clone Tera2.cl.SP12 and Ntera2.cl.Dl) were maintained 
in Dulbecco's modified Eagle's medium ( D M E M ; Sigma or P A A ) supplemented with 
10% (v/v) fetal calf serum (Gibco or Sigma), 2 m M L-glutamine (Cambrex) and 
lOOU/ml penicillin/streptomycin (Gibco) (referred to here in as D M E M F G ) in T75 
culture flasks (Nunc) at 37°C in a 5% CO2 incubator (Sanyo) (Przyborski et al., 2000; 
Przyborski, 2001). Beads were used to passage cells 1:3, every 2-3 days, once they 
had grown to a confluent state. 
Passage 46, 47, 49, 50, 51 and 54 Ntera2 cells were used as these passages were most 
available and all the passages showed characteristic embryonal carcinoma cell 
morphology as in Figure 2.1. Figure 2.2 shows the range of passages of 
Tera2.cl.SP12 cells used during this project. The bulk o f the cells used came from 
passages 15 to 24 and were deemed suitable for use based on their morphology and 
the time taken for them to reach a confluent state. A flask o f cells reaching a 
confluent state in a T75 in 2 to 3 days after passaging or growing from frozen was 
seen as viable for use ( i f the morphology was consistent with that in Figure 2.1). 
Maintenance of MG63 cell cultures 
The MG63 Osteoblast human cell line (Hattar et al., 2002; L iu et al., 2004) was used 
as a negative control. Cells were cultured in D M E M F G in T75 culture flasks (Nunc) 
at 37°C in a 5% CO2 incubator (Sanyo). Cells were passaged either 1:2 or 1:3, by 
incubating them at 3 7 ^ in a 5% CO2 incubator (Sanyo), for 5 minutes, in 1ml of 
0.25% (w/v) Trypsin/0.1% (w/v) EDTA (in HBSS) (Cambrex). Passage 9, 13, 16, 24, 
25, 26 and 27 cells were used experimentally as these passages were readily available 
in the laboratory at the time of carrying out the work using this cell type. 
Please note culture methods for PA6 and mesenchymal stem cells are covered in 
Chapter 6. 
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Figure 2.1; Characteristic EC cell morphology 
Figure 2 .1 : A moq)hological image o f a confluent culture o f Tera2.cl.SP12 embryonal 
carcinoma stem cells, this kind o f morphology i f observed would have been deemed 
suitable for use based on the advice given o f those in the laboratory at Durham who had 
significant experience o f working with this cell line. 
Figure 2.2: The di f ferent passages of Tera2.cI.SP12 cells used in this project 
The usage of different passage numbers of Tera2.cl.SP12 EC cells 
P12 P13 P14 P15 P16 P17 P18 P19 P20 P21 P22 P23 P24 P25 P26 P27 P28 P29 P30 P31 
Passage number 
Figure 2.2: The frequency o f use o f different passage numbers o f Tera2.cl.SP12 
embryonal carcinoma stem cells in this project. Some o f these cells may have been 
disposed o f i f not suitable for use judged against the guidelines outlined in the main 
text and some may have been generated in triplicate due to the process o f passaging 
1 in 3, this figure though gives an idea o f the spread o f passage numbers used. In 
general low passage numbers are preferred as this was seen as good practice in the 
laboratory at Durham. 
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2.2 Intracellular staining for Flow Cytometry 
Note: All solutions in this and the subsequent methods are made up in sterile distilled 
water unless stated otherwise in the particular method. 
Cultures of Tera2.cl.SP12 EC cells and their differentiated derivatives as well as 
MG63 controls were examined by f low cytometry. The media they were 
differentiating or proliferating in was removed and a Ix PBS wash was given, before 
incubation in 1ml o f 0.25% (w/v) Trypsin/0.1% (w/v) EDTA (in HBSS) for 5 minutes 
in a 37°C, 5% CO2 incubator (Sanyo), to release the cells f rom the surface o f the 
culture flask. The Trypsin was then neutralized by addition o f 4ml o f D M E M F G and 
any cells remaining loosely bound washed o f f the surface o f the flask by pipetting the 
DMEMFG/Trypsin-EDTA mix against the side o f the flask where cell attachment 
occurs. A further wash wi th Phosphate Buffered Saline (PBS) was carried out to 
optimize the retrieval o f the cells o f interest. The cell containing mix was then 
transferred to a 15ml Falcon tube and spun in a centrifuge (Eppendorf 581 OR (swing 
bucket rotor A-4-62)) at SOOrpm, 4°C, for 2 minutes and excess fluid was removed to 
leave a cell pellet. This was re-suspended in PBS and cell number was determined by 
using a haemocytometer. Once cell number was known the appropriate volume of 
PBS containing the cells o f interest was aliquoted into the required number o f Falcon 
tubes to give 1 mil l ion cells per tube. Samples were then centrifuged using the 
settings above, the supernatant aspirated and the cells re-suspended in 0.875ml o f cold 
PBS. 0.125ml of cold 2Vo (w/v) paraformaldehyde (Sigma) was added prior to a brief 
vortex o f the mixture. The suspension was incubated for at least 4 hours at 4°C before 
further centrifugation at 250g for 5 minutes after which the supernatant was removed 
and the samples were permeabilised as follows. 
Pellets were gently re-suspended in permeabilising solution (0.2% (v/v) Triton X-100 
(Fisher Scientific) in PBS for cytoskeletal or cytoplasmic antigens, 0.5-1% (v/v) 
Triton X-100 in PBS for nuclear antigens) at room temperature. Prior to incubation 
for 30 minutes at 37°C in a water bath, followed by addition of 1ml o f blocking buffer 
( 1 % (v/v) goat serum (Sigma), 0.2% (v/v) Tween 20 (Sigma), 0 .1% (w/v) sodium 
azide (Sigma) in PBS) before another round o f centrifugation at 250g for 5 minutes. 
56 
The supernatant was removed and pellets were dispersed in lOO^il volumes o f diluted 
primary antibody (see Table 2.1 for dilutions) in blocking buffer or blocking buffer 
alone for controls, this solution was then transferred to a 96 well plate, where samples 
were left to incubate in primary antibody for 30 minutes on ice. Post incubation cells 
were washed 3 times by adding blocking buffer before centrifuging at 250g for 5 
minutes (4°C) and removing the supernatant. After the final wash samples were 
dispersed in 100|il o f appropriate secondary antibody diluted in blocking buffer (see 
Table 2.2), and left to incubate in the dark for 30 minutes on ice. Samples were then 
washed 3 times using the above method. After washing cell samples were re-
suspended in 200^1 of blocking buffer and transferred to FACS tubes (BD 
Biosciences). The volume in each sample tube was then made up to 400|al by adding 
a further 200|al o f blocking buffer to give an ample volume for analysis. This was 
carried out on a B D Biosciences FACS Calibur machine used in accordance with the 
manufacturer's guidelines. 
Table 2.1: Primary Antibody Dilutions for Flow Cytometry 
Antibody Name Dilution 
Nestin (Chemicon) (mouse) 1:600 
Nurr l (Cambridge Bioscience) (rabbit) 1:200 
Tuj 1 (Covance) (rabbit) 1:1000 
Tyrosine Hydroxylase (Sigma) (mouse) 1:1000 
Table 2.2: Secondary Antibody Dilutions for Flow Cytometry 
Antibody Dilution 
AUophycocyanin conjugated anti-mouse IgG (Jackson Laboratories) 1:600 
Allophycocyanin conjugated anti-rabbit IgG (Jackson Laboratories) 1:600 
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2.3 Cell Surface Antigen Detection Flow Cytometry 
Cultures o f Tera2.cl.SP12 EC cells and their differentiated derivatives were examined 
by f low cytometry. The media they were differentiating or proliferating in was 
removed and a I x PBS wash was given, before incubation in 1ml o f 0.25% (w/v) 
Trypsin/0.1% (w/v) E D T A (in HBSS) for 5 minutes in a 37°C, 5% CO2 incubator 
(Sanyo), to release the cells from the surface o f the culture flask. The Trypsin was 
then neutralized by addition o f 4ml o f D M E M F G and any cells remaining loosely 
bound washed o f f the surface o f the flask by pipetting the DMEMFG/Trypsin-EDTA 
mix against the side o f the flask where cell attachment occurs. A further wash with 
Phosphate Buffered Saline (PBS) was carried out to optimize the retrieval o f the cells 
of interest. The cell containing mix was then transferred to a 15ml Falcon tube and 
spun in a centrifuge (Eppendorf 581 OR (swing bucket rotor A-4-62)) at SOOrpm, 4°C, 
for 2 minutes and excess fluid was removed to leave a cell pellet. This was re-
suspended in PBS and cell number was determined by using a haemocytometer. Once 
cell number was known the appropriate volume of PBS containing the cells o f interest 
was aliquoted into the required number of Falcon tubes to give 1 mil l ion cells per 
tube. Samples were then centrifuged using the settings above, the supernatant 
aspirated and the cells re-suspended in 1ml o f blocking buffer ( 1 % (v/v) goat serum, 
0.2% (v/v) Tween 20, 0 . 1 % (w/v) sodium azide in PBS) before centrifugation at 250g 
for 5 minutes to wash the cells. The supernatant was removed and cells were re-
suspended in lOOi^l o f primary antibody diluted in blocking buffer (see Table 2.3 for 
dilutions) or blocking buffer alone for controls, this solution was then transferred to a 
96 well round bottomed plate, where samples were left to incubate in primary 
antibody for 30 minutes on ice. Post incubation cells were washed 3 times by adding 
blocking buffer before centrifuging at 250g for 5 minutes (4°C) and removing the 
supernatant. After the final wash samples were dispersed in lOOial o f appropriate 
secondary antibody diluted in blocking buffer (see Table 2.4), and left to incubate in 
the dark for 30 minutes on ice. Samples were then washed 3 times using the above 
method. After washing cell samples were re-suspended in 200^1 o f blocking buffer 
and transferred to FACS tubes (BD Biosciences) on ice. The volume in each sample 
tube was then made up to 400|al by adding a further 200\x\ o f blocking buffer to give 
an ample volume for analysis. 10|.il propidium iodide solution (l.Omg/ml, Sigma) 
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was also added to each sample to label dead cells. The remaining live cell population 
was analysed using a BD Biosciences FACS Calibur machine used in accordance with 
the manufacturer's guidelines. 
Table 2.3: Primary Antibody Dilutions for Live Cell Flow Cytometry 
Antibody Dilution 
SSEA-3 ( IgM, Developmental Studies Hybridoma Bank) 1:5 
TRA-1-60 ( IgM, a gi f t f rom Prof P. Andrews, University o f Sheffield) 1:6 
VIN-IS-53 (IgG, Developmental Studies Hybridoma Bank) 1:5 
A2B5 ( IgM, R & D Systems) 1:100 
Table 2.4; Secondary Antibody Dilutions for Live Cell Flow Cytometry 
Antibody Dilution 
a-mouse IgG (Cappell) 1:100 
a-mouse I g M (Cappell) 1:100 
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2.4 Immunocytochemistry 
Immunocytochemical detection o f proteins was performed according to previous 
methods (Stewart et al., 2003). Cells were cultured on 22mm poly-D-lysine ( lO^g / j i l 
(Sigma)) coated glass coverslips in the wells o f a six well plate, under a variety o f 
induction conditions. Alternatively they were grown in 12 or 24 well plates (Nunc). 
Once cells had received the relevant treatment and were ready for analysis they were 
rinsed in PBS (Cambrex). They were subsequently fixed in ice cold methanol (BDH 
Biosciences) for 5 minutes, prior to 3 further washes in PBS. The cells were then 
permeabilised by incubation in 0 .1% (w/v) saponin (Sigma), and 0.3% (w/v) bovine 
serum albumin (Sigma) in PBS (referred to here in as SBP) for 60 minutes at room 
temperature. Following this the cells were incubated with either primary mouse or 
primary rabbit monoclonal antibodies diluted in SBP, overnight at 4°C or for 2 hours 
at room temperature. The fol lowing dilutions were used, nestin (mouse, 1:400, 
Chemicon), T H (mouse, 1:600, Sigma), T u j l (rabbit, 1:600, Covance). Cells then 
received three further 5 minute washes in SBP before incubation with fluorescein-
isothiocyanate-conjugated anti-mouse or anti-rabbit IgG secondary antibody (Sigma, 
diluted 1:400 in SBP) as appropriate for the primary antibody used, for 1 hour at room 
temperature. To remove unbound secondary antibodies cells were given five 3 
minute washes in PBS. Stained coverslips were inverted and mounted onto 
microscope slides using Vectashield (Vector Laboratories, Inc.) with added Hoescht 
nuclear stain. Samples were analysed by fluorescence microscopy using an inverted 
Nikon Diaphot 300 microscope. For cells grown in 12 or 24 well plates Hoescht 
nuclear stain was added to one o f the final PBS washes, prior to analysis via 
fluorescence microscopy. 
Cell Counts 
Cell counts based on immunocytochemical observations were made using Image J 
software with the cell counter add in installed (http://rsbweb.nih.gov/ij/plugins/cell-
counter.html). 
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2.5 Western Blotting Protocol 
Cultures o f Tera2.cl.SP12 EC cells and their differentiated derivatives as well as 
MG63 controls were examined by Western Blot Analysis. The media they were 
differentiating or proliferating in was removed and a Ix PBS wash was given, before 
incubation in 1ml o f 0.25% (w/v) Trypsin/0.1% (w/v) EDTA (in HBSS) for 5 minutes 
in a 37°C, 5% CO2 incubator (Sanyo), to release the cells f rom the surface o f the 
culture flask or six well plates (Nunc). The Trypsin was then neutralized by addition 
of 4ml o f D M E M F G and any cells remaining loosely bound washed o f f the surface of 
the flask by pipetting the DMEMFG/Trypsin-EDTA mix against the side of the flask 
where cell attachment occurs. A further wash with Phosphate Buffered Saline (PBS) 
was carried out to optimize the retrieval o f the cells o f interest. The cell containing 
mix was then transferred to a 15ml Falcon tube and spun in a centrifuge (Eppendorf 
581 OR (swing bucket rotor A-4-62)) at SOOrpm, 4°C, for 2 minutes and excess fluid 
was removed to leave a cell pellet. This was resuspended in 1ml of PBS and 
transferred to a 1.5 ml eppendorf tube, prior to being spun down in a bench top 
centrifuge (Eppendorf Minispin Plus (rotor F45-12-11)) at SOOrpm for 2 minutes. The 
supernatant was removed to leave a cell pellet that was subsequently snap frozen in 
liquid nitrogen, whilst awaiting analysis such samples were stored at -SOX. 
Western blot analysis was carried out in accordance with previous methods (Stewart 
et al., 2003). Collected samples were treated with protein isolation buffer ( 1 % IgePal 
(Sigma), 50mM Tris-HCl (pH 8.0), 150mM HCl, I m M MgCb and protease inhibitors 
(Roche) in distilled water). Protein concentrations were determined using a Bradford 
based assay, bovine serum albumin (Sigma) was used as a standard; sample volumes 
were adjusted as appropriate. Sodium dodecyl sulphate-PAGE gels were made 
according to the method of Laemmli, 1970, using the Bio-rad mini gel system. 
Loading gels (4% (w/v) polyacrylamide) and separating gels (10% (w/v) 
polyacrylamide) were poured to a thickness of 0.75mm. Before samples were loaded 
20|ig of protein were denatured for 3 minutes at 95°C in sample loading buffer 
(0.5mM Tris-HCl (pH 6.8), 10% (v/v) glycerol, 70mM sodium dodecyl sulphate, 5% 
(v/v) 2-mercaptoethanol, \5\xM bromophenol blue in distilled water). Samples were 
electrophoresed for 1 hour at 100 volts, prior to the immediate transfer o f resolved 
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proteins onto a nitrocellulose membrane (Whatman) at 100 volts for 2 - 2 . 5 hours (on 
ice) using the Bio-Rad mini gel transfer apparatus. Transfer o f protein was confirmed 
by staining membranes with amido black (in distilled water), this was washed out by 
diluting in water. 
For immunoblotting nitrocellulose membranes were blocked in a solution o f 5% (w/v) 
bovine serum albumin or 5% (w/v) dried milk powder (Tesco) in Ix TBS (Appendix 
A) for 30-45 minutes at room temperature, before being incubated overnight at 4°C 
with the primary antibody of interest, diluted in either 5% (w/v) bovine serum 
albumin or 5% (w/v) dried mi lk powder in I x TBS as outlined in Table 2.5. 
Nitrocellulose membranes were subsequently washed every 10 minutes for 1 hour in 
Ix TBS or I x TBS-T when using the Nur r l antibody (Appendix A ) . Prior to 
incubation for 45 minutes at room temperature with either mouse or rabbit IgG-
horseradish peroxidase linked secondary antibody (Amersham) diluted 1:2000 in 
either 5% (w/v) bovine serum albumin or 5% (w/v) dried milk powder in Ix TBS. 
This was followed by three five minute washes in I x TBS, before the membrane was 
gently dried using soft tissue and treated with a mixture o f equal volumes o f ECL 
detection reagents 1 and 2 (Amersham), that facilitated imaging o f the membrane, 
which was carried out in a Fu j i f i lm LAS 1000 Intelligent Dark Box. Images were 
also taken o f the molecular weight marker ladder to allow confirmation o f band size 
where detected. 
Membranes were blocked once again in a solution o f 5% (w/v) bovine serum albumin 
or 5% (w/v) dried milk powder in Ix TBS for 10-15 minutes at room temperature, 
before being incubated for 1 hour at room temperature in the presence o f a primary 
antibody for Beta-actin diluted in either 5% (w/v) bovine serum albumin or 5% (w/v) 
dried mi lk powder in Ix TBS. Blots were then washed every 10 minutes for 40-50 
minutes in Ix TBS, before incubation for 45 minutes at room temperature with mouse 
IgG-horseradish peroxidase linked secondary antibody (Amersham) diluted 1.2000 in 
either 5% (w/v) bovine serum albumin or 5% (w/v) dried milk powder in Ix TBS. 
This was followed by three five minute washes in Ix TBS, before the membrane was 
gently dried using soft tissue and treated with a mixture o f equal volumes of ECL 
detection reagents 1 and 2 (Amersham), prior to imaging o f the membrane, which was 
carried out in a Fu j i f i lm LAS 1000 Intelligent Dark Box. 
Table 2.5: Primary Antibody Dilutions for Western Blotting 
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Antibody Name Dilution Blocking/Antibody 
Incubation Solution 
Molecular 
weight (kDa) 
Beta-actin (Sigma) 
(mouse) 
1:5000 5% (w/v) milk powder/5% 
(w/v) bovine serum 
albumin 
42 
Nur r l (Cambridge 
Bioscience) (rabbit) 
1:500 5% (w/v) bovine serum 
albumin 
67 
T u j l (Covance) 
(rabbit) 
1:5000 5% (w/v) bovine serum 
albumin 
55 
Tyrosine 
Hydroxylase (Sigma) 
(mouse) 
1:10000 5% (w/v) mi lk powder 62 
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2.6 M T S Assay 
To assess cell proliferation, the commercially available colorimetric CellTiter 96® 
Aqueous One Solution Cell Proliferation Assay kit (Promega) was used. This assay 
contains a tetrazolium compound, 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) and phenazine 
ethosulfate (PES), which combine to make a stable solution. Cells reduce the reagent 
and this gives a coloured formazan compound. 
The amount o f product formed was quantified using a Nanodrop spectrophotometer at 
an absorbance o f 490nm, with the measured absorbance being directly proportional to 
the number o f viable cells in culture. For every 1ml o f media, 200|il o f MTS reagent 
was added to the culture well o f a 24 well plate containing the sample o f interest and 
left to incubate for 4 hours at 37°C. Media was changed prior to adding the MTS 
reagent to remove variation in the colour o f the media that was covering the cells. A 
control well that did not contain any cells was set up to take into account the 
background absorbance of the MTS reagent. After the 4 hour incubation, absorbance 
was measured at 490nm. The absorbance reading for the highest (on average) 
expressing sample was normalised to an arbitrary value o f 100 when presenting the 
data. 
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2.7 RNA Isolation Using Tri-Reagent® (Sigma) 
Homogenisation 
Cultures o f Tera2.cl.SP12 EC cells and their differentiated derivatives as well as 
MG63 controls grown as monolayers had the media in which they were differentiating 
or proliferating in removed, prior to being washed in Ix PBS. Suspension culture 
samples were collected by collecting the media containing the cellular aggregates into 
a Falcon tube, prior to centrifugation at SOOrpm, 4°C, for 2 minutes (Eppendorf 5810R 
(swing bucket rotor A-4-62)), to give a sample pellet. This was resuspended once in 
I x PBS, before further centrifugation at SOOrpm, 4°C, for 2 minutes (Eppendorf 
5S10R (swing bucket rotor A-4-62)). Cells (or aggregates o f them) were then lysed 
by incubating them for 10 minutes at room temperature in an appropriate volume of 
Tri-Reagent (1ml for a single well o f a six well plate, T25, or Falcon tube, 3ml for a 
T75). The cell lysate was then passed through a pipette several times before 1ml of it 
was transferred to a 1.5ml eppendorf tube. Insoluble materials were removed from 
the homogenate by centrifugation at 12,000g for 10 minutes at 4°C (Eppendorf 5415R 
(cooled standard rotor F45-24-11) all subsequent centrifugation steps recorded with a 
g value were carried out using this centrifuge and rotor combination). The 
supernatant (containing R N A ) was transferred to a fresh tube. 
Phase Separation 
0.2ml o f Chloroform (Fisher Scientific) was added (per 1ml o f Tri-reagent used in the 
homogenisation step) to the sample containing eppendorf tubes, which were securely 
capped and shaken vigorously by hand for 15 seconds. Samples were then incubated 
at room temperature to allow separation into layers, prior to being spun in a cooled 
bench top centrifuge at 12000g for 15 minutes at 4°C. After this centrifugation, 3 
layers were present; the RNA resides exclusively in the uppermost aqueous phase. 
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RNA Precipitation 
The RNA containing aqueous phase was carefully transferred to a fresh tube, with 
care being taken, not to carry over material from the other D N A and protein 
containing phases. 0.5ml o f isopropanol (Fisher Scientific) (per 1ml o f Tri-Reagent 
used in the homogenisation step) was added to the aqueous phase to precipitate the 
RNA and this sample was mixed by inverting it 2-3 fimes, before incubating for 10 
minutes at room temperature, prior to centrifugation at 12000g for 10 minutes at 4°C. 
A pellet containing the RNA precipitate is formed on the outer side o f the sample 
containing eppendorf tube. 
RNA Wash 
The supernatant was removed to leave the pellet which was then washed once with 
75% (v/v) ethanol (made up from a mix of 3 parts 100% ethanol (Sigma) to 1 part 
RNase free water (Sigma)) (at least 1ml of 75% (v/v) ethanol was used per 1ml o f Tri 
Reagent used in the homogenisation step). The pellet in 75% (v/v) ethanol washing 
solufion was centrifuged at lOOOOg for 10 minutes at 4°C. 
Redissolving the R N A 
After centrifugation the supernatant was removed to leave just the RNA pellet which 
was briefly air dried for 5-10 minutes. The RNA was then dissolved in RNase free 
water (15-75|xl) by passing the solution through an RNase free pipette tip a few times 
or by flick mixing. Samples were then incubated for 5 minutes at 55-60°C. The 
purity (A260/280nm) and concentration (A260nm) of the R N A sample were then 
measured using a Nanodrop 1000 spectrophotometer. RNA samples were stored at -
80°C prior to subsequent usage. 
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2.8 Reverse transcription & Real Time Polymerase Chain Reaction 
For mRNA expression analysis by real time PCR, total RNA was obtained from three 
different passages o f cells. Total RNA was isolated using Tri-Reagent (Sigma) 
according to the method presented previously, which was based upon the 
manufacturers' instructions. The amount of RNA was quantified (A260nm) and the 
purity (A260/280 ratio) assessed using a Nanodrop analyser. Purity values were 
deemed suitable within the range 1 .7 -2 .1 . 4\xg of total RNA was reverse transcribed 
to cDNA using the commercially available Taqman reverse transcription kit (Applied 
Biosystems) in accordance with the manufacturer's instructions. Real time PCR was 
performed on an Applied Biosystems 7500 Fast Real Time PCR instrument using 
SYBR green technology. Primers were synthesised by V H B i o (sequences are 
provided in Table 2.6) for the following genes: P-actin, P-catenin, D l , D2, D A T , 
Dopa Decarboxylase, Engrailed 1, FGFR4, Frizzled 8, GAPDH, L m x l a , M s x l , 
Nestin, Ngn2, Nkx 6-1, N u r r l , Oct4, Otx2, Patched, SLC23A1, Soxl , TBP, T H , 
T u j l (Beta I I I tubulin). A standard curve was constructed for each primer set to 
facilitate absolute quantification o f sample cDNA; samples were normalised by 
comparing the mean quantity o f the gene of interest against the mean quantity of the 
housekeeping gene GAPDH. To further clarify that the expression o f this gene 
(GAPDH) was relatively consistent and thus suitable for use samples were also 
normalised against another house keeping gene which possessed a broadly different 
cellular funcfion usually P-actin but on occasion TBP. The results for the gene of 
interest were compared to see i f the trends were comparable when normalised against 
the different housekeeping genes, to try to remove some of the uncertainty that the 
housekeeping gene normalisation process was not affecting the results due to 
differences in its expression that could have arisen f rom the varying sample growth 
conditions. Each standard curve was constructed f rom a range o f dilutions (1:5, 1:10, 
1:20, 1:50, 1:100, 1:1000 and NTC), with R" values exceeding 0.99. Standards and 
samples were amplified on the same reaction plate. Three technical repeats of three 
biologically independent samples were run; results show the average across the three 
independent biological samples. Each individual reaction mix consisted of the 
following: 5^1 SYBR green mastermix (Applied Biosystems), 3.2|al RNase free water 
(Sigma), 0.4|il o f forward and reverse primer (made up in RNase free water) and 1 | i l 
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of cDNA diluted 1:5 in RNase fi-ee water. The thermal cycling parameters were as 
follows: 50°C for 2 minutes, 95°C for 10 minutes, 95°C for 15 seconds followed by 
60°C for 1 minute (x40 cycles or x50 cycles for Otx2 only), a dissociation step o f 
95°C for 15 seconds, 60°C for 15 seconds and 95°C for 15 seconds was also added. 
This additional stage was included to check primer specificity and for the absence o f 
primer dimers. PCR product size and specificity were also checked on an agarose gel, 
as shown in Figure 2.3. 
Figure 2.3: Dissociation Curve and Agarose gel image for GAPDH 
VWw Took IriMniMM anttfit wmdow Hdp 
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i t 
r' 
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JXI j I I I I I I H 
Hyper ladder: 
1000 base pairs 
Hyper ladder: 
100 base pairs 
266 base pair band as expected 
for the GAPDH primer set used. 
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The hyper ladder marker gives a size reference, and the presence o f a single band at 
266 base pairs indicates that there is only one product o f the predicted correct size. 
This is in agreement wi th the single peak on the dissociation curve that indicates one 
specific product has been formed. 
Note: This method was used to produce the real time PCR data in Figures 3.1, 3.2, 
3.3, 3.4, 4.4, 4.6, 4.7, 4.10, 4.11, 4.15, 4.16, 4.17, 4.18, 4.19, 4.20, 4.30, 5.3, 5.4, 5.5, 
5.6, 5.9, 5.10, 5.11, 5.12, 5.13, 5.14, 5.15, 5.16, 5.17, 5.18, 5.19, 5.20, 5.21, 6.2, 6.3, 
6.4, 6.5, 6.16 and 6.17. 
This method and method 2.9 that follows have never been used in tandem; they 
have only ever been used in isolation hence why both are included separately in this 
Thesis. 
Table 2.6: Primer Sequences 
Gene Forward Reverse Source/Reference 
B-actin 5' CGCCCCAGGCACCAGGGC 3' 5' GCTGGGGTGTTGAAGGT 3' RTPrimer DB ID:2238 
B-catenin 5' TGCAGTTCGCCTTCACTATG 3' 5' ACTAGTCGTGGAATGGCACC 3' Tulac et al., 2003 
Dl 5' ATCCTCACTGCCTGTTTC 3' 5' TGTCGGAACCTGATAACG 3' Dr. V. Lakics 
D2 5' TGAATCTGTCCTGGTATGATGATG 3' 5' GTGTGGCATAGTAGTTGTAGTGG 3' Dr. V. Lakics 
DAT 5' TACCTGAGCGTTGACTTC 3' 5' TGGTGAACTTGTTGTAGC 3' Dr. V. Lakics 
Dopa 
Decarboxylase 
5' TGTCCAGCTGTCCCATGAGTT3' 5' GAATGACTTCCACACAGATTTCAAA 3' 
Engrailed 1 5'-CCCTGGTTTCTCTGGGACTT-3' 5'-GCAGTCTGTGGGGTCGTATT-3' Yan et al., 2005 
FGFR4 5' GGGTCCTGCTGAGTGTGC 3' 5' TGGGTAACTGTGCCTATTCG 3' Mawrin et a!., 2006 
Frizzled 8 5' GACACTTGATGGGCTGAGGT 3' 5' CAAATCTCGGGTTCTGGAAA 3' Rozen & Skaletsky, 2000 
GAPDH 5'ATGGGGAAGGTGAAGGTCGGAG 3' 5'TCGCCCCACTTGATTTTGGAGG 3' RTPrimer DB ID:2072 
Lmxla 5' TGAGGAAGGCAAGGACCATAA 3' 5' ATGCTCGCCTCTGTTGAGTTG 3' 
Msxl 5' AAGAGACTACAAGAGGCAGAG 3' 5' CCGAGAGGGAAGGAGAGG 3' Dr. V. Lakics 
Nestin 5' CAGCGTTGGAACAGAGGTTGG 3' 5' TGGCACAGGTGTCTCAAGGGTAG 3' Strojnik et al., 2007 
Ngn2 5'TGTCCTCCAATTCCACCTC 3' 5' CTGCCAATAGTCCATGTCTG 3' Dr. V. Lakics 
Nkx6-1 5' AAGAAGCAGGACTCGGAGACAG 3' 5' CAGAGGCTTATTGTAGTCGTCGTC 3' Dr. V. Lakics 
Nurrl 5' CCTGGCTGTTGGGATGGTC 3' 5' TGTGGGCTCTTCGGTTTCG 3' Dr. V. Lakics 
Oct4 5' GAGAACCGAGTGAGAGGCAACC 3' 5' CATAGTCGCTGCTTGATCGCTTG 3' Willems et al., 2006 
Otx2 5' AGAGGAGGTGGCACTGAAAA 3' 5' ATTGGCCACTTGTTCCACTC 3' Boon et al., 2003 
Patched 5' TCCTCGTGTGCGCTGTCTTCCTTC 3' 5' CGTCAGAAAGGCCAAAGCAACGTGA 3' Regl et al., 2002 
SLC23A1 5' AAAGCCTTGCAGCATACCTACAT 3' 5' TGTCAGCATCTAGGAAGAACAGCT3' RTPrimer DB ID:2566 
Soxl 5' CAATGCGGGGAGGAGAAGTC 3' 5' CTCTGGACCAAACTGTGGCG 3' Kim et al., 2006b 
TBP 5' TGCACAGGAGCCAAGAGTGAA 3' 5' CACATCACAGCTCCCCACCA 3' RTPrimer DB ID:2627 
TH 5' CCTGCTTCTCAGCGCAACAG 3' 5' GAGCCAGGACAGGACCTCAC 3' Dr. V. Lakics 
Beta I I I tubulin 5' GGCCAAGTTCTGGGAAGTC 3' 5' CGTTGTAGTAGACGCTGATCC 3' Kumar et al., 2007 
Table 2.6: Primer sequences and sources of reference, RTPrimer DB refers to primers found at 
http://medgen.ugent.be/rtprimerdb/. Primers with no source/reference were designed using Primer Express 3.0 
(https://products.appnedbiosystems.com/ab/en/US/adirect/ab;jsessionid=JXpzKJFHZ2hLvpyFdddbpnspMfPNm7XB23jTFLy0y 
w61GKSQsgz4!950160382?cmd=catNavigate2«&catID=605537). 
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2.9 Real Time Polymerase Chain Reaction (Lilly) 
For mRNA expression analysis by real time PCR, total RNA was obtained from three 
different passages of cells. Total RNA was isolated using Tri-Reagent (Sigma) 
according to the method presented previously, which was based upon the 
manufacturers' instructions. The amount of RNA was quantified (A260nm) and the 
purity (A260/280 ratio) assessed using a Nanodrop analyser. Purity values were 
deemed suitable i f they lay within the range 1.7 - 2.1. Samples were then DNase 
treated with the commercially available Turbo DNA-free'^'^ Kit. After this the 
TaqMan Reverse Transcription Kit (Applied Biosystems) was used to synthesise first 
strand cDNA. The final concentration of RNA in the reaction was 1 \ig I lOOfal for all 
samples. Quantitative real-time RT-PCR was performed using SYBR Green 
chemistry with a final concentration of 1000 ng/ml template in the PCR on an ABI 
Prism 7900HT real-time PCR system (Applied Biosystems, 384-well plate, 5 ml final 
reaction volume, in quadruplicates). The following cycling conditions were used: 
50°C for 2min (stage 1); 95°C for lOmin (stage 2); 95°C for 15sec; 60''C for Imin 
(stage 3) X 40. At the end of the run threshold cycles (Ct) were determined for each 
PCR reaction on the plate. To establish the relative expression of TH, Nurrl , Nkx6-1, 
Msxl , DAT, D l and D2 genes in various samples, the normalisation procedure 
described by Vandesompele et al., 2002 has been used. Briefly, dCt values of a given 
target gene were calculated for each sample, relative to a selected calibrator (the 
highest expresser sample for that gene), then converted into fold differences by 
raising them to the power of 2. Similarly, the dCt values of selected reference genes 
(beta-actin, RNA-polymerase2, PSMB2), were created for each sample, relative to the 
same calibrator sample used for the respective target gene, and were also converted to 
fold differences. The expression of the target gene was then normalized with a factor 
created by using the geometric mean of the fold difference values of the 3 reference 
genes in each sample. Finally, the relative quantities of the various samples have been 
expressed as a percentage relative to the chosen calibrator sample, which was 
arbitrarily set to 100%. 
Note: This method was used to generate the data presented in Figures 3.5, 3.6, 4.8, 
4.12, 4.13, 4.14 and Appendix B. My thanks go to Dr. V. Lakics for providing this 
method and carrying out this analysis as mentioned in the acknowledgements. 
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2.10 Statistical Analysis 
All bar charts were produced in Microsoft Excel; custom error bars representing either 
the standard deviation or standard error of the mean were added using this package. 
All statistical analyses were performed using SPSS 15.0 for Windows; the line graph 
shown in Chapter 3 was also produced using this package. 
The statistical tests used can be categorised as a Student's T-test, a one way anova 
including Tukey post hoc analysis to compare differences between groups, or a two 
way anova. Significance is attributed in all these tests at a Sig. value < 0.05. T-test 
outputs where significant are shown on bar charts by lines linking the samples 
between which there is a statistically relevant difference, an exemplar T-test data 
output is shown in Figure 2.4. From here on in a one way anova output refers to the 
one way anova including Tukey post hoc analysis, for presentation purposes an 
example is given in Figure 2.5. Significant differences determined using this test are 
indicated by lines linking the samples between which there is a statistically relevant 
difference. Two way anova outputs are exemplified in Figure 2.6 which also 
highlights the relevance of the line graph (used in Chapter 3) to support such analysis. 
Figure 2.4 Example T-test output 
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Independent Samples Test 
Levene's Test for 
Equality of Variances 
_Sig_ t df 
l-test for Equalily of Means 
Sifl(2-'ailed) 
Mean 
Difference 
Std. En-or 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower 
Expression Equal variances 
assumed 
Equal variances 
not assumed 
.033 -6.460 
-6.460 
4 
2.067 .021 
-1093.660 
-1093.660 
169.30746 
169.30746 
-1563.73 
-1799.88 
-623.587 
-387.443 
If the S ig . value for the 
Levene 's test Is greater than 
0.10 then the var iances can 
be a s s u m e d to be equal. 
Here it is not, s o unequal 
var iances are assumed . 
In this example unequal var iances are assumed 
based on the result of the Levene 's test (blue box), 
the red box highlights the result is significant on this 
occas ion . If equal var iances had been assumed (i.e. 
if there was a value greater than 0.10 in the blue box) 
then the upper figure 0.03 would be used a s an 
indicator of signif icance. 
Figure 2.5: Example one way anova output 
The condition column s h o w s the 
condit ions being compared . 
Dependent Variable: Expression 
Tukey HSD 
Multiple Comparisons 
Mean 
Difference 
(l-J) Std. Error 
95% Confidence Interval 
(1) Condition (J) Condition Sig. Lower Bound Upper Bound 
E C 17Day(R .A .+ Wnt1) 
3W R.A. 
-1.56700 
-11.28167* 
2.71339 
2.71339 
.837 
.014 
-9.8924 
-19.6071 
6.7584 
-2.9562 
17Day (R.A. + Wnti) E C 
3W R.A. 
1.56700 
-9.71467* 
2.71339 
2.71339 
.837 
.027 
-6.7584 
-18.0401 
9.8924 
-1.3892 
3W R.A. E C 
17 Day (R.A.+ Wnt1) 
11.28167* 
9,71467/ 
2.71339 
2.71339 
.014 
.027 
2.9562 
1.3892 
19.6071 
18.0401 
*• The mean difference is significant at the .05 level. 
The mean difference column highlights any di f ferences 
(between the s a m p l e s outlined In the condition co lumn 
(blue box)) that are signif icant at the 0.05 level, where an 
aster isk Is p resent there is a correlation with the value in 
the S ig . co lumn (red) being l e s s than 0.05 a s c a n be s e e n in 
this example. 
The S i g . column s h o w s whether there 
are signif icant d i f ferences between the 
sample g roups outlined in the condition 
column (blue box). 
Figure 2.6: Example two way anova output 
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Tests of Between-Subjects Effects 
Dependent Variable: Expression 
Type III Sum 1 
Bource 1 of Squares df Mean Square F Sio. 1 
Con'ected Model 1667.109= 3 555.703 .204 .891 
Intercept 84097.139 1 84097.139 30.841 .001 
Pressure 1293.179 1 1293.179 .474 .511 
rime 372.604 1 372.604 .137 .721 
Pressure • Time 1.326 1 1.326 .000 .983 
Error 21814.080 8 2726.760 
Total 107578.329 12 
Corrected Total 23481.189 11 
a R Squared .071 (Adjusted R Squared = -.277) 
- The S ig . values in the red box if < 
0.05 would be deemed significant 
(in this c a s e they are not). They 
display significance in relation to 
the variables defined in ttie 
S o u r c e column (blue), both 
individually for time and pressure 
and for the two combined, to see 
if there is an interaction between 
the variables being a s s e s s e d . 
Parallel l ines on the line graph are 
indicative that there is no 
interaction between the variables 
(pressure and time). The almost 
perfectly parallel lines in this 
example correspond with the 
almost total lack of significance 
(Sig. value of 0.983) in the two way 
anova output above. 
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Chapter 3 
Characterisation of the 
Tera2.cLSP12 Human E C 
cell system as a model to 
study dopaminergic 
neurogenesis, in the 
presence of retinoic acid 
and in a lowered oxygen 
culture enyironment 
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3.1 Introduction 
In any cell culture system there are a number of variables, such as the media and physical 
environment. There are already well established protocols (for example Stewart et al., 
2003) for the culture of Tera2.cl.SP12 cells and their retinoic acid treated derivatives, 
therefore a logical first step in this project was to characterise the embryonal carcinoma 
stem cell system pre and post retinoic acid differentiation to begin to gain an 
understanding of its potential as a model to study dopaminergic neurogenesis and this 
forms the basis of this Chapter. In addition given the availability and ease of use of 
lowered oxygen cell culture technology in the laboratory and the findings of Studer et al., 
2000, who were able to show enhanced dopaminergic differentiation from rat 
mesencephalic precursor cells cultured in physiological oxygen conditions, it was also 
decided that the Tera2.cl.SP12 system would be investigated in a 5% oxygen environment 
as well. The rationale for doing these extra experiments being that i f 5% oxygen could 
enhance dopaminergic differentiation of the embryonal carcinoma stem cells then it could 
be easily utilised to try and augment subsequent efforts to achieve the production of an 
enriched population of dopaminergic neurons. The evidence provided by Colton et al., 
1995, that 5% oxygen culture could provide an approximately twofold increase in 
survival of tyrosine hydroxylase positive neurons in primary cultures of embryonic rat 
midbrain gave further support to the argument for using lowered oxygen, as in the initial 
stages of experimentation it is impossible to know when expression of dopaminergic 
markers by the cells under study will occur or peak, so any variable that may stabilise this 
expression to a detectable level at a measured time point is highly favourable. 
This also highlights the need to define the time period of retinoic acid induced 
differentiation. Work using the four and five week old retinoic acid differentiated 
derivatives of the human embryonal carcinoma stem cell line Ntera2.Dl showed that 
there was significantly more tyrosine hydroxylase positive cells (60%) in four week 
retinoic acid treated cultures than in their five week (<15%) counterparts (Zigova et al., 
2000). This finding, combined with the need for temporal efficiency i f the Tera2.cl.SP12 
system were to be viable for use in screening assays, lead to the decision that the longest 
time point to be used in this study would be four weeks of retinoic acid treatment. A two 
week retinoic acid treatment time point was included to bridge the gap between the 
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embryonal carcinoma stem cell and four week retinoic acid treated samples in the studies 
into the effects of different oxygen concentrations, and a series of short time points, 1,3, 
5 and 7 days were used to investigate the possible favourable effects of retinoic acid in 
normoxic conditions, as well as to gain greater insight into, and understanding of the 
Tera2.cl.SP12 cell line in the context of it as a model to study dopaminergic neurogenesis. 
The next two sections aim to outline the purpose of and background to the investigations 
that are subsequently reported in this Chapter. 
The Induction of Nurrl with Retinoic Acid 
The transcription factor Nurrl is expressed in a variety of regions of the brain such as the 
hippocampus, hypothalamus and cerebellum (Zetterstrom et al., 1996) and is a member of 
the orphan nuclear receptor family. In mouse the mRNA is expressed from embryonic 
day El0.5 in the ventral mesencephalic flexure and continues into adulthood (Zetterstrom 
et al., 1997). This study also showed by immunological methods that tyrosine 
hydroxylase (the rate limiting enzyme in dopamine biosynthesis) was not expressed in the 
ventral mesencephalon of Nurrl' '" mice where it is usually found. Other dopaminergic 
cell groups for example those of the pontine locus coeruleus (A6), displayed no 
differences in tyrosine hydroxylase immunoreactivity between wild type and Nurrl 
deficient mice. This coupled with an absence of positive tyrosine hydroxylase 
immunostaining at all pre-natal stages in the developing midbrain when it would normally 
be expected from El 1.5 in mouse (Foster et al., 1988) strongly indicate Nurrl as a critical 
determinant in the differentiation of ventral midbrain dopaminergic neurons (Groups A8-
AlO) (Zetterstrom et al., 1997). 
High performance liquid chromatography analysis of the levels of dopamine and its 
metabolite DOPAC in portions of ventral mesencephalon and striatum showed an absence 
of dopamine in Nurrl deficient mice, and a reduction in the amount of the metabolites in 
heterozygous new born animals, indicative of a gene dosage effect on nigrostriatal 
dopamine levels. This second group though appeared healthy and were not hypoactive as 
was the case for the Nurrl"'" population which also died soon after birth (Zetterstrom et 
al., 1997). Overall these results suggest Nurrl is not only a key factor in the production 
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of a ventral midbrain dopaminergic phenotype but is also a contributor to the maintenance 
of a differentiated phenotype in adult mice. 
In a similar fashion Nurrl is expressed in human Ntera2 embryonal carcinoma cells and 
their 3, 4 and 5 week retinoic acid differentiated derivatives. In addition all the observed 
tyrosine hydroxylase positive Ntera2 derived neurons in these cultures were Nurrl 
positive (Misiuta et al., 2003). These findings therefore suggest that Nurrl expression is 
maintained to some level throughout the retinoic acid driven differentiation process and 
that the human embryonal carcinoma cell system may possess similarities to the mouse 
model where tyrosine hydroxylase expression may be linked to that of Nurrl . Subsequent 
work also showed that after 1 day of retinoic acid treatment of Ntera2 cells it was possible 
to achieve a significant rise in expression of Nurrl from approximately 12 to 20% 
(Misiuta et al., 2006). This is a rapid and therefore potentially desirable effect especially 
given the importance of time as a variable. Another study where Nurrl was over 
expressed again carried out in the Ntera2 cell line showed that cultured Ntera2.Nurrl 
transfected cells were nestin negative despite the fact 'wild type' Ntera2 cells are nestin 
immunopositive indicating that Nurrl may trigger an early commitment towards the 
neuronal lineage. It was observed that after 4 weeks of retinoic acid treatment Ntera2 
cells over expressing Nurrl exhibited greater tyrosine hydroxylase expression than their 
non-transfected Ntera2 counterparts (Hara et al., 2007). These findings give additional 
support to the concept that Nurrl may influence tyrosine hydroxylase expression in 
human embryonal carcinoma stem cells, this is in stark contrast to observations in human 
neural progenitor cells where tyrosine hydroxylase gene regulation appears to be 
independent of Nurrl (Jin et al., 2006), showing there may not just be species specific 
differences in dopaminergic neurogenesis but cell type specific idiosyncrasies within a 
species. They also indicate that Nurrl may help promote neuronal differentiation which 
is highly desirable given the mixture of cell types produced following retinoic acid 
treatment of Tera2.cl.SP12 cultures. Therefore the key aspects to test for were: can Nurrl 
be induced rapidly with retinoic acid treatment in the Tera2.cl.SP12 system and if so does 
this have any effect on enhancing neuronal differentiation or can it be linked to the 
stimulation of neurogenesis in this cell line? 
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Cell Culture at Lower Oxygen Tensions 
The use of lowered oxygen culture is founded on the principle that greater mimicry of the 
in vivo environment of the mammalian brain where oxygen pressures are much lower, 
around 1 to 5% (Silver & Erecinska, 1998) than those used in standard (20 to 21% 
oxygen) cell culture; may enhance the production of neuronal cell types. The main 
evidence that showed physiological oxygen conditions could help promote acquisition of 
a dopaminergic phenotype was provided by Studer et al., 2000, who used rat 
mesencephalic precursor cells to demonstrate four clear effects of 3±2% oxygen culture. 
First of all in lowered oxygen apoptosis was reduced, secondly progenitor cell 
proliferation was increased, with both of these factors helping to contribute to increased 
precursor cell numbers. A differentiated state was also achieved more rapidly in 
physiological oxygen conditions which would be a highly desirable effect to reproduce 
given the need for temporal efficiency. Finally lowered oxygen was able to alter the 
proportions of neurons displaying particular neurotransmitter phenotypes. The 
percentage of dopaminergic neurons increased from 18% in 20% oxygen to 56% in 3±2 
oxygen. The combined effect of the increases in absolute cell number and the percentage 
of neurons of a dopaminergic phenotype gave rise to a nine fold increase in yield of 
dopaminergic neurons (Studer et al., 2000). Given that Tera2.cl.SP12 embryonal 
carcinoma stem cells are very highly proliferative and robust the first two effects are of 
lesser importance. However the ability to rapidly produce cells reflective of a 
differentiated state and the capacity to increase specifically the yield of dopaminergic 
neurons were both favourable concepts to attempt to duplicate in the context of the 
Tera2.cl.SP12 system. The main reasons being that the lowered oxygen conditions may 
act in synergy with retinoic acid to promote cells to adopt a differentiated, more mature 
phenotype and when set against the back drop of retinoic acid treated embryonal 
carcinoma stem cells producing a mixture of neural cell types, the capacity of 
physiological oxygen levels to influence a large proportion of cells to take up a 
dopaminergic phenotype was extremely appealing. 
In the light of advice provided by other members of the Przyborski lab group and the 
technician for the lowered oxygen incubator, an oxygen pressure of 5Vo was chosen, as 
below this level the oxygen pressure may be susceptible to fluctuations. Although this is 
higher than in the work of Studer et al., 2000 it is in the range of oxygen pressures they 
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used in this work as 3±2% = 1-5% oxygen. In addition Colton et al., 1995 showed 
positive effects on tyrosine hydroxylase positive cell survival when using 5% oxygen. It 
therefore seemed reasonable especially given the effects in the work of Studer et al., 2000 
were striking to think that using 5% oxygen would at least highlight any major 
differences between it and standard oxygen culture on the acquisition of a dopaminergic 
phenotype by retinoic acid treated Tera2.cl.SP12 embryonal carcinoma stem cells. 
When set against the background of available knowledge a number of hypotheses could 
then be set up to test. The most basic of these are can retinoic acid induce expression of 
dopaminergic markers over time and do embryonal carcinoma stem cells themselves 
express any of these markers? To build on this is there any pattern to the way particular 
markers or sets of them are regulated? Also how are some of the key mechanistic 
determinants of a dopaminergic phenotype regulated in this system? In addition can 
lowered oxygen culture enhance the dopaminergic differentiation of retinoic acid treated 
Tera2.cl.SPI2 embryonal carcinoma stem cells in vitro? By growing the Tera2.cl.SP12 
cells under a range of conditions and by carrying out a range of molecular analyses these 
theories were investigated. Section 3.2 describes the specific culture methods and section 
3.3 outlines the results obtained. 
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3.2 Cell Culture Methods 
Retinoic Acid Induced Differentiation of E C cell cultures 
Cultures of Tera2.cl.SP12 EC cells were grown to confluency, the media aspirated from 
them, before being washed with Ix PBS, prior to treatment for 5 minutes with 0.25% 
(w/v) Trypsin/0.1% (w/v) EDTA (in HBSS) (Cambrex), to release the cells from the 
surface of the culture flask. The Trypsin was then neutralized by addition of 4ml of 
DMEMFG and any cells remaining loosely bound washed off the surface of the flask by 
pipetting the DMEMFG/Trypsin-EDTA mix against the side of the flask where cell 
attachment occurs. A further wash with Ix PBS was carried out to optimize the retrieval 
of EC cells for use. The cell suspension was then transferred to a 15ml Falcon tube and 
spun in a centrifuge (Eppendorf 581 OR (swing bucket rotor A-4-62)) at 800rpm, 4°C, for 
2 minutes. The excess fluid was removed to leave an EC cell pellet. This was 
resuspended in DMEMFG and cell number was obtained by using a haemocytometer. 
Once the cell number was known the EC cells were seeded out at the following densities 
depending on the culture ware used: 
• For a T75-1.5x10* cells per flask, 
• For a T25 (Nunc) - 0.5x10* cells per flask, 
• For a single well of a 6 well plate (Nunc) containing a 22mm poly-D-lysine coated 
glass coverslip - 0.2x10^ cells per well. 
Cultures were induced to differentiate by exposure to a final concentration of lO^iM all 
trans retinoic acid (made up in dimethyl sulfoxide (both Sigma)). They were then placed 
into either the same atmospheric (normal, 21%) oxygen, 5% CO2 incubator that the EC 
cells were maintained in or depending on the investigations being undertaken a 5% O2, 
5% CO2 incubator (Sanyo) (for the studies into the effect of oxygen tension on the 
dopaminergic differentiation potential of retinoic acid induced EC cells). Media was 
changed every 2 - 4 days. 
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3.3 Results 
Before starting to characterise the embryonal carcinoma stem cell system Tera2.cl.SP12 
in both its undifferentiated state and in the presence of retinoic acid at different oxygen 
concentrations, some classical experiments were performed to act as controls to show that 
the cells were exhibiting predictable patterns of behaviour. The first experiment involved 
using real time PGR to show the drop in expression of Oct4 mRNA following retinoic 
acid treatment of the embryonal carcinoma cells (Figure 3.1 A). This yielded similar 
results to those in Przyborski, 2001, where Northern blotting was used to demonstrate 
how this marker of human pluripotent stem cells was reduced following retinoic acid 
induction. 
Figure 3.IB then shows the results of a flow cytometry based analysis of markers of 
human pluripotent stem cells and neural phenotypes. Undifferentiated Tera2.cl.SP12 
embryonal carcinoma stem cells express high levels of SSEA-3 and Tra 1-60 (markers 
associated with pluripotent stem cells) (Andrews et al, 1982; Andrews et al, 1984) but 
express only minimal levels of A2B5 and VINIS-53 (markers of a neural phenotype) 
(Eisenbarth et al, 1979; Andrews et al, 1990). In contrast following treatment with 
retinoic acid for two weeks, the pattern of regulation is switched with high expression of 
the neural markers and low levels of the stem cell markers being observed in a consistent 
manner with earlier work (Przyborski, 2001). These results were therefore positive as 
they indicated that the embryonal carcinoma stem cells were behaving in a characteristic 
fashion and could respond to retinoic acid as expected, which in turn suggested any 
subsequent work with them would hopefully be representative of them acting in a similar 
way to that in previous studies. Different passages of cells were used and there did not 
appear to be any major passage number related effects. 
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Figure 3.1; Characterisation of stem cell differentiation 
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Figure 3.1A: The relative levels of Oct4 mRNA expression assessed by real time PCR in 
Tera2.cI.SP12 cells and their derivatives following 10(xM retinoic acid treatment at different 
time points up to two weeks. B: A flow cytometry based analysis of changes in the pattern of 
human pluripotent stem cell and neural marker expression in Tera2.cl.SP12 cultures pre and 
post two weeks of lOjiM retinoic acid induced differentiation. In all experiments n=3. Error 
bars represent the S.D. of the mean. C: Flow cytometry traces, first of all to gate out dead 
cells propidium iodide is used. This penetrates dead or dying cells and its signal can be 
detected using the 488nM argon-ion laser, live cells negative for propidium iodide (below a 
threshold) are gated out and further analysed by the flow cytometer. Prior to analysing the 
test samples a background fluorescence threshold is determined by analysing cells stained 
with only secondary antibody that are not stained for the antigen of interest. These control 
samples are used to define the threshold which identifies i f a cell is antigen positive or not, 
any cell that shows a fluorescence value above this threshold is counted as positive. The 
traces above on the left hand side show how the secondary only control peak sits to the left of 
the threshold and essentially all the EC cells in these experiments are negative. In the upper 
right quadrant the single peak has moved to the right and shows positive expression of Tra 1-
60 a marker that would be expected to be expressed by EC cells. The lower right quadrant 
shows that there is only a small movement of the peak to the right for VrNIS-53, this results in 
only a few EC cells being positive for this marker which would be expected as it is more 
normally associated with cells showing characteristics of neural differentiation hence its 
greater expression after 2 weeks of exposure of the EC cells to retinoic acid. 
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After the initial experiments, the next step was to start to assess the dopaminergic 
differentiation potential o f the Tera2.cl.SP12 cell line pre and post retinoic acid treatment. 
This was first undertaken at the mRNA level using real time PCR. In the light o f the 
work o f Misiuta et al., 2006 where retinoic acid caused a significant increase in Nur r l 
protein expression in the Ntera2.Dl embryonal carcinoma stem cell line investigations 
were undertaken to assess i f an analogous peak in mRNA expression was seen using the 
Tera2.cl.SP12 system. Figure 3.2 shows that there is a peak in N u r r l mRNA expression 
after 1 day o f retinoic acid exposure. It is not a statistically significant effect however 
which may be due to the variation in the expression o f this transcription factor in the 
Tera2.cl.SP12 cells themselves. The trend though is consistent wi th the earlier 
observations o f Misiuta et al., 2006 and it is also noticeable that expression although 
variable persists until the final two week time point. This is again a compatible trend wi th 
the concept that N u r r l expression may persist throughout different stages o f development 
wi th the transcription factor possibly possessing a range o f time dependent roles. 
Figure 3.2: N u r r l m R N A Expression i n Tera2.cl.SP12 cells and their derivatives 
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Figure 3.2: Real time PCR data showing the changes in the relative expression levels of 
Nurrl mRNA in undifferentiated cultures of Tera2.cl.SP12 embryonal carcinoma stem cells 
and their lO^iM retinoic treated derivatives over a two week period (n=3). Error bars 
represent the S.D. of the mean. Student's T-test revealed that there was not a statistically 
significant difference between EC and 1 day R.A. treated samples. 
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With a mind to future work the next factor to be assessed was Otx2, a homeodomain 
transcription factor expressed in dividing midbrain dopaminergic precursors that is 
essential for their formation (Puelles et al., 2004). In a mouse model W n t l was able to up 
regulate Otx2, in turn repressing expression o f Nkx2-2 which is involved in the 
acquisition o f alternative non dopaminergic neuronal fates (Prakash et al., 2006). W n t l 
could also help expand the number of Nur r l positive precursors in rat mesencephalic 
cultures (Castelo Branco et al., 2003). Given the peak in Nur r l expression at 1 day o f 
retinoic acid treatment, the combined use o f W n t l and retinoic acid was seen as a possible 
area for subsequent investigations. Therefore given the favourable effects Otx2 could 
potentially possess, its m R N A expression pattern fol lowing retinoic acid treatment was 
studied, see Figure 3.3. In the untreated embryonal carcinoma stem cells Otx2 mRNA is 
present, which would suggest that i f it is a part o f the machinery required to specify a 
dopaminergic fate, then it may be the case that embryonal carcinoma cells are a viable 
model for use in the study o f dopaminergic neurogenesis. However upon retinoic acid 
treatment as is clearly seen in Figure 3.3, expression plummets and shows no signs o f 
recovery within the two week time frame. Although this appears to be a negative finding 
it does pose the question o f whether expression o f Otx2 can be rescued fol lowing addition 
of retinoic acid by adding another compound such as W n t l . It is also an interesting 
observation alongside the Nur r l result in the sense that embryonal carcinoma stem cells 
are seemingly able to express markers that may indicate they are further towards a 
differentiated state than the embryonic stem cells for which they act as a model. 
Figure 3.3: Otx2 m R N A Expression in Tera2.cl.SP12 cells and their derivatives 
i2 
140 
120 
S2 
S 100 
CM 
O 
(0 (0 0) 
a. 
X 0) 
0) 
> 
0) 
a: 
80 
60 
40 
20 
E C D a y l E C + R A D a y 3 E C + R.A D a y 5 E C + R A D a y 7 E C + R A 2 W e e k E C + R A 
Relative expression of Otx2 in different samples 
Figure 3.3: Real time PCR data showing the changes in the relative expression levels of Otx2 
mRNA in undifferentiated cultures of Tera2.cl.SP12 embryonal carcinoma stem cells and their 
10(4,M retinoic treated derivatives over a two week period (n=3). Error bars represent the S.D. 
of the mean. 
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Figure 3.4: Soxl m R N A Expression in Tera2.cl.SP12 cells and their derivatives 
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Figure 3.4: Real time PCR data showing the changes in the relative expression levels of Soxl 
mRNA in undifferentiated cultures of Tera2.cl.SP12 embryonal carcinoma stem cells and their 
10|xM retinoic treated derivatives over a two week period (n=3). Error bars represent the S.D. of the 
mean. 
Further analysis by the same technique o f the embryonal carcinoma plus retinoic acid 
system focussed on Sox l , a marker o f dividing neural precursors that is strongly 
associated with neuronal fate acquisition both in vivo and in vitro (Pevny et al., 1998). 
The expression o f which was highlighted as being an important factor when studying the 
dopaminergic differentiation o f human embryonic stem cells in the presence o f Sonic 
hedgehog and Fibroblast growth factor 8 (Yan et al., 2005). The effect in this work was 
temporal and given the likelihood o f using these molecules in later studies especially 
given that W n t l which was possibly another factor to be investigated may interact or 
create permissive conditions for them (Burbach & Smidt, 2006), it seemed prudent to gain 
an understanding o f the regulation o f Soxl expression. Figure 3.4 clearly demonstrates 
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that expression is low in the embryonal carcinoma stem cells and rises in a predictable 
almost linear fashion with increasing exposure time to retinoic acid over the two week 
period o f study. This is indicative that i f Sonic hedgehog and Fibroblast growth factor 8 
are to be utilised effectively then it is probably going to be necessary to apply them 
reasonably early in the differentiation process. It also illustrates that in general as was the 
case in Figure 3 . IB , retinoic acid can cause increased neural marker expression over time. 
When real time PCR was put to further use to investigate the effects o f retinoic acid over 
both two and four weeks in both normal and 5% oxygen, similar trends were observed for 
other markers associated with a dopaminergic cell fate. This work also started to give an 
insight into the effects o f oxygen pressure as a dopaminergic phenotype inducing agent in 
Tera2.cl.SP12 embryonal carcinoma stem cells. Figure 3.5 shows that there is a 
predictable rise in the expression o f tyrosine hydroxylase over time, up to four weeks in 
both oxygen environments. However there is no real difference in the expression o f 
tyrosine hydroxylase between 5 and 2 1 % oxygen cultures. The output of the two way 
anova performed to assess i f there are any statistically significant effects indicates that 
between two and four weeks o f retinoic acid application there is almost a significant 
effect due to time (p value o f 0.051). Oxygen pressure though alone has no effect and 
there does not appear to be any favourable interaction between pressure and time. 
Figure 3.6 illustrates the pattern o f expression for dopamine receptor 2 under the same 
conditions; however although the trend here is the same as for tyrosine hydroxylase, the 
time o f exposure to retinoic acid from two to four weeks has a less significant effect upon 
expression. Again oxygen pressure exhibits no statistically significant or tangible effect 
and the slight trend observed is that normal oxygen is the favourable condition at both 
two and four weeks which contradicts the hypothesis that lowered oxygen is likely to up 
regulate dopaminergic marker expression and the acquisition o f that specific 
neurotransmitter phenotype. The parallel lines on the line graph (Figure 3.6) also neatly 
indicate that there is no obvious interaction between oxygen pressure and time period o f 
retinoic acid treatment. 
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Figure 3.5: The effect of oxygen pressure and durat ion o f R.A. exposure on the 
relative expression of tyrosine hydroxylase m R N A in Tera2.cl.SP12 cultures 
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Figure 3.5: The relative expression of tyrosine hydroxylase mRNA in undifferentiated 
Tera2.cl.SP12 cells and their derivatives exposed to \0\iM retinoic acid for 2 or 4 weeks in 
either a 5% or normal (21%) oxygen culture environment. The output of the 2 way anova 
indicated that between 2 and 4 weeks there is almost a statistically significant effect (p value 
of 0.51) due to time period of retinoic acid exposure but that there is no effect due to oxygen 
pressure. In addition it also shows that there is no significant synergistic interaction between 
oxygen pressure and the duration of retinoic acid treatment. Error bars represent the S.D. of 
the mean. In all experiments n=3. 
Figure 3.6: The effect o f oxygen pressure and durat ion o f R.A. exposure on the relative expression of D2 m R N A in Tera2.cl.SP12 
cells 
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F i g u r e 3.6: The relative expression of dopamine receptor 2 (D2) mRNA in undifferentiated Tera2.cl.SP12 cells and their derivatives exposed to lOuM retinoic acid for 2 or 4 weeks 
in either a 5% or normal (21%) oxygen culture environment. The output of the 2 way anova performed indicated that between 2 and 4 weeks there is no statistically significant effect 
due to time period of retinoic acid exposure and that there is also no effect due to oxygen pressure. In addition it indicates that there is no significant synergistic interaction between 
oxygen pressure and the duration of retinoic acid treatment. The almost perfectly parallel nature of the lines on the lower graph neatly supports this observation as this would be the 
expected result if there were no interaction between the two factors under investigation. Error bars represent the S.D. of the mean. In all experiments n=3. 
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Figure 3.7: Morphological Images 
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Figure 3.7: Morphological phase images of Tera2.cl.SP12 EC cells in their undifferentiated 
state and their 4 week 10)a.M retinoic acid induced derivatives in 5% and normal oxygen 
environments. The Tera2.cl.SP12 cells were viewed using a 40x objective lens (scale bar 
represents 25nm) and have a characteristic reasonably uniform appearance. Their 4 week 
retinoic acid treated derivatives were viewed using a lOx objective lens (scale bars represent 100 
l^m). There are no clear morphological differences between the 4 week cuhures in the different 
oxygen conditions but it is apparent that the cultures have lost their uniformity during the 
process of differentiation producing a mixture of cell types. 
Some additional real time PCR was also performed on R N A samples sent to Dr. V . 
Lakics (Appendix B). These analyses indicated that in the embryonal carcinoma cells and 
their 1, 3, 5 and 7 day retinoic acid treated derivatives there was a generally low 
expression o f the dopaminergic markers tyrosine hydroxylase, dopamine receptor 1, 
dopamine receptor 2, dopamine transporter and N u r r l . However dopamine receptor 1, 
dopamine transporter and Nur r l could all be detected at four weeks in both 5 and 2 1 % 
oxygen samples. These findings are congruous with the observations shown previously in 
that retinoic acid treatment o f Tera2.cl.SP12 embryonal carcinoma stem cells is able to 
induce expression o f a range o f dopaminergic markers in such samples. Once again the 
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use o f lowered (5%) oxygen as for tyrosine hydroxylase and dopamine receptor 2 has 
seemingly no effect in this cell system, at least at the oxygen pressure tested. 
Figure 3.7 shows some morphological images of the embryonal carcinoma cells 
themselves and fol lowing four weeks o f retinoic acid induced differentiation in both 
oxygen environments. Retinoic acid causes a mix o f cell types to form from the original 
embryonal carcinoma stem cells but there are no obvious differences at the basic level o f 
observable cell morphology. This too is in keeping with the results from the real time 
PCR analyses. 
After making an assessment o f the effects o f retinoic acid and physiological oxygen at the 
morphological and m R N A level and in the light o f the fact that proteins are the functional 
components o f a cell the next step experimentally was to start to gain an understanding of 
the patterns o f protein expression. Indeed although the mRNA was present for several 
dopaminergic markers this is not proof that the translated protein is expressed. Flow 
cytometry, Western blotting and immunocytochemistry were employed to confirm the 
expression o f known neuronal and dopaminergic phenotypic indicators, as well as to gain 
an insight into the levels at which they are present ( f low cytometry) and their cellular 
distribution (immunocytochemistry). After having seen a peak in the expression of Nurr l 
mRNA this protein was the first to be investigated. In the light o f this finding and the 
work o f Misiuta et al., 2006, where N u r r l protein expression rose significantly after one 
day o f exposure o f Ntera2.Dl embryonal carcinoma stem cells to retinoic acid, the 
expectation was that a peak may also be observed in the Tera2.cl.SP12 system. However 
using both flow cytometry and Western blotting as can be seen in Figure 3.8 it was 
impossible to gain any meaningful data. There are large fluctuations in the percentage o f 
cells expressing N u r r l and the intensity o f expression is very low being comparable to 
that o f negative controls. There is in addition little to no detection o f the protein via 
Western blotting. There are a number o f possible reasons for these results; one option is 
that in the Tera2.cl.SP12 cells the mRNA is expressed but the protein is not. Another is 
that the antibody used did not work particularly well . The antibody was however tested 
on some brain material where expression o f Nur r l is normally expected to be detectable. 
The data from this (Appendix C) display a quite diffuse band on a Western blot. This 
would suggest that it may well be the case that the immunological reagent used was part 
o f the problem, as a positive control would usually be expected to give a strong clear band 
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and this was not obtainable after a number o f attempts. Beta-actin used as a loading 
control was clearly detectable and amido black staining o f the nitrocellulose membrane 
confirmed there was protein present, giving support to the notion that the antibody was 
the limiting factor. There is also the possibility that the expression o f the mRNA and 
protein do not correlate and thus different patterns are seen. The only small trends that 
can be seen from the flow cytometry results are that on average Nur r l protein is 
expressed in more cells at a slightly greater intensity fol lowing one day o f retinoic acid 
treatment than after three, five or seven days. The data though are too ambiguous to 
make any real conclusions from. 
This is particularly highlighted by the Western blot data in Figure 3.8 which show that 
there is seemingly a faint non specific binding o f the antibody resulting in detection o f 
multiple bands. These could be break down products or complexes o f proteins containing 
N u r r l but there is a strong possibility that given the technical problems with the antibody 
that they result f rom non specific binding o f it to non-target proteins. This reinforces the 
notion that the data provide insufficient evidence on which to make any f i rm judgements. 
The expression o f tyrosine hydroxylase, the rate l imit ing enzyme in dopamine 
biosynthesis was also assessed using the same techniques as for N u r r l . Figure 3.9 shows 
there are generally large numbers o f cells expressing this protein. The intensity o f this 
expression varies in the initial seven days o f retinoic acid exposure but over time retinoic 
acid has an inductive effect. The Western blot (Figure 3.9C) is indicative o f weak levels 
o f expression where there is no major observable difference. The protein data for tyrosine 
hydroxylase show a basic correlation with the findings o f the real time PCR analyses, 
with low expression in the starting material and in the first seven days leading to an 
eventual rise by four weeks. However the faint nature o f the Western blot detection 
although limited to a discrete band may reflect a broad and possibly non specific binding 
o f the antibody, this idea is supported by the widespread expression o f this marker by a 
large number o f cells in the flow cytometry analysis. The detection seen may also be 
more an artefact o f the sensitivity o f the technique than a reflection of a true robust 
expression o f the protein. Overall therefore there is unlikely to be any significant level o f 
tyrosine hydroxylase present at the early stages o f differentiation. 
Figure 3.8: N u r r l protein expression in Tera2.cLSP12 cells and their derivatives 
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Figure 3.8A: Flow cytometric analysis of the number of cells expressing Nurrl in 
Tera2.cl.SP12 cultures and their 10)a.M retinoic acid induced counterparts up to 7 days. Error 
bars represent the S.D. of the mean. B: The intensity of Nurrl expression in such cultures. 
Error bars represent the S.E.M. C: A Western blot showing protein expression in identical 
samples. D: (i) A Western blot probed for Nurrl carried out on 3 different passages of MG63 
cell samples expected to be negative for Nurrl expression. Although a band of Nurrl 
expression is not seen there does appear to be some non specific binding of the antibody in other 
areas, this is also the case in C. above, (ii) Detection of beta-actin in the MG63 cell samples 
used as a loading control. Given the non specific binding of the antibody and technical 
problems with it as mentioned in the main text neither the Western blot nor flow cytometry data 
yielded any meaningful result. In all experiments n=3. 
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Figure 3.9: T H protein expression in Tera2.cl.SP12 cells and their derivatives 
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Figure 3.9A: Flow cytometric analysis of the number of cells expressing tyrosine hydroxylase 
in Tera2.cl.SP12 cultures and their !0|i.M retinoic acid induced counterparts up to 4 weeks. 
Error bars represent the S.D. of the mean. B: The intensity of tyrosine hydroxylase expression 
in such cultures. Error bars represent the S.E.M. C : A Westem blot showing faint but 
detectable tyrosine hydroxylase protein expression in comparable samples up to 7 days of 
retinoic acid driven differentiation. Beta-actin was used as a loading control. In all 
experiments n=3. 
Figure 3.10: Beta I I I tubul in protein expression in Tera2.cl.SP12 cells and their 
derivatives 
A. 
a> 60 
EC 
(Untreated) 
Day 1 Day 3 Day 5 Day? 2 Week 4 Week 
B. 
Duration of R.A. Exposure 
5000 
« 3500 
= 3000 
Sig. <0.05 
A 1500 
EC Day 1 Day 3 Day 5 Day 7 
Duration of R.A. Exposure 
2 Week 4 Week 
Figure 3.10A: Flow cytometric analysis of the number of cells expressing the neuronal 
marker Tuj 1 in Tera2.cl.SPl 2 cultures and their 1 OiiM retinoic acid induced counterparts up to 
4 weeks. Error bars represent the S.D. of the mean. B: The intensity of Tuj 1 expression in 
such cultures. Error bars represent the S.E.M. Student's T-test indicated that there was a 
statistically significant increase in mean fluorescence intensity from the EC cells to their 
derivatives treated with retinoic acid for 1 day. In all experiments n=3. 
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Figure 3.10 shows that the neuronal marker Beta III tubulin when assessed by flow 
cytometry displays a similar pattern of expression. However there are a couple of key 
differences. The first of these is that the starting material expresses tyrosine hydroxylase 
more strongly than the cells after one day of retinoic acid treatment. The opposite is true 
for Beta III tubulin which shows a statistically significant rise in expression following 
induction with retinoic acid for one day. This mirrors the rise in expression of Nurrl and 
is in accordance with the concept that Nurrl may help promote neuronal differentiation. 
The other main difference is that although Beta III tubulin, as for tyrosine hydroxylase, 
appears overall to be induced with lengthening exposure to retinoic acid, at two weeks 
there is a dip in both the amount and intensity of its expression. Therefore although 
predictable almost linear rises in certain markers can be observed upon retinoic acid 
treatment of Tera2.cl.SP12 cultures, this is not always the case and there may be subtle 
effects at different times when assessing the regulation of certain proteins of interest. 
Figure 3.11 summarises the mean fluorescence intensity data for all three markers 
displaying the overall trend of retinoic acid induction by four weeks and the peak in Beta 
III tubulin expression after one day. 
Figure 3.11: Summary mean fluorescence intensity flow cytometry data 
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Figure 3.11: The intensity of Nurrl, TH and Beta III tubulin protein expression assessed by 
flow cytometry, in Tera2.cl.SP12 cultures and their lOuM retinoic acid induced derivatives 
over 4 weeks of differentiation. Error bars represent the S.E.M. (n=3). 
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When the effect of lowered oxygen was also investigated utilising the same techniques a 
pattern of protein expression comparable to that for the mRNA was observed. Figure 
3.12 shows that there is little difference in the number of cells expressing tyrosine 
hydroxylase from two to four weeks but there is a rise in the intensity of this expression. 
Oxygen pressure appears to exert no real or statistically significant effect and at the 
protein level time also has less of an impact on the induction of tyrosine hydroxylase. 
However overall as for the mRNA there is still the trend of oxygen pressure having little 
effect and increased duration of retinoic acid exposure leading to higher levels of 
expression of this dopaminergic marker. 
Figure 3.13 shows that for the neuronal marker Beta I I I tubulin the situation is similar to 
that for tyrosine hydroxylase. There is more of an induction due to retinoic acid exposure 
between two and four weeks although this may in part be due to the observed dip at 2 
weeks. There is also once again no tangible or statistical effect caused by using lowered 
oxygen conditions. 
Western blotting was also used to try and give further support to these observations. 
Figure 3.14 neatly shows that for tyrosine hydroxylase there appears to be an induction of 
expression with retinoic acid treatment over time (although mainly at 4 weeks) and in a 
consistent manner with other techniques, the data indicate that oxygen pressure has no 
effect. Figure 3.15 shows that there is some very faint inconclusive expression of Nurrl 
at two and four weeks but as for the earlier data no firm conclusions can be made for the 
reasons outlined previously, non specific binding of the antibody being one major 
problem as evidenced by the presence of multiple bands. 
Figure 3.12: The effect of oxygen on TH protein expression in Tera2.cl.SP12 cells 
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Figure 3.12A: Flow cytometry was used to assess the percentage of Tera2.cl.SP12 cells 
expressing TH protein after 2 or 4 weeks of lOjiM retinoic acid induced differentiation in 
5% or normal oxygen culture conditions. Error bars = S.D. of mean. B: The intensity of 
TH expression in these cell samples was also measured. Between 2 and 4 weeks neither the 
duration of retinoic acid exposure or oxygen pressure exerted any significant effect, either 
alone or in concert. Error bars represent the S.E.M. (n=3). 
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Figure 3.13: The effect of oxygen on Beta I II tubulin protein expression in 
Tera2.cl.SP12 cells 
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Figure 3.13A: Flow cytometry was used to assess the percentage of Tera2.cl.SP12 cells 
expressing Tuj 1 protein after 2 or 4 weeks of 1 OnM retinoic acid induced differentiation in 
5% or normal oxygen culture conditions. Error bars represent S.D. of mean. B : The intensity 
of TH expression in these cell samples was also measured. Between 2 and 4 weeks neither the 
duration of retinoic acid exposure or oxygen pressure exerted any significant effect, either 
alone or in concert. Error bars represent the S.E.M. (n=3). 
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Figure 3.14: Assessment of T H expression via Western Blotting 
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Figure 3,14: A Western blot showing tyrosine hydroxylase protein expression in 
Tera2.cl.SPI2 stem cells and their 2 and 4 week 10|iM retinoic acid treated derivatives in 
both 5% and normal oxygen culture environments. The best representation of n=3 blots 
each ran using biologically independent samples is shown. Beta-actin was used as a 
loading control. The presence of multiple bands may indicate non specific binding of the 
antibody or be the result of break down products given the bands are smaller in size than 
the main band. Non specific binding is more likely as the products are only slightly 
smaller than the main band of interest. This non specific binding would support the flow 
cytometry data that indicate many cells are antigen positive which could be accounted for 
by the binding of the antibody in a non specific manner. There does though appear to be 
some inductive effect particularly at 4 weeks due to retinoic acid exposure in a consistent 
manner with the flow cytometry (mean fluorescence intensity) and real time PGR data. 
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Figure 3.15: Assessment of N u r r l expression via Western Blotting 
Nurrl (67 kDa) 
3-actin (42 kDa) 
Staining very 
diffuse/inconclusive 
Figure 3.15: A Western blot showing Nurrl protein expression in Tera2.cl.SP12 stem cells 
and their 2 and 4 week lO^M retinoic acid treated derivatives in both 5% and normal 
oxygen culture environments. The best representation of n=3 blots each ran using 
biologically independent samples is shown. Beta-actin was used as a loading control. The 
presence of multiple bands indicates that there may well be non specific binding of the 
antibody as mentioned previously. This in combination with the technical problems found 
when using the antibody essentially gives rise to a result that is far too ambiguous to base 
any meaningful conclusions on, as was the case in Figure 3.8 where the same reagent was 
used and where no real outcome was found. 
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The final technique used was immunocytochemistry. This gave an insight into the 
changing distribution and expression of Beta II I tubulin and tyrosine hydroxylase. It was 
also used to assess nestin expression as the presence of this neuroprogenitor marker 
would confirm that retinoic acid treated cultures at four weeks were still populated by 
some cells that were less mature and relatively undifferentiated. In the longer term i f 
nestin expression could be down regulated or turned off it may then favour acquisition of 
neuronal phenotypes as in Hara et al., 2007. Figures 3.16 and 3.17 show nestin 
expression in both sub confluent and confluent Tera2.cl.SP12 cultures, both conditions 
were tested as cells exist in both states at some point in their cycle of usage. In both 
scenarios nestin is clearly expressed, however tyrosine hydroxylase is expressed in a 
diffuse pattern and this too is the case for Beta II I tubulin. The expression is so weak it is 
hard to detect in the merged images. This may be due to a degree of non specific binding 
of the antibodies used giving rise to a diffuse but detectable haze when recording the data. 
There is certainly no clear staining associated with neuronal cell body or process like 
structures. In the light of this positive staining is only viewed as such in the remainder of 
this Thesis i f clear detection is observed alongside a characteristic morphological pattern 
indicative of potential neurites in culture (i.e. cell body and process like structures). 
Figure 3.18 shows the expression of these three markers following four weeks of retinoic 
acid treatment in both oxygen environments. Beta II I tubulin staining is more intense and 
generally seen in neuronal process like structures leading from what could be neuronal 
cell bodies. It is hard by eye to discern any major differences due to oxygen tension. For 
tyrosine hydroxylase, which as a cytosolic protein is more diffuse in its appearance than 
the cytoskeletal Beta I I I tubulin, the scenario is somewhat different. There is expression 
associated with small process like structures emanating from possible cell bodies but the 
detection of such cells is scarce. Circles highlight possible candidates as in the merged 
image the Hoescht stained nuclei predominate heavily. This would suggest that there 
may be a low number of tyrosine hydroxylase positive cells that display neuronal type 
morphology present in such cultures. It does though highlight that the high numbers of 
cells detected as antigen positive in the earlier flow cytometry analysis are probably not a 
reflection of a high number of truly tyrosine hydroxylase positive cells of a potentially 
neuronal nature being present but are more likely the result of a broad non specific 
binding of the andbody. This is further supported by the detection of multiple bands in 
the Western blot in Figure 3.14, which are a further indication of non specific binding of 
the antibody. There once again at both time points appears to be little difference between 
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5 and 21 % oxygen culture environments. The presence of nestin at four weeks shows that 
the cultures even after exposure to retinoic acid still possess some relatively immature 
cells. However the pattern of nestin expression as for tyrosine hydroxylase and Beta III 
tubulin is different from the undifferentiated to the differentiated cells which is 
compatible with the idea that as the cultures mature in the presence of retinoic acid there 
is a remodelling of the cellular architecture as more differentiated cell types form. 
Essentially these along with the results outlined previously indicate that retinoic acid can 
induce expression of neuronal as well as dopaminergic markers and give rise to cells 
reflective of a neuronal morphology. In addition they demonstrate that using 5% oxygen 
has no favourable effects over using standard (21%) oxygen culture conditions when 
utilising the Tera2.cl.SP12 cell line as a tool to study dopaminergic neurogenesis. 
109 
Figure 3.16: Immunostaining of Sub-Confluent Undifferentiated Tera2.cLSP12 E C 
cell cultures 
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Figure 3.16: Immunostaining of sub-confluent Tera2.cl.SP12 cultures for Nestin, TH and 
Tuj 1. Hoescht nuclear stain was used to confirm the presence of cells by staining their nuclei. 
Secondary only controls received no primary antibody treatment just the vehicle that primary 
antibodies were diluted in for the test conditions. All images were merged using Adobe 
Photoshop (scale bars represent 50|im). In all experiments n=3. Nestin is clearly detectable 
in EC cells. However TH and Beta III tubulin are only detectable as a weak haze on the 
image that is barely observable. This background level of detection is almost too faint to 
discern and may arise from a degree of non specific binding of the primary antibodies used. 
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Figure 3.17: Immunostaining of Confluent Undifferentiated Tera2.cl.SP12 E C cell 
cultures 
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Figure 3.17: Immunostaining of confluent Tera2.cl.SP12 cultures for Nestin, TH and Tujl . 
Hoescht nuclear stain was used to confirm the presence of cells by staining their nuclei. 
Secondary only controls received no primary antibody treatment just the vehicle that primary 
antibodies were diluted in for the test conditions. All images were merged using Adobe 
Photoshop (scale bars represent SO i^m). In all experiments n=3. Nestin is clearly detectable 
in EC cells. However TH and Beta III tubulin are only detectable as a weak haze on the 
image that is barely observable. This background level of detection is almost too faint to 
discern and may arise from a degree of non specific binding of the primary antibodies used. 
This background detection is slightly more apparent for TH than Beta III tubulin, which is 
consistent with the TH antibody detecting multiple bands on the Western blot in Figure 3.14. 
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Figure 3.18: Immunostaining of 4 week R.A. differentiated E C cells 
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Figure 3.18: Immunostaining for Nestin, TH and Tujl of Tera2.cl.SP12 cultures treated with 
10|iM retinoic acid for 4 weeks in either 5% or normal (21%) oxygen conditions. All images 
were merged using Adobe Photoshop, Hoescht was used to stain cell nuclei (scale bars 
represent SO i^m). In all experiments n=3. Nestin is still detectable in EC cell cultures after 4 
weeks of exposure to retinoic acid. Beta 111 tubulin is detectable in structures resembling 
neuronal cell bodies and processes. TH is in areas such as those highlighted with circles 
present in small process like structures associated with potential cell bodies. This staining 
although dominated by the blue Hoescht stain is stronger than the background haze observed 
in Figures 3.16 and 3.17 and may indicate that there are a very small number of cells that are 
tyrosine hydroxylase positive that possess a morphology characteristic of what might be 
expected for a TH positive neurite in culture. 
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3.4 Discussion 
In this Chapter the core objective was to gain an understanding of the human 
Tera2.cl.SP12 embryonal carcinoma stem cell line as a model to study dopaminergic 
neurogenesis. A number of hypotheses based on the literature outlined in the introductory 
Section 3.1 were specifically tested, in addition to a broader characterisation of the system 
being undertaken. The most basic hypothesis to be tested was whether retinoic acid can 
be used to induce expression of dopaminergic markers over time and also do embryonal 
carcinoma stem cells express any of these markers? From the results obtained it can be 
seen that Tera2.cl.SP12 cells do express often low but detectable levels of (at both the 
mRNA and protein level) a range of factors associated with a dopaminergic phenotype. 
However in some cases for proteins this may be questionable due to possible non specific 
binding of the immunological reagents used, but in terms of detecfion of the mRNA 
although detectable expression is often weak, this is a coherent finding in the context of 
embryonal carcinoma cells generally showing a propensity for neural differentiation. It 
appears that although the Tera2.cl.SP12 embryonal carcinoma cells express markers of 
pluripotency in a similar fashion to embryonic stem cells for which they are an apposite 
model system, they also differ in that they appear to be primed for neural differentiation 
and possibly exist in a state between an embryonic stem cell and a neuroprogenitor based 
on the marker expression data obtained (Figure 3.19) (Abeliovich & Hammond, 2007) 
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Figure 3.19: Midbrain dopaminergic neuron development (based on Abeliovich <& 
Hammond. 2007) 
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Figure 3.19: Changes in marker expression during dopaminergic development. Markers 
expressed by embryonal carcinoma cells are shown in red. The fact that such cells express 
markers associated with a range of developmental stages makes it difficult to assess where 
they lie in terms of them acting as a developmental model. It may be that it is the amount of 
certain markers present at any given time that is critical to their effect, based on Abeliovich & 
Hammond, 2007. 
It is also clear from the findings presented in Section 3.3 that retinoic acid can induce and 
generally up regulate a number of factors associated with a dopaminergic phenotype. 
However there are differences in the patterns of regulation seen. Soxl mRNA expression 
for example is controlled in an almost linear, highly predictable manner following retinoic 
acid treatment. In contrast Otx2 mRNA levels are driven to almost zero after just one day 
of expositre to retinoic acid, in an on/off type response. Some determinants of a 
dopaminergic phenotype like Nurrl are seemingly expressed throughout the 
differentiation process, as has been observed elsewhere (Misiuta et al., 2003), with 
possible peaks such as that seen for the mRNA at one day. In addition other markers like 
tyrosine hydroxylase and Beta I I I tubulin show a differential regulation with peaks and 
troughs, such as the peak in Beta II I tubulin expression after one day of retinoic acid 
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induction, the level of these factors though ultimately tends to increase with retinoic acid 
exposure time. 
There also appears to be some correlation between mRNA and protein expression levels. 
This could indicate that a high level of mRNA can rapidly be processed to yield a 
comparably large amount of protein. I f this is the case then the peak seen in Nurrl 
mRNA expression after exposure to retinoic acid for one day, that mirrors the peak seen 
in Nurrl protein expression in the work of Misiuta et al., 2006, where the sister Ntera2.Dl 
cell line is utilised, could correlate with the statistically significant increase observed in 
Beta I I I tubulin protein expression at this time point. Kara et al., 2007 were able to show 
Ntera2 cells over expressing Nurrl were nestin immunonegative which could indicate 
Nurrl may trigger an early commitment towards the neuronal lineage. I f this simple 
correlation exists between mRNA and protein levels and the processing of mRNA to 
protein is rapid then the results obtained here for Nurrl mRNA and Beta III tubulin 
protein may be related, with Nurrl possibly having an effect on the levels of Beta III 
tubulin present. This possible interaction is extremely unlikely to be instantaneous prior 
to the time of sample collection but could feasibly occur in the first day of differentiation. 
Given retinoic acid treatment of Tera2.cl.SP12 cultures results in a mix of cell types, it 
may be that the neuronal lineage is specified early via a mechanism involving Nurrl. 
However there may not be such a simple correlation between mRNA and protein levels. 
I f this is the case then the finding that Nurrl is expressed in the Tera2.cl.SP12 cells 
themselves may be at least part of the reason why this rise in Beta II I tubulin after one 
day of retinoic acid exposure is observed. This is in keeping with the concept that the 
embryonal carcinoma cells are primed for neural and possibly particularly neuronal 
differentiation. I f either of these scenarios is true and the early rise in neuronal marker 
expression is not due to chance or another set of factors not investigated here then there is 
the suggestion that the Tera2.cl.SP12 cell line might be a suitable vehicle for studying 
dopaminergic neurogenesis. 
Oxygen pressure however appears to be unable to exert any effect on the acquisition of a 
dopaminergic phenotype by Tera2.cl.SP12 cells. In the light of the work of Studer et al., 
2000 who showed that this variable can strongly influence the production of 
dopaminergic neurons from rat mesencephalic precursors, the absence of any real 
difference in the Tera2.cl.SP12 system could be viewed as surprising. It may even 
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suggest that the embryonal carcinoma cells are perhaps unsuitable for use or incapable of 
responding in a similar fashion to the rat midbrain cells to oxygen. This however might 
be expected given that rat mesencephalic precursors are very disparate from human 
embryonal carcinoma stem cells, not just in the fact they come from different species but 
also different locations. A midbrain cell may be more responsive to in vitro replication of 
its in vivo environment, where as an embryonal carcinoma stem cell may exhibit no 
preference, as it would not naturally be found in the brain. This is a negative in that 
embryonal carcinoma cells are unresponsive to one factor that may increase the 
production of dopaminergic neurons. It could though be viewed as a positive in that they 
offer a robust system in which other factors can be studied without the variable of oxygen 
having an effect on any findings. Also during the specification of a dopaminergic 
phenotype, a cell bound for this fate may experience a range of oxygen pressures during 
its development, so although the embryonal carcinoma system may appear to simplify the 
possible level of understanding that can be obtained, it may actually in the light of current 
knowledge act as a more realistic base from which to develop. In addition a study by 
Kim et al., 2008 showed only a 1.34 fold increase in the number of tyrosine hydroxylase 
positive cells when a lowered (3.5%) oxygen environment was used to try to enhance the 
dopaminergic differentiation of murine embryonic stem cells. This again supports the 
notion that lowered oxygen may be best reserved for work using mesencephalic cultures, 
where it has a markedly greater effect both alone as in Studer et al., 2000 and in concert 
with other inductive factors (Maciaczyk et al., 2008) . Given the observations in this 
Chapter the decision was made that all future work was to be carried out under standard 
culture conditions. 
Two other observations of interest that may also influence future work are those relating 
to the expression of the mRNA for Soxl and Otx2. First of all it appears that i f Sonic 
hedgehog and Fibroblast growth factor 8 are to be used then as shown for embryonic stem 
cells in Yan et al., 2005 and in the light of the findings of Stull and laccovitti, 2001, it is 
highly probable that they need to be applied reasonably early in the differentiation process 
to try and maximise their effect. Given the steady rise in Soxl, it is likely that no more 
than seven days of retinoic acid treatment will be required. However given that the most 
significant effects of this molecule appear to be at one day, the combined use of retinoic 
acid, Sonic hedgehog and Fibroblast growth factor 8 could be highly optimal, especially 
in a temporal sense. 
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The observation though that retinoic acid strongly down regulates the level of Otx2 
mRNA appears to be a negative indicator in terms of the suitability for use of the 
Tera2.cl.SP12 system in the context of studying dopaminergic differentiation. The 
counter balance to this is the question of whether Wntl or another means could be used to 
rescue Otx2 expression. Wntl has also been shown to possess a range of other effects 
(shown in Figure 3.20), of particular interest are its ability to increase the number of 
Nurrl positive precursors and the number of neurons produced by rat midbrain precursor 
cultures (Castelo Branco et al., 2003). I f these possible effects could augment those of 
retinoic acid on Nurrl and Beta II I tubulin expression already observed then this could be 
one route to enriching the number of neurons particularly those of a dopaminergic 
phenotype produced from Tera2.cl.SP12 cultures and for this reason the effects of Wntl 
were decided upon as the next factor for investigation. 
Figure 3.20: Investigating the potential effects of Wntl on the dopaminergic 
differentiation potential of Tera2.cl.SP12 human E C stem cells 
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Figure 3.20: Potential effects of Wntl that could possibly be exploited in the Tera2.cl.SP12 
cell system, based on the in vitro work of Castelo Branco et al., 2003 (red text), and the in 
vivo work of Prakash et al., 2006 (blue text). 
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Chapter 4 
The effects of Wntl on the 
dopaminergic 
differentiation of the 
Tera2.cl.SP12 cell line 
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4.1 Introduction 
Wnts are a family o f proteins consisting o f nineteen members that are typically 350 to 
500 amino acids in length (Castelo-Branco & Arenas, 2006). They are subject to post 
transcriptional modifications such as glycosylation (Nusse & Varmus, 1992), and 
palmitoylation (Willert et al., 2003) and it is these alterations that account for their 
poor solubility in aqueous solutions, hydrophobic nature and preference for being 
located in cell membranes and the extracellular matrix. These properties may indicate 
that Wnts are likely to possess an action mainly at short range; however they are also 
able to exert an activity on targets at a distance (Zecca et al., 1996). As a family they 
are known to regulate a broad range o f developmental processes including 
proliferation (Taipole & Beachy, 2001), stem cell self renewal (Rega et al., 2003), fate 
specification (Dorsky et al., 1998) and differentiation in neural cells (Rosso et al., 
2005). 
Wnts bind to and can activate two different types of receptor. The first o f these are 
the seven pass transmembrane protein frizzled receptor family which comprises ten 
members. In addition Wnts may also interact wi th two low density lipoprotein related 
receptor proteins, LRP5 and LRP6. Generally Wnt family proteins are classified as 
either canonical or non canonical in relation to the means by which they relay their 
signals. W n t l is a classical example o f a canonical Wnt that transduces its signal 
intracellularly by causing the stabilisation o f beta-catenin, with a subsequent 
activafion at the transcriptional level o f T-cell factor/lymphoid enhancer elements 
(Figure 4.1) (Logan & Nusse, 2004). Non canonical Wnts like Wnt5a may signal in a 
variety o f ways, for example, via activation o f small GTPases, by activation of the c-
Jun N-terminal kinase/planar cell polarity pathway or through increases in the amount 
of intracellular calcium (Veeman et al., 2003). A number o f different processes f rom 
the early to late stages o f neural development are regulated by members o f the Wnt 
family (Castelo-Branco & Arenas, 2006), making it unsurprising that the effects o f 
one such protein were the subject o f investigation in this work. W n t l was chosen as 
the specific target to be studied for a number o f reasons, the background to which is 
detailed below. 
Figure 4.1: Wnt Signalling Pathways (redrawn from Arenas, 2005) 
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Figure 4.1: Canonical and non canonical Wnt signalling pathways, based on Arenas, 
2005. 
To begin, W n t l is expressed in the midbrain/hindbrain boundary by E8 and by E10.5 
the expression o f it has extended specifically to the domain in the ventral midbrain 
where dopaminergic neurons are formed. W n t l null mutant mice display a deletion o f 
the posterior midbrain that includes the area where dopaminergic neurons are located, 
as well as an absence o f the anterior hindbrain (McMahon & Bradley, 1990; Thomas 
& Kapecchi, 1990). Mice mutant for the receptor LRP6 have been reported to display 
a similar phenotype (Pinson et al., 2000). These results together indicate that Wnt l is 
likely to play a key role in the processes specifying neural precursor cells in specific 
brain regions. Theoretically it may exert an effect either on their proliferation, their 
differentiation or possibly even elicit a response based on a combination o f both 
factors (Arenas, 2005). Interestingly when W n t l is over expressed in transgenic 
animals under the control o f the promoter for engrailed 1, the result via a mechanism 
that involves proliferation and differentiation based effects is an increase in the cell 
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numbers and size o f the midbrain/hindbrain structures (Panhuysen et al., 2004). A l l 
o f this evidence is indicative o f W n t l possessing a key role in neural development. 
Further specific effects o f this signalling molecule have also been identified in other 
in vivo as well as in, in vitro systems. 
In a series o f experiments using a murine model and explant cultures, i t was found 
that W n t l exerts two clear effects. First o f all it is implicated in the formation o f the 
mesencephalic dopaminergic progenitor domain. It carries out this function via its 
ability to maintain expression o f Otx2 in the ventral mesencephalon which 
subsequently is involved in repressing the expression o f Nkx2-2 in this area. I f Nkx2-
2 is not repressed in the midbrain floor plate and basal plate, this results in the 
production o f serotonergic neurons rather than their dopaminergic counterparts 
(Prakash et al., 2006). Given the observation in Chapter 3 that retinoic acid causes a 
rapid decrease in Otx2 mRNA expression relative to that seen in the Tera2.cl.SP12 
cells themselves. It appeared prudent to investigate the potential ability o f Wnt l to 
rescue this effect or override the retinoic acid induced down regulation via its facility 
to maintain Otx2 expression. 
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Figure 4.2; Possible Signalling Pathways Implicated in Dopaminergic 
Neurogenesis (Adapted from Abeliovich & Hammond, 2007) 
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Figure 4.2: Transcription factors are in black text and soluble factors are in blue 
text. In the context of this work the question is; does Otx2 effect Lmxla expression 
in the Tera2.ci.SPI2 cell line in the presence of Wntl and retinoic acid? 
In addition in a fate mapping study that utilised fluorescence activated cell sorting 
involving corin, a floor plate specific cell surface marker. One et al., 2007, were able 
to demonstrate that mesencephalic floor plate cells possess a neurogenic activity and 
are able to form midbrain dopaminergic neurons in vitro, but that caudal floor plate 
cells lack this neurogenic potential. By carrying out further work in dreher mutant 
mice that contained a mutation in the locus for L m x l a and via the use o f transgenic 
mice that displayed ectopic expression o f Otx2 in caudal floor plate cells, Ono et al., 
2007 were able to illustrate that Otx2 establishes an anterior identity that imparts 
neurogenic activity to cells o f the floor plate. In turn defining a mesencephalic 
dopaminergic fate at least to some degree via induction of L m x l a (Ono et al., 2007). 
Given the concept that W n t l may create a permissive environment in which inductive 
cues such as Sonic hedgehog and Fibroblast growth factor 8 can operate to specify the 
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formation o f dopaminergic neurons (Burbach & Smidt, 2006) and the finding that 
W n t l can maintain expression o f Otx2 which itself may help specify a dopaminergic 
fate at least in part by a mechanism involving L m x l a . This poses the question o f 
whether W n t l could not only rescue or maintain Otx2 expression in itself but could it 
also display positive effects on the expression o f L m x l a and other downstream 
determinants (Figure 4.2) o f a dopaminergic phenotype? Also Sonic hedgehog pre 
treated mouse embryonic stem cells that have had the L m x l a gene introduced into 
them show a strong capacity for dopaminergic differentiation (Andersson et al., 
2006). This opens up the possibility i f Wnt l is able to exert a positive effect in the 
Tera2.cl.SP12 system that the next investigations to be undertaken could coherently 
link the W n t l studies into new work involving Sonic hedgehog and Fibroblast growth 
factor 8, based on the model presented in Burbach & Smidt, 2006 (Figure 4.3). 
Figure 4.3; Factors & Signals Involved in The Specification of a Dopaminergic 
Neuronal Fate from Neuroepithelial Stem Cells (based on Burbach & Smidt. 
2006) 
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Figure 4.3: Wntl may create a permissive environment in which Sonic hedgehog and 
Fibroblast growth factor 8 can function to drive the sequential development of 
dopaminergic neurons (based on Burbach & Smidt, 2006). 
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On top o f the possibilities for investigation that W n t l offers based on the first clear 
effect seen in Prakash et al., 2006, in this work they were also able to demonstrate that 
this glycoprotein has a secondary activity that is seen later in the process o f 
dopaminergic fate specification. It appears that Wnt l is required for the terminal 
differentiation o f midbrain dopaminergic precursors into mature dopaminergic 
neurons (Prakash et al., 2006). 
In an in vitro system using rat mesencephalic cultures W n t l was likewise able to exert 
two effects. In a similar fashion to WntSa, it was able to promote neurogenesis by a 
mechanism involving proliferation of Nur r l positive precursors. In a comparable 
manner but to a lesser extent than WntSa, it was able to influence the differentiafion 
of such precursors into mature dopaminergic neurons. The general ability o f W n t l to 
increase the number o f T u j l positive cells by two fold but unfortunately not the 
proportion o f tyrosine hydroxylase positive cells within this subpopulation (Castelo 
Branco et al., 2003) was another desirable effect to pursue, as it offered the prospect 
o f at least producing a more heavily neuronal, less mixed culture than those obtained 
using only retinoic acid in conjunction with the Tera2.cl.SP12 embryonal carcinoma 
stem cell system. In the light o f the sharp rise in Nur r l expression seen in this 
retinoic acid only condition after just 1 day o f exposure to it, and given the effects o f 
Wnt l on Nur r l posifive precursor cells, this too opened up the possibility o f whether 
W n t l could augment or cause some sort o f additional complimentary effect to that 
already observed. Therefore given that it may exert two effects rather than just one as 
appeared to be the case for Wnt3a and WntSa, and that any positive potentially 
demonstrable effects may not only tie in wi th previous work but also facilitate further 
study possibly involving the application o f Sonic hedgehog and Fibroblast growth 
factor 8, W n t l seemed a prime factor for investigation. 
The fact that it is a classical example o f a canonical Wnt added fiirther to this 
argument as over expression of beta-catenin in neural stem cells can both enhance 
their proliferation when Fibroblast growth factor 2 is present, as well as helping to 
induce neuronal differentiation when it is absent. As a canonical Wnt, it would be 
expected that W n t l would stabilise expression o f beta-catenin and thus possibly exert 
favourable effects in terms o f achieving production o f a dopaminergic phenotype 
from Tera2.cl.SP12 cells. Further work in rat El4.5 ventral midbrain precursor 
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cultures gave extra support to this idea. In this study the focus was on glycogen 
synthase kinase - 3p a key part o f the canonical signalling pathway. By applying two 
competitive inhibitors o f glycogen synthase kinase - 3p to the precursors, Castelo 
Branco et al., 2004 were able to show in a concentration dependent manner an 
increase in the number o f tyrosine hydroxylase positive cells. Beta-catenin over 
expression in such cultures was also capable o f causing an increase in tyrosine 
hydroxylase positive cell numbers. Interestingly both inhibitors increased the number 
of neurons present as well as the number of tyrosine hydroxylase positive cells within 
the neuronal population (Castelo Branco et al., 2004). One o f the inhibitors, 
KenpauUone, was able to raise the number of N u r r l positive precursors gaining a 
tyrosine hydroxylase positive phenotype, as well as causing an increase in expression 
of the dopaminergic marker c-ret. This compound was then applied to the 
dopaminergic cell line M N 9 D causing significant neurite outgrowth but exerting no 
effect on the proliferation rate of such cultures. Overall these observations suggest 
that the effects o f Wnts on dopaminergic differentiation may be mimicked by 
inhibition o f glycogen synthase kinase - 3p (Castelo Branco & Arenas, 2006). As 
described in Castelo Branco & Arenas, 2006, it is o f interest that inhibition o f 
glycogen synthase kinase - 3p can be achieved via stimulation o f other pathways, for 
example by Sonic hedgehog, giving a possible synergy with beta-catenin signalling 
( M i l l et al., 2005). This raises the question as to whether dopaminergic neurogenesis 
is regulated at key junctions where signals from different pathways intersect and are 
integrated (Castelo Branco & Arenas, 2006). 
A l l o f this evidence points to W n t l potentially possessing a number o f effects that 
could be effectively harnessed to influence the dopaminergic differentiation o f the 
Tera2.cl.SP12 embryonal carcinoma stem cell line. In summary the main hypotheses 
to be tested are; can Otx2 expression be rescued and i f so has this any effect on the 
expression o f L m x l a and its downstream partners? Can W n t l exert any additional 
effect on N u r r l expression in comparison to that already observed using retinoic acid 
in Chapter 3? Can any other dopaminergic markers be up regulated in their 
expression and is it possible to achieve an enhanced yield o f neurons? Also i f any o f 
these effects were achieved might they occur via a mechanism involving regulation o f 
beta-catenin? The methods used to test these theories fol low in the next section and 
the experimental results are described in section 4.3. 
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4.2 Cell Culture Methods 
Treatment of E C cell cultures with Retinoic acid and Wnt l 
Cultures o f Tera2.cl.SP12 EC cells were grown to confluency, the media aspirated 
f rom them, before being washed wi th I x PBS, prior to treatment for 5 minutes with 
0.25% (w/v) Trypsin/0.1% (w/v) EDTA (in HBSS) (Cambrex), to release the cells 
f rom the surface o f the culture flask. The Trypsin was then neutralized by addition o f 
4ml o f D M E M F G and any cells remaining loosely bound washed o f f the surface of 
the flask by pipetting the DMEMFG/Trypsin-EDTA mix against the side o f the flask 
where cell attachment occurs. A further wash with I x PBS was carried out to 
optimize the retrieval o f EC cells for use. The cell suspension was then transferred to 
a 15ml Falcon tube and spun in a centrifuge (Eppendorf 581 OR (swing bucket rotor 
A-4-62)) at SOOrpm, 4°C, for 2 minutes. The excess fluid was removed to leave a 
pellet. This was resuspended in D M E M F G and cell number determined by using a 
haemocytometer. Once the cell number was known the EC cells were subsequently 
seeded out at the fol lowing densities depending on the culture ware used: 
• For a T25-0 .5x10^ cells per flask, 
• For a single well o f a 6 well plate containing a 22mm poly-D-lysine coated 
glass coverslip - 0.2x10^ cells per well. 
Once cells were seeded out at an appropriate density for the culture vessel, they were 
exposed to one o f the fol lowing 3 conditions for varying periods o f time to attempt to 
induce differentiation. The 3 treatment regimes were exposure to a final 
concentration o f l O ^ M all trans retinoic acid (Sigma). Exposure to a final 
concentration o f 10|AM all trans retinoic acid (Sigma) along with Wnt l (Peprotech) 
(made up in sterile autoclaved distilled water) at a final concentration o f 2ng/ml, and 
finally exposure to a final concentration of 2ng/ml of W n t l . Media was changed 
every 2 - 4 days. A l l cells were maintained in standard 37°C, 5% CO2 incubators 
(Sanyo). 
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4.3 Results 
Prior to investigating the potential effects of W n t l , a small control experiment was 
carried out to try and assess i f the commercially available compound that had been 
purchased for use was able to function and exert an effect on the Tera2.cl.SP12 
system. In addition as the W n t l that was to be applied exogenously was dissolved in 
water before use, a vehicle control containing only water was included in the analysis 
to see i f the vehicle was able to cause any effect. In theory i f the vehicle caused little 
or no effect then any results observed were likely to be due to the presence o f W n t l . 
Real time PCR was used to assess expression o f the mRNA for Oct4 and Soxl as 
these two markers had previously been shown to be regulated in a predictable manner. 
Figure 4.4A shows that for Oct4, expression is high in the embryonal carcinoma cells 
and is subsequently down regulated fol lowing exposure o f them to retinoic acid. 
Exposure in the W n t l only condition is almost identical to that in the starting 
material, which may suggest Wnt l can maintain expression o f this stem cell marker or 
more realistically may indicate that Wnt l alone is insufficient to gain control o f the 
highly proliferative embryonal carcinoma cell cultures. The vehicle control appears 
to have no real effect and the embryonal carcinoma cells in practice just become very 
confluent and display continued Oct4 expression. The combined use o f retinoic acid 
and Wnt l shows little difference to the effect observed using retinoic acid alone. This 
may suggest W n t l has no effect in this instance or that retinoic acid is predominant in 
down regulating expression o f markers o f pluripotent stem cells and as such more 
responsible for exercising control over the cell system possibly by driving it towards a 
more differentiated state as was broadly seen in Chapter 3. 
Figure 4.4B shows that Soxl is up regulated as expected fol lowing 7 days of retinoic 
acid treatment o f the Tera2.cl.SP12 cell line in which it is only expressed at a low 
level. The W n t l only and vehicle control conditions show a highly similar result. 
This could indicate that the W n t l is not able to exert a detectable effect. However it 
may indicate that at the dose used W n t l alone is unable to exert any control over Soxl 
mRNA expression in the embryonal carcinoma cells. This latter option appears more 
likely as in the retinoic acid and W n t l condition there is a greater expression of Soxl 
mRNA than that seen in the retinoic acid only sample. This would suggest therefore 
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that W n t l in conjunction with retinoic acid can funcfion and possibly influence the 
differentiation o f the Tera2.cl.SP12 cell line. It also underpins the concept that 
retinoic acid may be necessary to gain control over the proliferative embryonal 
carcinoma stem cell starting material, by acting as an inducer o f differentiation. 
Figure 4.4: Testing f o r an effect due to the exogenously applied W n t l 
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Figure 4.4A: Real time PCR analysis of Soxl expression in Tera2.cl.SP12 cultures under a 
range of treatment conditions involving the application for 7 days of 10|iM retinoic acid, 
2ng/ml Wntl or water in the vehicle control. B: Real time PCR analysis of Oct4 expression 
in Tera2.cl.SP12 cultures under a range of treatment conditions involving the application for 
7 days of lO^M retinoic acid, 2ng/ml Wntl or water in the vehicle control. Error bars 
represent the S.D. of the mean. 
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Figure 4.5 shows the results o f an MTS assay used to assess cell proliferation. After 
seven days in culture the W n t l only condition is nearly identical to that for the 
embryonal carcinoma cell only control. This suggests that W n t l alone has no real 
tangible effect on the cell system. Retinoic acid alone and in combination with Wnt l 
does however show a clear effect after seven days as would be predicted. There is 
though no statistically significant difference between the retinoic acid only and 
retinoic acid plus W n t l conditions. Both these sample sets do display statistically 
significant differences from the Wnt l only condition, thus it appears that retinoic acid 
as suspected is likely to be required in some capacity to induce differentiation and 
gain a basic level o f control when trying to utilise W n t l at the concentration tested in 
this cell system. As a result most subsequent analyses in this Chapter do not include 
Wnt l only samples. When such a condifion is included it is just as a small scale 
screen to see i f W n t l alone can cause a result that may be detectable by one o f the 
range of techniques used. 
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Figure 4.5: Prol i ferat ion of Tera2.cl.SP12 cultures treated w i t h R.A. and W n t l 
Sig < 0.05 
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Figure 4.5: MTS assay data showing the differences in cell proliferation between 
untreated Tera2.cl.SP12 cells cultured for 7 days and their counterparts following 
treatment with 2ng/ml Wntl alone, 10 fiM retinoic acid alone, or a combination of both 
reagents for the same time span. In all experiments n=3 and error bars represent the S.D. 
of the mean. The one way anova output indicates that the Wntl only condition differs 
significantly from the retinoic acid only and combined Wntl plus retinoic acid samples, 
but these data sets do not differ significantly from each other. 
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Although W n t l could seemingly exert an effect when used alongside retinoic acid, i f 
it were to do so it would be expected to act via an appropriate receptor and by a 
canonical signalling mechanism. The pattern o f expression o f Frizzled 8, the receptor 
for W n t l , was assessed using real time PCR (Figure 4.6). This confirmed the 
presence of the m R N A for it and was therefore indicative that W n t l may be able to 
apply an effect on Tera2.cl.SP12 cultures. Receptor expression was also assessed in 
7, 14 and 21 day old cultures treated with retinoic acid alone or in combination with 
W n t l . There was a generally variable expression pattern, however at 7 days in the 
presence of both reagents there was almost double the mean expression level seen in 
the retinoic acid only samples. In other work presented later in this Chapter a similar 
effect is apparent at this time point. This may suggest that W n t l in conjunction with 
retinoic acid may regulate its own activity to some degree, possibly by up regulating 
expression o f the receptor for it. The difference though between the retinoic acid only 
and retinoic acid plus W n t l conditions as indicated by the one way anova output, is 
not statisfically significant, nor do the levels o f mRNA expression in either test 
condition at seven days differ to a statistically significant degree f rom those seen in 
the embryonal carcinoma stem cells. Interestingly after three weeks o f exposure to 
retinoic acid there is a noticeable peak in Frizzled 8 expression, this could be due to 
the system being primed at this stage for further neuronal differentiation or maturation 
possibly driven by W n t l . Alternatively it may be due to a difference in expression o f 
the house keeping gene used, however this is not that likely as the same trend is 
observed across two different house keeping genes, which serve different cellular 
fiinctions. Therefore it may reflect that after three weeks o f retinoic acid treatment 
Tera2.cl.SP12 cells are potentially open to manipulation by W n t l . It may be that such 
cultures are themselves producing this molecule in this condition at this time. This 
would be in line theoretically wi th the notion that W n t l may be able to self regulate 
its activity. 
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Figure 4 .6 : The effects of W n t l and R.A. on Frizzled 8 m R N A expression 
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Figure 4.6: The relative expression of Frizzled 8 mRNA in Tera2.cl.SP12 cells and their 
derivatives treated with 10|iM retinoic acid only, or 10|iM retinoic acid plus 2ng/ml Wntl for 7, 
14 and 21 days. The one way anova output indicates there is no statistically significant 
difference between the two test conditions at 7 days and that these samples do not differ to a 
statistically significant level from the embryonal carcinoma stem cell starting material. In all 
experiments n=3 and error bars represent the standard deviation of the mean. 
Figure 4.7: The effects o f W n t l and R.A. on Beta-catenin m R N A expression 
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Figure 4.7: The relative expression of Beta-catenin mRNA in Tera2.cl.SPI2 cells and their 
derivatives treated with lOuM retinoic acid only, or lOfxM retinoic acid plus 2ng/ml Wntl for 7, 
14 and 21 days. The one way anova output indicates there is no statistically significant difference 
between the two test conditions at 7 days and that these samples do not differ to a statistically 
significant level from the embryonal carcinoma stem cell starting material. In all experiments n=3 
and error bars represent the standard deviation of the mean. 
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I f W n t l is having an effect it would be expected to do so via a canonical route, 
involving stabilisation o f beta-catenin. Although there is no statistically significant 
difference in the expression o f beta-catenin mRNA between the two seven day 
conditions tested and the embryonal carcinoma cell starting material, a similar trend 
as is seen for Frizzled 8 expression is observed (Figure 4.7). In the presence of W n t l 
and retinoic acid at seven days there appears to be a greater expression o f beta-
catenin, suggesting W n t l may be exerting any possible effects at this time via a 
canonical signalling mechanism. Beyond seven days though there is little difference 
between samples. Ideally i f possible it would be worthwhile to test for differences in 
protein expression o f this molecule as it is the protein that would be responsible for 
any tangible effect. The m R N A data though imply that there may be positive effects 
due to W n t l that could be mediated by increases in beta-catenin mRNA levels, that 
may logically in theory be related to stabilisation o f this protein. 
In the light o f these initial findings it appears that W n t l may be able to influence the 
dopaminergic differentiation o f Tera2.cl.SP12 embryonal carcinoma cells in the 
presence o f retinoic acid. The next step therefore was to try and test the hypotheses 
outlined in the introductory section 4.1. Given the positive effects on N u r r l mRNA 
expression seen using retinoic acid in Chapter 3 and the work o f Castelo Branco et al., 
2003, who were able to demonstrate that W n t l could increase the number of Nur r l 
positive precursors in rat mesencephalic cultures, this was the first factor to be 
investigated. Figure 4.8 shows that at the mRNA level there is hardly any difference 
in the expression pattern o f this transcription factor. Wnt l may slightly augment the 
relative level o f it at 1 day but given the variation in the results, there is no real 
difference. The W n t l only condition was also included in this analysis and shows a 
highly variable expression profile, supporting the view that W n t l alone is insufficient 
to direct the differentiation o f Tera2.cl.SP12 embryonal carcinoma stem cells. It 
appears in this instance that even in the presence of retinoic acid; Wnt l is unable to or 
does not play a role in the regulation o f N u r r l , a key determinant of a dopaminergic 
phenotype. 
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Figure 4.8: The effects of W n t l and R.A. on N u r r l m R N A expression 
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Figure 4.8: The relative expression of Nurrl mRNA in Tera2.cl.SP12 cells and their derivatives 
treated with lOuM retinoic acid only, 2ng/ml Wntl only, or 10|4,M retinoic acid plus 2ng/m\ Wntl 
for 1, 3, 5, 7, 14 and 21 days. In all experiments n=3, error bars represent the S.D. of the mean. 
Flow cytometry was used to try and assess i f there was any detectable difference 
between test conditions at the protein level. However Figure 4.9 shows that as in 
Chapter 3 technical problems with the antibody used, essentially led to low intensity 
expression that was highly variable between cultures and gave no results on which 
meaningful conclusions could be made. 
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Figure 4.9: N u r r l protein expression in EC cells treated w i t h W n t l and R.A. 
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Figure 4.9A: The number of Nurrl antigen positive cells in Tera2.cl.SP12 cultures treated 
with lOuM retinoic acid only, 2ng/ml Wntl only, or a combination of both reagents after 7, 14 
and 21 days. Error bars represent the S.D. of the mean. B: The intensity of Nurrl expression 
in the same culture conditions outlined above. Error bars represent the standard error of the 
mean. In all experiments n=3. The resuhs from this analysis as discussed in the text are 
essentially meaningless due to the possibility of non specific binding of the antibody and 
technical problems with its use. 
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These results offered little prospect o f providing a route forward, so the focus o f study 
was switched to other variables that may influence the acquisition o f a dopaminergic 
cell fate, starting with Otx2. Wnt l can maintain expression o f this molecule in other 
systems (Prakash et al., 2006) and as such it was hypothesised that it may rescue the 
rapid drop in expression o f Otx2 shown fol lowing retinoic acid treatment of 
Tera2.cl.SP12 embryonal carcinoma stem cells in Chapter 3. Figure 4.10 displays a 
similar trend to that recorded previously whereby Otx2 mRNA expression drops 
rapidly upon retinoic acid induction in the first five days o f culture. However at one 
and three days in the presence of W n t l and retinoic acid there is a small rescue effect 
that appears to be due to W n t l . By the fifth day though expression is almost zero in 
both treatment regimes. The one way anova comparing the two 1 day test conditions 
to each other as well as the embryonal carcinoma cell starting material, demonstrates 
that there is a statistically significant drop in Otx2 mRNA expression in the 
embryonal carcinoma cells after 1 day o f treatment with retinoic acid alone and with 
retinoic acid in combination with W n t l . However there is no statistically significant 
difference between the retinoic acid only and retinoic acid plus W n t l condition at 1 
day. Therefore it appears that although the trend at 1 and 3 days indicates Wnt l may 
be able to cause a rescue of Otx2 expression, this effect is small in magnitude, is not 
statistically significant (at 1 day) and given the almost total absence o f expression at 5 
days in either test sample set, short lived. That is not to say that this effect although 
small and insignificant may not be able to cause a real difference. A minor change as 
is observed may be sufficient to instigate more considerable developments 
downstream of it. As a result the mRNA expression patterns o f L m x l a , M s x l , Ngn2 
and Nkx 6-1 were assessed using real time PGR based on the scheme in Figure 4.2 
showing the possible pathway that Otx2 may influence. 
First o f all L m x l a appears to be up regulated in its expression by increasing the 
duration o f retinoic acid exposure up to 3 weeks (Figure 4.11). O f perhaps greater 
interest is the difference in expression between the retinoic acid only and retinoic acid 
plus W n t l samples at 7 days. Although the one way anova output indicates there is 
no statistically significant difference between these two conditions or between them 
and the embryonal carcinoma cell starting material, the trend o f W n t l augmenting 
expression o f L m x l a in the presence o f retinoic acid is comparable to that seen for 
Frizzled 8 in Figure 4.6 and that seen for beta-catenin (Figure 4.7) as well . The lack 
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of a statistically significant induction at 7 days is consistent with the findings o f 
analyses carried out in collaboration with Dr. V . Lakics mentioned in Chapter 3, 
whereby expression o f dopaminergic markers is generally low in this early time 
period. This lower level o f expression may contribute to the lack o f a statistically 
significant difference as the error is often greater when making small measurements, 
thus making it harder to observe an effect. The trend though of W n t l in combination 
with retinoic acid having a favourable effect at 7 days is reinforced. Figure 4.12 
indicates that for M s x l there is little difference between the retinoic acid only and 
retinoic acid plus W n t l conditions. Although as for Nur r l the retinoic acid plus W n t l 
samples show a slightly higher level of expression at 7 days than their retinoic acid 
only counterparts. The same almost identical trend is seen for Ngn2 expression in 
Figure 4.13 and similarly for Nkx 6-1 in Figure 4.14. For all three o f these markers 
the W n t l only condition shows a highly variable expression supporting the notion that 
it is not suitable for use as no control over the process o f differentiation is possible. 
These findings therefore suggest that the small amount o f Otx2 rescue by W n t l is not 
having a larger effect on the initial downstream targets its expression may influence. 
However at 7 days W n t l in conjunction with retinoic acid may cause small increases 
in expression o f these markers associated with a dopaminergic fate, or in the case of 
Nkx 6-1, a ventral midbrain phenotype. Also retinoic acid alone over the time course 
investigated tends to up regulate expression of all these markers with increasing 
duration o f exposure to i t . This is coherent wi th the observations in Chapter 3 for the 
other markers o f a dopaminergic phenotype studied there. Given the trend seen at 7 
days further analysis was carried out to assess the combined effects o f W n t l and 
retinoic acid on some o f these as well as additional factors in the Tera2.cl.SP12 
system. 
Figure 4.10: The effects of W n t l and R.A. on Otx2 m R N A expression 
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Figure 4.10: The relative expression of Otx2 mRNA in Tera2.cl.SP12 cells and their derivatives 
treated with lO^M retinoic acid only, or \0\iM retinoic acid plus 2ng/ml Wntl for 1, 3 and 5 
days. The one way anova output indicates that although there is no statistically significant 
difference between the two test conditions at 7 days, both of these samples do differ to a 
statistically significant level from the embryonal carcinoma stem cell starting material. In all 
experiments n=3 and error bars represent the standard deviation of the mean. 
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Figure 4.11: The effects of W n t l and R.A. on L m x l a m R N A expression 
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Figure 4.11: The relative expression of Lmxla mRNA in Tera2.cl.SP12 cells and their 
derivatives treated with 10|aM retinoic acid only, or lOfiM retinoic acid plus 2ng/ml Wntl for 
7, 14 and 21 days. The one way anova output indicates there is no statistically significant 
diff"erence between the two test conditions at 7 days and that these samples do not differ to a 
statistically significant level from the embryonal carcinoma stem cell starting material. In all 
experiments n=3 and error bars represent the standard deviation of the mean. 
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Figure 4.12: The effects of W n t l and R.A. on M s x l m R N A expression 
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Figure 4.12: The relative expression of Msxl mRNA in Tera2.cl.SP12 cells and their derivatives 
treated with lOuM retinoic acid only, 2ng/ml Wntl only, or lOjiM retinoic acid plus 2ng/ml Wntl 
for 1, 3, 5, 7, 14 and 21 days. In all experiments n=3, error bars represent the S.D. of the mean. 
Figure 4.13: The effects of W n t l and R.A. on Ngn2 m R N A expression 
Ngn2 expression in EC ceils after all-trans retinoic acid and wnt-1 
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Figure 4.13: The relative expression of Ngn2 mRNA in Tera2.cl.SP12 cells and their derivatives 
treated with lOjuM retinoic acid only, 2ng/ml Wntl only, or lO^iM retinoic acid plus 2ng/ml Wntl 
for 1, 3, 5, 7, 14 and 21 days. In all experiments n=3, error bars represent the S.D. of the mean. 
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Figure 4.14: The effects of W n t l and R.A. on Nkx 6-1 m R N A expression 
NKx6.1 expression in E C cells after all-trans retinoic acid and wnt-1 
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Figure 4.14: The relative expression of Nkx 6-1 mRNA in Tera2.cl.SP12 cells and their derivatives 
treated with lOfxM retinoic acid only, 2ng/ml Wntl only, or lOfiM retinoic acid plus 2ng/ml Wntl for 
1, 3, 5, 7, 14 and 21 days. In all experiments n=3, error bars represent the S.D. of the mean. 
Before any markers associated specifically with a dopaminergic phenotype were 
investigated, the expression o f beta I I I tubulin, a classical indicator o f the presence of 
neurons, was assayed (Figure 4.15). In the presence o f both retinoic acid and W n t l at 
7 days there was almost double the level o f mRNA present in comparison to the 
retinoic acid only condition. This difference was not statistically significant and 
neither test condition at this time showed any statistically relevant difference in 
relation to the embryonal carcinoma cell starting material. The trend though was as 
observed previously, supporting the notion that W n t l may exert an effect early in the 
process o f differentiation. Interestingly the expression seen in the embryonal 
carcinoma cells o f this marker is quite high and variable, perhaps indicating that 
Tera2.cl.SPI2 cells are primed for neural differentiation, or actually slightly more 
differentiated along a neural pathway than might be expected for a cell line that acts 
as a model for embryonic stem cells. As seen in Chapter 3, in the f low cytometry data 
for Beta I I I tubulin, there is a lul l in expression at 2 weeks in the retinoic acid only 
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samples before a subsequent rise as time progresses. This suggests that at both the 
mRNA and protein level there is a non linear regulation o f neuronal differentiation in 
this cell system, under the conditions tested. This may be due to the involvement o f 
different signalling pathways at different times during the process o f differentiation. 
Also it may be that retinoic acid provides the initial signal but that this causes the 
embryonal carcinoma cells to produce factors that subsequently continue to drive the 
cultures towards the acquisition of neural phenotypes. 
Beyond 7 days it is also noticeable that Wnt l appears to exert no effect on the mRNA 
expression levels o f beta I I I tubulin. This is indicative that in the Tera2.cl.SP12 
system Wnt l has an early effect on differentiation but up to 3 weeks of culture may 
not cause any subsequent effects. It may be however that beyond 3 weeks it can have 
an impact; this is a potential area for further work. 
When a panel o f dopaminergic markers had their expression patterns assessed, a very 
strong conserved trend was found. First o f all two components o f the biosynthetic 
machinery involved in the production o f dopamine were discovered to display almost 
identical tendencies in the conditions tested. Figure 4.16 demonstrates that for 
tyrosine hydroxylase in the presence o f retinoic acid alone, expression starts low and 
rises over time as observed in Chapter 3. However when W n t l is included with 
retinoic acid, after 7 days there is approximately double the mRNA expression o f this 
marker. Beyond this time point though, in the combined Wnt l plus refinoic acid 
condition up to 3 weeks there is a plateau in the levels o f mRNA for tyrosine 
hydroxylase. A close to identical trend is seen for dopa decarboxylase in Figure 4.17 
which is unsurprising given it is involved in the same pathway of dopamine 
biosynthesis; indeed it acts on the product o f the reaction catalysed by tyrosine 
hydroxylase. In both instances there is no statistically significant difference between 
the two test conditions at 7 days and neither o f them differs significantly f rom the 
starting material. However the trend is consistent with other data presented 
previously and reinforces the notion that W n t l may play an early role (at around 7 
days) in the differenfiation process o f Tera2.cl.SP12 cells. The plateau effect seen for 
these two markers helps support this. 
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Figure 4.15: The effects of W n t l and R.A. on Beta I I I Tubulin mRNA expression 
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Figure 4.15: The relative expression of beta III tubulin mRNA in Tera2.cl.SPI2 cells and 
their derivatives treated with lOjaM retinoic acid only, or IO|iM retinoic acid plus 2ng/ml 
Wntl for 7, 14 and 21 days. The one way anova output indicates there is no statistically 
significant difference between the two test conditions at 7 days and that these samples do 
not differ to a statistically significant level from the embryonal carcinoma stem cell starting 
material. In all experiments n=3 and error bars represent the standard deviation of the 
mean. 
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Figure 4.16: The effects of W n t l and R.A. on T H mRNA expression 
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Figure 4.16: The relative expression of tyrosine hydroxylase mRNA in Tera2.cl.SP12 cells 
and their derivatives treated with lO^iM retinoic acid only, or 10|iM retinoic acid plus 2ng/ml 
Wntl for 7, 14 and 21 days. The one way anova output indicates there is no statistically 
significant difference between the two test conditions at 7 days and that these samples do not 
differ to a statistically significant level from the embryonal carcinoma stem cell starting 
material. In all experiments n=3 and error bars represent the standard deviation of the mean. 
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Figure 4.17: The effects of Wnt l and R.A. on A A D C mRNA expression 
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Figure 4.17: The relative expression of dopa decarboxylase mRNA in Tera2.cl.SP12 cells 
and their derivatives treated with lO^M retinoic acid only, or lO^M retinoic acid plus 
2ng/ml Wntl for 7, 14 and 21 days. The one way anova output indicates there is no 
statistically significant difference between the two test conditions at 7 days and that these 
samples do not differ to a statistically significant level from the embryonal carcinoma stem 
cell starting material. In all experiments n=3 and error bars represent the standard deviation 
of the mean. 
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Three other indicators o f a dopaminergic phenotype that are involved in a more 
physical aspect o f the dopaminergic system in that they help to detect and respond to 
dopamine in the case o f dopamine receptors 1 and 2, and transport it in the case of the 
dopamine transporter, also show a comparable expression profile to that seen for 
tyrosine hydroxylase and dopa decarboxylase. First of all, as can be seen in Figure 
4.18, dopamine transporter mRNA is up regulated over time fol lowing retinoic acid 
treatment o f Tera2.cl.SP12 cultures. When Wnt l is added in combination with 
retinoic acid there is a higher expression at 7 days but then a plateau at subsequent 
time points up to 3 weeks. Figure 4.19 depicts a similar trend for dopamine receptor 
1, although the expression of this marker appeared weaker, as shown by higher cycle 
threshold values when carrying out the real time PCR. A higher value indicates it has 
taken more cycles for detection to occur and therefore results tend to be more 
erroneous, in this case though the trends still hold true to those for other markers. 
Finally in Figure 4.20 dopamine receptor 2 displays an analogous profile. Although 
here expression in the embryonal carcinoma cells is highly variable and on average 
slightly greater than in the 7 day samples treated with only retinoic acid. The trend 
though between the 7 day retinoic acid only and retinoic acid plus W n t l conditions is 
congruous with that for the other markers tested. Once again for all three o f these 
phenotypic indicators there is no statistically significant difference between the two 7 
day conditions and likewise no relevant statistical distinction between either o f these 
two test samples and the embryonal carcinoma cell starting material. However given 
the trend at 7 days and plateau effect at subsequent time points are repeatedly able to 
be observed, there is a strong case to suggest that W n t l in the presence o f retinoic 
acid exerts an effect on the early stages o f the dopaminergic differentiation of 
Tera2.cl.SP12 embryonal carcinoma cell cultures. 
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Figure 4.18: The effects of W n t l and R.A. on D A T mRNA expression 
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Figure 4.18: The relative expression of dopamine transporter mRNA in Tera2.cl.SP12 cells 
and their derivatives treated with 10|j,M retinoic acid only, or 10|iM retinoic acid plus 2ng/ml 
Wntl for 7, 14 and 21 days. The one way anova output indicates there is no statistically 
significant difference between the two test conditions at 7 days and that these samples do not 
differ to a statistically significant level from the embryonal carcinoma stem cell starting 
material. In all experiments n=3 and error bars represent the standard deviation of the mean. 
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Figure 4.19: The effects of W n t l and R.A. on D l mRNA expression 
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Figure 4.19: The relative expression of dopamine receptor 1 mRNA in Tera2.cl.SP12 cells and 
their derivatives treated with lOuM retinoic acid only, or 10|xlVI retinoic acid plus 2ng/ml Wntl 
for 7, 14 and 21 days. The one way anova output indicates there is no statistically significant 
difference between the two test conditions at 7 days and that these samples do not differ to a 
statistically significant level from the embryonal carcinoma stem cell starting material. In all 
experiments n=3 and error bars represent the standard deviation of the mean. 
Figure 4.20: The effects of W n t l and R.A. on D2 m R N A expression 
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Figure 4.20: The relative expression of dopamine receptor 2 mRNA in Tera2.cl.SP12 cells and 
their derivatives treated with 10|xM retinoic acid only, or 10|aM retinoic acid plus 2ng/ml Wntl 
for 7, 14 and 21 days. The one way anova output indicates there is no statistically significant 
diflFerence between the two test conditions at 7 days and that these samples do not differ to a 
statistically significant level from the embryonal carcinoma stem cell starting material. In all 
experiments n=3 and error bars represent the standard deviation of the mean. 
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Given that W n t l in combination with retinoic acid is seemingly able to influence the 
expression o f the m R N A for neuronal and dopaminergic markers during the process 
of differentiation o f Tera2.cl.SP12 cells under the conditions tested. The next logical 
step appeared to be to investigate i f there were any detectable changes at the 
morphological and protein level. Immunocytochemistry was employed to assess 
expression o f the neuronal marker Beta I I I tubulin at 7 days, as f rom experience 
staining for this cytoskeletal protein was more readily observable than for cytosolic 
dopaminergic marker proteins such as tyrosine hydroxylase. Figure 4.21 shows that 
in the W n t l only condition, cultures are overgrown, messy and display no true 
staining, just patchy blotches where cells are over confluent and physical entrapment 
of the antibodies used probably occurs, hence the fuzzy detection that is seen. The 
retinoic acid only condition displays only very faint staining. However the combined 
Wnt l plus retinoic acid condition demonstrates an enhanced level o f detection relative 
to the retinoic acid only samples. At this stage though there are few neuritic 
processes, therefore staining was carried out after 2 weeks. Figure 4.22 shows that at 
this stage there is some process formation and some positive staining in the retinoic 
acid only and retinoic acid plus W n t l samples. Interestingly as for the mRNA data 
there appears to be little detectable difference in Beta I I I tubulin expression at this 
time. This could be due to the seemingly general lull in expression o f this neuronal 
marker at this particular time point. However when staining is carried out after 3 
weeks, there is again an observable difference. Figures 4.23, 4.24 and 4.25 display 
nestin, Beta I I I tubulin and tyrosine hydroxylase staining at this stage of 
differentiation in the W n t l only, retinoic acid only and retinoic acid plus W n t l 
conditions. The W n t l only condition (Figure 4.23) shows no true staining for Beta I I I 
tubulin or tyrosine hydroxylase, there is some nestin staining as might be predicted 
when using embryonal carcinoma cells. The phase image and Hoescht control panels 
all indicate that the cultures are very confluent to overgrown. This in essence 
confirms earlier findings that the Wnt l only condition is not viable for use. Figure 
4.24 shows that when using only retinoic acid after 3 weeks, there is still expression 
of nestin as expected, tyrosine hydroxylase is detectable but being a cytosolic protein 
its presence is more dif f icul t to define. There is though clear Beta I I I tubulin 
expression with neuronal like cell bodies and neuritic processes being clearly 
observable. Figure 4.25 however shows there are clearly more Beta I I I tubulin 
positive cells present in the combined retinoic acid plus Wnt l treated cultures at 3 
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weeks. There are neuronal cell body type structures with clear processes emanating 
from them. Tyrosine hydroxylase expression is faint but detectable once again and it 
is hard to tell i f there is any difference between conditions for this dopaminergic 
marker. The non specific binding o f the antibody observed in Chapter 3 also makes 
the tyrosine hydroxylase data questionable as it might be that as in the highly 
confluent/overgrown W n t l only condition there is a degree of entrapment o f the 
antibody or non specific binding of it. Hence the tyrosine hydroxylase staining as it is 
not clear and not associated with a morphology one might expect o f a potential neuron 
in culture, is viewed as being negative or at least too inconclusive on which to base 
any conclusions. Nestin is still expressed indicating that there are still some relatively 
immature cells in these cultures. The presence o f nestin may indicate W n t l is having 
less o f an effect on the maturation o f Tera2.cl.SP12 cells. 
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Figure 4.21; Beta I I I tubu l in staining of Tera2.cl.SP12 cultures treated w i t h R.A. . W n t l or a combination of both reagents f o r 7 days 
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Figure 4.22; Beta I I I tubu l in staining of Tera2.cl.SP12 cultures treated w i t h R.A.. W n t l or a combination o f both reagents f o r 14 days 
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Figure 4.22: A, B, and C show Beta HI tubulin staining using a FITC labelled secondary antibody in the three different treatment conditions described 
individually above or below each image. E, F, and G display phase images of the cultures. D shows a FITC labelled secondary antibody control for a 
R.A. only treated culture. H represents Hoescht staining of the corresponding R.A. treated culture to confirm the presence of cells by making their nuclei 
detectable. Wntl only and R.A. + Wntl cultures were also negative in their secondary only control samples and did have cells present confirmed by 
Hoescht staining for cell nuclei. These images were not included. In all experiments n=3. Scale bars represent 100|im in all cases. As in Figure 4.21 
not all cells are antigen positive, these images are included solely to bridge the time lag between one and three weeks. They also serve to show that in the 
retinoic acid only and retinoic acid plus Wntl conditions that there are signs of morphological development of the cultures with Beta III tubulin positive 
cells being detected that appear to be extending possible neuritic type processes. As mentioned previously the Wntl only condition is sub optimal and 
any faint detection is most probably due to non specific binding or physical entrapment of the antibody used. 
Figure 4.23: Immunostaining of Tera2.cl.SP12 cultures treated w i t h W n t l f o r 21 days 
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Figure 4.23: Nestin, Beta III tubulin and tyrosine hydroxylase immunostaining using a FITC labelled secondary antibody, of Tera2.cl.SP12 cultures 
treated with Wntl for 3 weeks. The lOx phase image shows how the cultures are very confluent to overgrown. The mouse secondary FITC labelled 
antibody only control is applicable for the nestin and tyrosine hydroxylase primary antibodies, the rabbit equivalent is for the Beta III tubulin antibody. 
The corresponding Hoescht control images confirm the presence of cells by staining their nuclei. Scale bars represent 100|im in all cases. In all 
experiments n=3. The Wntl only condition shows clear nestin staining suggesting the cultures are relatively immature which would be expected given 
the overgrown nature of them. This is reflected in the cell count data that follow by a high number of total cells relative to the two conditions that 
involve the use of retinoic acid. The TH and Beta III tubulin staining is not true staining and as discussed elsewhere for this sub optimal condition, 
cannot be viewed as positive. It is more likely a product of physical entrapment of the antibody by the overgrown cultures or a result of non specific 
binding of the antibodies used. 
Figure 4.24: Immunostaining of Tera2.ci.SP12 cultures treated w i t h retinoic acid f o r 21 days 
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Figure 4.24: Nestin, Beta III tubulin and tyrosine hydroxylase immunostaining using a FITC labelled secondary antibody, of Tera2.cl.SP12 cultures 
treated with retinoic acid for 3 weeks. The lOx phase image shows that the cultures display a mix of cell morphologies. The mouse secondary FITC 
labelled antibody only control is applicable for the nestin and tyrosine hydroxylase primary antibodies, the rabbit equivalent is for the Beta III tubulin 
antibody. The corresponding Hoescht control images confirm the presence of cells by staining their nuclei. Scale bars represent lOOjim in all cases. 
In all experiments n=3. Appendix D supports this data and that in Figure 4.25, it shows merged images indicating the Beta II I tubulin positive cells 
against a background of the total number of cells detected by Hoescht staining of cell nuclei. These images were used to produce the total cell 
number and Beta II I tubulin positive cell counts in the data that follow (Figures 4.28 and 4.29). Although there are a number of Beta II I tubulin 
positive cells in the image in this figure, clearly from Appendix D and the cell count data it is apparent not all cells are positive for the antigen of 
interest. Nestin expression was detectable but this staining was not carried out for quantifiable purposes and is merely an indicator that the cultures 
still possess some relatively immature cells after this period of differentiation. In further work sorting out of such cells may be desirable. The TH 
staining is diffuse relatively hard to detect and not associated with cells of any kind of morphology that might be expected of a potential neuritic cell 
in culture. Given the possible non specific binding of this antibody observed in Chapter 3 this TH staining is highly inconclusive. 
Figure 4.25: Immunostaining of Tera2.cl.SP12 cultures treated w i t h W n t l plus retinoic acid f o r 21 days 
Nestin Beta III Tubulin 
PhaseX10 
Mouse Control Mouse Control Hoescht 
Rabbit Control Rabbit Control Hoescht 
Figure 4.25: Nestin, Beta III tubulin and tyrosine hydroxylase immunostaining using a FITC labelled secondary antibody, of Tera2.cl.SP12 cultures treated with Wntl 
plus retinoic acid for 3 weeks. The lOx phase image shows that the cultures display a mix of cell morphologies; however the Tujl staining shows enhanced levels of this 
marker being present relative to retinoic acid only samples. The mouse secondary FITC labelled antibody only control is applicable for the nestin and tyrosine 
hydroxylase primary antibodies, the rabbit equivalent is for the Beta III tubulin antibody. The corresponding Hoescht control images confirm the presence of cells by 
staining their nuclei. Scale bars represent lOOjim in all cases. In all experiments n=3. Appendix D supports this data and that in Figure 4.24, it shows merged images 
indicating the Beta III tubulin positive cells against a background of the total number of cells detected by Hoescht staining of cell nuclei. These images were used to 
produce the total cell number and Beta III tubulin positive cell counts in the data that follow (Figures 4.28 and 4.29). Although there are a number of Beta III tubulin 
positive cells in the image in this figure, clearly trom Appendix D and the cell count data it is apparent not all cells are positive for the antigen of interest. Nestin 
expression was detectable but this staining was not carried out for quantifiable purposes and is merely an indicator that the cultures still possess some relatively 
immature cells after this period of differentiation in this experimental condition. In ftirther work sorting out of such cells may be desirable. The TH staining is diffuse 
relatively hard to detect and not associated with cells of any kind of morphology that might be expected of a potential neuritic cell in culture. Given the possible non 
specific binding of this antibody observed in Chapter 3 this TH staining is highly inconclusive. 
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Flow cytometry was use to try and assess i f there were any differences in the 
expression o f tyrosine hydroxylase and nestin between the test conditions. Figure 
4.26 shows that for tyrosine hydroxylase given the variability in the results there is 
essentially no real difference in the expression o f it between the viable for use retinoic 
acid only and refinoic acid plus W n t l conditions at 7, 14 and 21 days. Interestingly 
though the greatest level o f expression is at 7 days perhaps supporting the notion that 
at this time point there is an effect. However the retinoic acid only and retinoic acid 
plus W n t l samples at this point show little variation and the results are generally 
highly variable so no real conclusion can be made based on the flow cytometry data, 
especially given the possible non specific binding o f the antibody discussed 
previously. Figure 4.27 shows that nestin levels initially rise from 7 to 14 days and 
then fal l o f f by 3 weeks. Given the deviation in the sample readings there appears to 
be little difference between the retinoic acid only and retinoic acid plus Wnt l 
conditions. The embryonal carcinoma cells express nestin at lower levels on average 
(68.44 ± 5.96 (S.E.M.) % positive cells, and 79.58 ± 8.24 (S.E.M.) mean fluorescence 
intensity) than their retinoic acid and retinoic acid plus W n t l treated counterparts, 
which given the small differences between these samples indicates that as might be 
predicted it is mainly retinoic acid that is responsible for the differential regulation of 
nestin expression observed. 
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Figure 4.26: T H protein expression in EC cells treated w i t h W n t l and R.A. 
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Figure 4.26A: The number of tyrosine hydroxylase antigen positive cells in Tera2.cl.SP12 cultures treated 
with lOuM retinoic acid only, 2ng/ml Wntl only, or a combination of both reagents after 7, 14 and 21 days. 
Error bars represent the S.D. of the mean. B: The intensity of tyrosine hydroxylase expression in the same 
culture conditions outlined above. Error bars represent the standard error of the mean. In all experiments n=3. 
The data show no real difference in TH expression, this may be due to no such difference existing, or as for 
the TH immunostaining shown previously it may be that the antibody is potentially binding in a non specific 
manner as discussed in Chapter 3 and as a result this is affecting the experimental output. These results 
though are far too inconclusive to make any kind of conclusions from. 
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Figure 4.27: Nestin protein expression in EC cells treated w i t h W n t l and R.A. 
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Figure 4.27A: The number of nestin antigen positive cells in Tera2.cl.SP12 cultures treated 
with lOpM retinoic acid only, 2ng/ml Wntl only, or a combination of both reagents after 7, 
14 and 21 days. Error bars represent the S.D. of the mean. B: The intensity of nestin 
expression in the same culture conditions outlined above. Error bars represent the standard 
error of the mean. In all experiments n=3. 
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In the light o f the variation seen in the f low cytometry data and the obvious disparity 
between retinoic acid only and retinoic acid plus W n t l treated cultures at 3 weeks in 
terms o f their expression o f Beta I I I tubulin, manual counts o f cell number and Beta 
I I I tubulin positive cell number were performed. 5 fields o f view for 3 biologically 
independent samples were counted using Image J. Hoescht stained nuclei were used 
as a measure to obtain total cell number, corresponding Beta I I I tubulin stained cells 
were counted to give a number o f cells positive for this marker. Appendix D shows 
merged images o f Beta I I I tubulin positive cells on a background o f Hoescht stained 
nuclei to exemplify visually the nature o f the counts. Figure 4.28 displays clearly that 
more cells were present in the W n t l only cultures, but that there was no significant 
difference between retinoic acid only and retinoic acid plus W n t l samples. Both of 
these conditions though differed to a statistically significant level from their W n t l 
only counterparts. The W n t l only condition was excluded f rom further statistical 
analysis as this condition by all the techniques used appeared unsuitable for use. 
Figure 4.29 shows both in terms of the average number o f Beta I I I tubulin positive 
cells and percentage o f Beta I I I tubulin positive cells per field o f view that there is a 
statistically significant difference between the retinoic acid only and retinoic acid plus 
W n t l samples. The retinoic acid plus W n t l condition displays approximately double 
the number and percentage o f Beta I I I tubulin positive cells in relation to its retinoic 
acid only counterpart. This is a promising result as it offers the possibility o f 
producing more potentially neuronal (Beta I I I tubulin positive), less phenotypically 
mixed cultures f rom the Tera2.cl.SP12 cell line. 
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Figure 4.28: Cell counts in Tera2.cl.SP12 cultures treated with R.A. , Wnt l or 
both reagents for 3 weeks 
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Figure 4.28: The mean number of cells per field of view at x20 magnification quantified by 
counfing Hoescht stained nuclei in samples of Tera2.cl.SP12 cells treated with retinoic acid, Wntl 
or a combination of both reagents. 5 fields of view for 3 biological repeats were counted to give a 
mean value. The one way anova output indicates there is no statistically significant difference in 
cell numbers between retinoic acid only and Wntl plus retinoic acid cultures. However both of 
these two conditions display a clear statistically significant difference from their Wntl only 
counterparts. 
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Figure 4.29: The number and % of Beta I I I tubulin positive cells in 
Tera2.cl.SP12 cultures treated with R.A. , Wnt l or both reagents for 3 weeks 
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Figure 4.29: The mean number of Beta 111 tubulin positive cells (upper graph) and mean 
percentage of Beta 111 tubulin positive cells (lower graph) per field of view at x20 magnification, 
quantified by counting Beta 111 tubulin positive stained cells to get a mean number of cells 
positive for this marker and by counting Hoescht stained nuclei (a percentage was then taken by 
dividing the number of antigen positive cells by the number of cells) in Tera2.cl.SP12 cultures 
treated with retinoic acid, Wntl or a combination of both reagents. 5 fields of view for 3 
biological repeats were counted to give a mean value. Student's T-test was used to assess if 
there was a statistically significant difference between the viable for use retinoic acid only and 
Wntl plus retinoic acid conditions. In terms of both number and percentage of Beta III tubulin 
positive cells there was a statistically significant difference (Sig. < 0.05) found, indicating that 
the presence of Wntl causes a statistically relevant approximately 1.5-2 fold increase in the 
number and percentage of Beta 111 tubulin positive cells. 
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4.4 Discussion 
The initial objective in this study was to elucidate i f the exogenously applied 
commercially available human W n t l was able to influence the dopaminergic 
differentiation o f the Tera2.cl.SP12 cell line, either alone or in concert with retinoic 
acid. Early indications were that retinoic acid was required and the entire range o f 
techniques were all consistent in supporting this idea as the W n t l only condition 
appeared to be totally unsuitable for use at the concentration tested. Further work 
could be carried out to test the effects o f varying the dose o f this molecule to see i f it 
could alone exert an effect on this cell line under different conditions. This though is 
possibly unlikely as retinoic acid is used in the vast majority o f work using embryonal 
carcinoma cells. Perhaps therefore it would be more worthwhile to study the potential 
of different concentrations o f W n t l in the presence o f this molecule or after a pre-
treatment with it. 
To try and build on the findings in Chapter 3 where retinoic acid caused a peak in 
Nur r l m R N A expression after 1 day in an analogous manner to that observed for 
Nurr l protein in the Ntera2 embryonal carcinoma cell line (Misiuta et al., 2006) and 
given that Castelo Branco et al., 2003 had demonstrated W n t l could have a positive 
effect on N u r r l positive precursors in rat mesencephalic cultures, this key 
dopaminergic transcription factor was investigated. W n t l appeared to have no 
significant effect on N u r r l expression in Tera2.cl.SP12 cells treated with Wnt l and 
retinoic acid and there was no augmentation o f the peak in expression at 1 day when 
both reagents were used. Therefore it appears that W n t l does not directly impact on 
Nur r l expression in Tera2.cl.SP12 cultures. However Prakash et al., 2006 were able 
to demonstrate that W n t l can maintain Otx2 expression and in turn repress Nkx2-2 
expression, helping to promote acquisifion of a dopaminergic phenotype. I f Wnt l 
could rescue the down regulation o f Otx2 caused by retinoic acid seen in Chapter 3 
then potentially via a route independent of N u r r l , up regulation o f dopaminergic 
markers could be achieved. Otx2 caused a minimal amount o f rescue but it appears in 
the embryonal carcinoma cell system that retinoic acid tends to exert the greatest 
influence over Otx2 m R N A expression. In collaboration Dr. V . Lakics tested primers 
for Nkx2-2 that worked on cDNA samples f rom human brain reference RNA 
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(Ambion) in real time PCR analyses, contrastingly in the W n t l , refinoic acid and 
combined Wnt l plus retinoic acid treated samples it was not possible to detect 
expression o f it. Similar analyses were carried out independently by myself and 
yielded no result. Therefore either Nkx2-2 mRNA is not expressed in Tera2.cl.SP12 
cells and their derivatives, or it is not detectable, this may be due to the cancerous 
aberrant nature o f this cell line which may mean that there is a disruption or absence 
of the Nkx2-2 gene. Whatever the scenario the observation that Nkx2-2 is hard or not 
possible to detect may mean that the minimal level o f rescue o f Otx2 is o f lesser 
importance as this system may not favour acquisition o f other non dopaminergic fates 
i f it doesn't possess the molecular machinery to produce them. As a result although 
the Otx2 and N u r r l observations may not display strongly positive effects as might be 
hypothesised, they do not necessarily mean the Tera2.cl.SP12 cell line is an unsuitable 
model as there may be other routes to achieve a dopaminergic cell fate f rom cultures 
o f it. 
In addition Ono et al., 2007 had shown that Otx2 may have an inductive effect on 
Lmxla . It is highly debateable i f the small increases in Otx2 mRNA expression in 
Wnt l plus retinoic acid treated cultures are able to impart such an effect on L m x l a 
levels in the Tera2.cl.SP12 system; although further analysis o f Otx2 protein levels 
would be beneficial in revealing more about this possible process. However L m x l a 
mRNA expression is approximately double in the W n t l plus retinoic acid samples 
relative to their retinoic acid only counterparts at 7 days. So perhaps the minimal 
difference in Otx2 levels observed in the presence of W n t l and retinoic acid at 1 and 
3 days is enough to influence the downstream pathway. Even i f this is not the case a 
range o f dopaminergic markers display an almost identical trend to L m x l a in the 
regulation o f their mRNA expression as does the neuronal marker Beta I I I tubulin. At 
a conceptual level this is in keeping with the in vivo work o f Prakash et al., 2006, 
where W n t l possesses two main effects, the first o f which is an early one where it is 
implicated in the formation o f the mesencephalic dopaminergic progenitor domain. It 
is also congruous wi th the in vitro work o f Castelo Branco et al., 2003, where W n t l 
again plays two possible roles, but the one o f greater magnitude is an early ability to 
promote neurogenesis by a mechanism involving proliferation o f N u r r l positive 
precursors. Although none o f the differences are statistically significant the trend is 
so strongly apparent and reproducible across a panel o f markers that there does appear 
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to be via a mechanism that may or may not involve Otx2 an early dopaminergic 
differentiation enhancing effect at 7 days attributable to the presence of Wnt l in 
cultures o f Tera2.cl.SP12 cells treated with this glycoprotein and retinoic acid. 
This early action o f W n t l in the Tera2.cl.SP12 system is highly desirable not only in 
the context that it may aid in the design o f a temporally efficient assay system using 
this cell line but also in the experimental rationale for ftirther work that may include 
the use o f Sonic hedgehog and Fibroblast growth factor 8. It is known f rom the work 
of Yan et al., 2005 that in human embryonic stem cells prior to any or before a 
threshold o f Soxl expression that Sonic hedgehog and Fibroblast growth factor 8 
application is capable o f promoting the formation o f dopaminergic neurons. I t has 
been suggested that W n t l may create a permissive environment for these inductive 
cues to act (Burbach & Smidt, 2006). After 7 days o f culture Soxl m R N A levels are 
still relatively low in the Tera2.cl.SP12 cell line fol lowing treatment wi th retinoic acid 
alone or in concert wi th W n t l (Figure 4.30). Therefore the positive effects o f W n t l 
after 7 days may be able to be combined with the potentially optimal use o f Sonic 
hedgehog and Fibroblast growth factor 8, with a view to ideally producing an 
enriched population o f dopaminergic neurons, and in turn giving a coherent 
progression to this work. 
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Figure 4.30: The effects of W n t l and R.A. on Soxl mRNA expression 
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Figure 4.30: The relative expression of Soxl mRNA in Tera2.cl.SPI2 cells and their derivatives 
treated with \0\iM retinoic acid only, or 10(iM retinoic acid plus 2ng/ml Wntl for 7, 14 and 21 
days. The one way anova output indicates there is no statistically significant difference between the 
two test conditions at 7 days and that these samples do not differ to a statistically significant level 
from the embryonal carcinoma stem cell starting material. In all experiments n=3 and error bars 
represent the standard deviation of the mean. Due to the relatively low levels of expression of Soxl 
in the samples at 7 days, it may be an optimal temporal window/opportunity to integrate the use of 
Sonic hedgehog and Fibroblast growth factor 8 into the experimental design to try and facilitate the 
production of an enhanced population of dopaminergic neurons. 
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Before contemplating areas for additional study further, there are a couple of 
hypotheses outlined in the introductory section 4.1 to consider. The first o f these is 
can Wnt l enhance the yield o f Beta I I I tubulin positive cells f rom Tera2.cl.SP12 
cultures. In the presence o f retinoic acid at 7 days W n t l appears to be able to up 
regulate the mRNA levels o f the neuronal marker Beta I I I tubulin approximately 2 
fold. Likewise at this time immunostaining for the same marker is much stronger in 
cultures treated with retinoic acid and Wnt l in comparison to those that have been 
induced with retinoic acid alone. The difference between the two conditions is less 
apparent at 2 weeks both in terms o f the immunostaining results and mRNA levels 
observed. It appears f rom this and earlier flow cytometry based work in Chapter 3 
that at this developmental stage there is an interlude in the expression o f this neuronal 
marker, possibly whilst other cell types predominate in the phenotypically mixed cell 
cultures. A t 3 weeks at the mRNA level there again appears to be little difference in 
Beta I I I tubulin expression. However the immunostaining and cell counts reveal a 
different story as there is clearly a more intense expression o f Beta I I I tubulin and 
almost double the number o f cells express this neuronal marker in the retinoic acid 
plus Wnt l samples relative to their retinoic acid only counterparts. This 
approximately 1.5-2 fold increase is in line with that observed in rat mesencephalic 
precursor cells (Castelo Branco et al., 2003) which may suggest W n t l has a conserved 
effect between species. In the work o f Castelo Branco et al., 2003 there was no 
difference in tyrosine hydroxylase expression within the neuronal population, the flow 
cytometry data may possibly support the notion that the same is true in the 
Tera2.cl.SP12 cell line, but the results are too variable to make any firm conclusion. 
The immunostaining for tyrosine hydroxylase in both conditions appears to the naked 
eye to be comparable but is too faint to accurately quantify. Therefore the same effect 
may be present in the Tera2.cl.SP12 cells but this would require further repeats to 
validate this possible finding. 
One interesting quesfion raised by the immunocytochemistry data is; does W n t l in the 
presence of retinoic acid have two separate effects on the dopaminergic differentiation 
of Tera2.cl.SP12 cells? An early one at 7 days and a later activity at 3 weeks, in a 
fashion resembling the dual effects observed in Prakash et al., 2006. Alternatively 
does it have a single main early effect with a minor role later on that is harder to 
detect in a similar way to Castelo Branco et al., 2003, or does it exert an early effect 
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the features o f which are only observed at later stages o f the differentiation process? 
This final option is probably the most likely as the mRNA data indicate a difference 
only at 7 days. This is also seen via the more intense immunostaining. However at 7 
days the Beta I I I tubulin positive staining is not seen in such clear neuronal body like 
and neuritic process type structures as the cultures earlier in the course o f 
differentiation are not as morphologically developed. By 3 weeks the cultures have 
matured in morphology neuron like cells are able to be observed so the effect seen at 
7 days is more apparent and quantifiable. It is possible there may be a lag time 
between the recognition o f differences at the mRNA level being seen at the 
morphological and protein levels. However i t may be that there is actually a 
difference at the protein level demonstrated by the more intense staining in the Wnt l 
plus retinoic acid samples at 7 days, with a lag period to the morphological 
differences becoming more clearly observable at 21 days when the cultures are further 
developed. In the light o f the trend at 7 days in the W n t l plus retinoic acid condition 
relative to retinoic acid only treated samples and the plateau effect observed for other 
markers, on balance it seems more likely that Wnt l exerts its influence early but that 
morphologically this difference is apparent at later stages. 
The final question to try and address given that W n t l appears able to direct the 
dopaminergic differentiation o f Tera2.cl.SP12 cells is does W n t l act via a canonical 
pathway as expected? It appears possible that it does so, as the receptor for it is 
present and up regulated at the point when it exerts its maximum effect indicating 
W n t l in the presence o f retinoic acid in this model system may be capable o f self 
regulation o f its action, mediated via an up regulation o f its receptor. It would be o f 
interest to try and confirm this at the protein level. Also beta-catenin mRNA is more 
prevalent at 7 days in the combined Wnt l plus retinoic acid condition in comparison 
to the retinoic acid only samples. This may correlate wi th more stable beta-catenin 
protein being present, in turn facilitating the effects o f W n t l , although this too would 
need to be confirmed by protein based analysis. However it appears that W n t l is 
acting via a canonical mechanism, given that a part o f this pathway glycogen synthase 
kinase - 3(3 could be a key junction at which signals f rom different pathways that 
could be activated by Wnts or Sonic hedgehog intersect (Castelo Branco & Arenas, 
2006). This finding provides a further basis for study into the effects o f Sonic 
hedgehog and Fibroblast growth factor 8 along with W n t l in the Tera2.cl.SP12 
1 7 4 
model. Therefore along with the other possible reasons discussed earlier there is a 
strong rationale for an experimental strategy devised to facilitate investigations into 
this area. Chapter 5 deals with the construction of this approach to try and elucidate a 
greater understanding o f the potential for dopaminergic differentiation o f the 
Tera2.cl.SP12 ceil line. 
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Chapter 5 
The effects of suspension 
culture. Sonic hedgehog. 
Fibroblast growth factor 8 
and ascorbic acid, on the 
acquisition of a 
dopaminergic phenotype 
by human embryonal 
carcinoma stem cells 
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5.1 Introduction 
In the previous Chapter W n t l in combination with retinoic acid was shown to have 
positive effects on the ability o f Tera2.cl.SP12 embryonal carcinoma stem cells to 
acquire a neuronal and possibly more specifically a dopaminergic fate. Given the 
concept that W n t l may create a permissive environment for inductive factors such as 
Sonic hedgehog and Fibroblast growth factor 8 to act (Burbach & Smidt, 2006) the 
primary purpose o f the experiments reported in this Chapter was to try and utilise 
these molecules in an optimal fashion to potentially yield an enriched population of 
dopaminergic neurons. 
Sonic hedgehog and Fibroblast growth factor 8 have been used widely in attempts to 
try and produce dopaminergic neurons f rom a variety o f stem cells. In the human 
Ntera2 embryonal carcinoma cell line there is conflicting evidence as to whether these 
molecules can exert an effect on the dopaminergic differentiation potential o f this 
model system. StuU & lacovitti, 2001, were only able to detect around 2% of cells 
treated with Sonic hedgehog/Fibroblast growth factor 8 as being tyrosine hydroxylase 
immunopositive. However these Ntera2 cells had already received a period o f 
retinoic acid pre treatment and were possibly not susceptible to the effects o f Sonic 
hedgehog/Fibroblast growth factor 8 application as they may have already become too 
differentiated. In work using human embryonic stem cells Yan et al., 2005 
demonstrated that the early application of these two inductive molecules prior to or at 
a threshold o f Soxl expression was necessary to obtain a population o f neurons 
displaying characteristics o f a midbrain dopaminergic phenotype. Therefore it may be 
that the Ntera2 cells were not incapable o f responding to Sonic hedgehog and 
Fibroblast growth factor 8 but that they were unable to do so due to the period of 
refinoic acid treatment they had previously received. The concept o f there being an 
optimal early temporal window for use of these molecules presented by Yan et al., 
2005 is in support o f this idea. Further work in the Ntera2 cell system carried out in 
the absence of retinoic acid indicated that this system was able to show a positive 
dopaminergic differentiation response when treated with these two molecules in 
concert (Ravindran & Rao, 2006). This work was based on the sequential protocol o f 
Lee et al., 2000, who used mouse embryonic stem cells. Both o f these studies made 
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use of the formation o f aggregates in suspension, termed embryoid bodies in the 
embryonic stem cell work, as part o f the differentiation protocol. 
In a more recent paper using human embryonic stem cells the concept o f growing 
cells as aggregates in suspension was extended to produce structures that resemble 
neurospheres termed spherical neural masses (Cho et al., 2008). When these were 
then treated with Sonic hedgehog and Fibroblast growth factor 8 for 10 days, with 
ascorbic acid being added as well for the final 6 days o f this 10 day period, a high 
percentage o f tyrosine hydroxylase positive cells were formed. Indeed 86% of the 
total number o f neurons were tyrosine hydroxylase positive in test cultures; given that 
W n t l was able to enhance the number o f Beta I I I tubulin positive cells produced from 
Tera2.cl.SP12 cells, i f its use could be linked to this differenfiation protocol, there was 
a possible opportunity not only to enhance the yield o f potential neurons but also the 
number o f them displaying markers o f a dopaminergic phenotype. In addiUon 
Tera2.cl.SP12 embryonal carcinoma stem cells have previously been shown to be able 
to produce neurosphere type structures rapidly when cultured in suspension in the 
presence of refinoic acid (Horrocks et al., 2003). Therefore this posed an interesting 
question, does growth o f Tera2.cl.SP12 cells in suspension in the presence of retinoic 
acid alone or in combination with Wnt l offer the possibility o f enhanced 
dopaminergic differentiation in comparison to adherent culture? In the light o f 
previous findings that Wnt l exerts its greatest effect at 7 days and given that 
neurosphere type structures can be formed in this time frame, this would appear to be 
a logical point at which to test this hypothesis. 
Although the direct approach o f culturing retinoic acid induced Tera2.cl.SP12 cells in 
different oxygen environments seemed to exert no effect on the dopaminergic 
differentiation capacity of such cultures at the oxygen tensions tested in Chapter 3. 
The use o f suspension culture may facilitate some effect i f any is possible due to 
oxygen, as cells at the periphery o f an aggregate are likely to experience a different 
set o f conditions to those in the core, wi th the strong possibility that cells in the centre 
w i l l receive a lower oxygen pressure (Gassmann et al., 1996). Whether or not there is 
an oxygen effect, the growth o f the Tera2.cl.SP12 cells as aggregates essentially 
creates a more complex 3D microenvironment. Where not only may cell - cell 
interactions play a role but also there may be a different regulation o f the extracellular 
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matrix, which itself may influence cell fate decisions, for example laminin in 
conjunction wi th basic Fibroblast growth factor and heparin may help induce the 
formation o f dopaminergic neurons f rom rat neural stem cells (Yu et al., 2007). In 
addition the possibly shorter distances between cells growing in an aggregate may 
facilitate the effects o f any soluble factors the cells under investigation may release, 
which could help drive the process o f differentiation. Therefore there are a number o f 
potentially favourable effects that could arise f rom growth o f the Tera2.cl.SP12 cells 
in suspension. There is even the prospect that W n t l may exert a greater effect than it 
does when used in conjunction with retinoic acid on adherent cultures. 
Once an assessment has been carried out to address the possibility of there being some 
differences between suspension and adherent culture of Tera2.cl.SP12 cells in the 
presence of retinoic acid alone or in combination with W n t l , the premier (most 
favourable in relation to potential for dopaminergic differentiation) condition i f there 
is one w i l l be taken forward to extend the investigations. At this point either the cells 
w i l l be grown in suspension or adherent cultures for 7 days with retinoic acid or 
retinoic acid plus W n t l being applied and then subsequently treated with Sonic 
hedgehog/Fibroblast growth factor 8 and retinoic acid for 4 days wi th ascorbic acid 
being added to this mix for the final 6 days (Figure 5.1) in a similar fashion to Cho et 
al., 2008 who omitted the retinoic acid. The choice to include retinoic acid is based 
on the previous findings in Chapter 4 where its use appeared necessary to drive the 
differentiation o f and give control over the highly proliferative Tera2.cl.SP12 cells. 
However given the work o f Stull & lacovitti, 2001 where retinoic acid treatment o f 
Ntera2 cultures prior to application o f Sonic hedgehog and Fibroblast growth factor 8 
possibly curtailed the effects o f these two molecules, an additional set o f experiments 
is to be included. In these investigations the most optimal (highly neuronal) condition 
w i l l be selected f rom the samples treated as per figure 5.1. This set o f samples w i l l be 
compared to a set o f cultures given an identical treatment for the first 7 days but after 
this time point the retinoic acid w i l l be omitted and the 10 day scheme as per Cho et 
al., 2008 w i l l be used to try and drive the dopaminergic differentiation process. The 
plus and minus retinoic acid condifions defined in Figure 5.2 w i l l then be analysed to 
determine i f this molecule has an inhibitory effect on dopaminergic differentiation in 
the context o f this experimental strategy. 
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In total the duration o f differentiation is no more than 17 days, sampling w i l l also 
occur at 1 Idays to try and build up some impression o f the changes in dopaminergic 
marker expression over time in the presence of the different inductive factors. This 
relatively short 17 day protocol though is designed with a view to downstream 
applications. I f the Tera2.cl.SP12 cell line is a viable tool that can be utilised to carry 
out basic pharmacological screens then the procedures by which dopaminergic 
neurons are produced f rom it need to be temporally efficient. The effects of W n t l at 7 
days, the ability o f the embryonal carcinoma stem cells to rapidly form neurospheres 
and the propensity o f them for neural differentiation may all combine to provide the 
required efficiency, especially i f they can be linked neatly into the 10 day 
differentiation protocol o f Cho et al., 2008. This work w i l l further address the 
question not only o f whether Tera2.cl.SP12 embryonal carcinoma stem cells possess 
the capacity for dopaminergic differentiation but also are they likely to be viable for 
any applied usage, or are they more suited to a role as a basic research tool? Other 
hypotheses may also be tested such as does Sonic hedgehog affect the signalling 
pathway outlined in Figure 4.2 as may be expected and does the initial presence of 
W n t l have any favourable effects in creating a permissive environment in which the 
inductive cues Sonic hedgehog and Fibroblast growth factor 8 can act to influence the 
dopaminergic differentiation o f the embryonal carcinoma stem cells? 
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5.2 Cell Culture Methods 
Suspension culture of E C cells with Retinoic acid and W n t l 
Cultures o f Tera2.cl.SP12 EC cells were grown to confluency, the media aspirated 
from them, before being washed with Ix PBS, prior to treatment for 5 minutes with 
0.25% (w/v) Trypsin/0.1% (w/v) EDTA (in HBSS) (Cambrex), to release the cells 
from the surface o f the culture flask. The Trypsin was then neutralized by addition of 
4ml o f D M E M F G and any cells remaining loosely bound washed o f f the surface o f 
the flask by pipetting the DMEMFG/Trypsin-EDTA mix against the side o f the flask 
where cell attachment occurs. A further wash with I x PBS was carried out to 
optimize the retrieval o f EC cells for use. The cell suspension was then transferred to 
a 15ml Falcon tube and spun in a centrifuge (Eppendorf 581 OR (swing bucket rotor 
A-4-62)) at SOOrpm, 4°C, for 2 minutes. The excess fluid was removed to leave a cell 
pellet. This was resuspended in D M E M F G and cell number was determined using a 
haemocytometer. Once the cell number was known the EC cells were seeded out at a 
density o f 2 x 10^ cells per 90mm bacterial culture dish. They were then exposed to 
either a final concentration o f l O j i M all trans retinoic acid (Sigma), or a final 
concentration o f 1 0 | J M all trans retinoic acid (Sigma) along with W n t l (Peprotech) at 
a final concentration o f 2ng/ml for 7 days. Media was changed every 1-2 days to 
prevent EC cells adhering to the surface o f the culture dish. A new culture dish was 
used for each individual culture every time the media was changed. To perform a 
media change the floating spheres o f EC cells and the media they were differentiating 
in were collected using a serological pipette; transferred to a 15 or 50ml Falcon tube 
prior to being spun down in a centrifuge for 2 minutes at 800 rpm at 4°C. The media 
was then aspirated and the cell pellet resuspended in 10ml o f fresh media. This was 
then pipetted into a fresh 90mm bacterial culture dish and a further 10ml of 
D M E M F G added. The culture was then treated with either retinoic acid alone or in 
combination with W n t l (as appropriate) to give exposure to the final concentrations 
outlined above. 
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Treatment of suspension cultures with Shh/FGF8/A.A. /R.A. 
After 7 days in suspension culture with retinoic acid or W n t l plus retinoic acid 
samples not harvested for analysis at this point were plated out in total into 6 well 
plates or at a 1 in 5 dilution (to account for relative well area) into 24 well plates. 
This was done by collecting the floating spheres o f EC cells and the media they were 
differentiating in using a serological pipette, transferring this mix to a 15 or 50ml 
Falcon tube prior to spinning it down in a centrifuge for 2 minutes at 800 rpm at 4°C. 
The media was then aspirated and the cell pellet resuspended with vigorous 
mechanical agitation (using a pipette to break up the clusters o f treated EC cells) in an 
appropriate volume for the vessel the cells were about to be seeded into. In practice 
3ml o f media were used for samples that were to be plated out in 6 well plates (with 
all 3ml being transferred to the recipient well). Whilst for a 24 well plate the cell 
pellet was ressupended in 5ml o f media, and after agitation 1ml of the solution 
containing approximately one fifth o f the cells was added to the recipient culture 
vessel. 
In the initial experiments immediately after plating out cells were exposed to final 
concentrations o f 200ng/ml Shh ( R & D Systems) (made up in Ix PBS), lOOng/ml 
FGF8 (Peprotech) (made up in lOmM Tris pH 8.0), and lOf iM retinoic acid (Sigma) 
for 4 days, this treatment was continued for a further 6 days but 200| iM ascorbic acid 
(Sigma) (made up in sterile distilled water) was also included. Vehicle controls 
exposed to only I x PBS and lOmM Tris pH 8.0 for the first four days as well as 
sterile distilled water alongside these 2 components for the final 6 days were also run. 
Figure 5.1 gives a summary o f the conditions used for the entire protocol including 
the initial 7 day suspension culture step. At all times cells were maintained at 37°C in 
a standard 5% CO2 incubator. 
Figure 5.1 - Shh/FGF8/A.A. /R.A. Differentiation Protocol (based on Cho et al.. 2008) 
Shh/FGF8/A.A./R.A. Differentiation Protocol 
Control 
Conditions 
Treatment 
Conditions 
R.A. Only 
Day 0 
Vehicle Control 
R.A. + Wnt1 Vehicle Control 
R.A. Only Shh/FGF8/R.A. 
» 
Shh/FGF8/A.A./R.A. 
R.A. + Wnt1 Shh/FGF8/R.A. Shh/FGF8/A.A./R.A. 
Day 7 Day 11 Day 17 
Note: Vehicle control consisted of treatment with 1x PBS and lOmM Tris pH 8.0 for 4 days 
(green arrow), this was continued for a further 6 days but with the addition of autoclaved 
sterile water to the regime as well (orange anrow). 
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Subsequent experiments investigated whether the inclusion o f retinoic acid has a 
negative effect on the dopaminergic differentiation potential o f the Tera2.cl.SP12 
model. Samples were prepared as previously outlined for the plus R.A. samples; 
however for the minus R.A. samples as would be expected retinoic acid was omitted. 
This is summarised in Figure 5.2. 
Figure 5.2 - Shh/FGFS/A.A. +/- R .A. Differentiation Protocol (based on Cho et 
al.. 2008 
Shh/FGF8/A.A. +/- R.A. Differentiation Protocol 
Vehicle 
Control 
R.A. + Wnti Vehicle Control 
Minus R.A. 
Condition 
R.A. + Wnt1 Shh/FGF8 Shh/FGFS/A.A. 
Plus R.A. 
Condition 
Day 0 
R.A. * Wnti Shh/FGF8/R.A. Shh/FGF8/A.A./R.A. 
Day 7 Day 11 Day 17 
Note: Vehicle control consisted of treatment with 1 x PBS and 10mM Tris pH 8.0 for 4 days 
(green arrow), this was continued for a further 6 days but with the addition of autoclaved 
sterile water to the regime as well (orange arrow). 
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5.3 Results 
Prior to the assessment o f whether or not Sonic hedgehog, Fibroblast growth factor 8 
and ascorbic acid in the presence or absence of retinoic acid can drive the 
dopaminergic differentiation o f the Tera2.cl.SP12 ceil line. The first step in this study 
was to compare the effects o f retinoic acid alone and in combination with W n t l under 
adherent and suspension culture conditions. I f the suspension based method was 
comparable or favourable the rationale was then to integrate this approach into the 
protocol o f Cho et al., 2008 with the embryonal carcinoma cell derived neurospheres 
replacing the spherical neural masses formed f rom the embryonic stem cells in that 
work. The spherical neural masses in Cho et al., 2008 were shown to express nestin, 
Soxl and Beta I I I tubulin. Therefore the first step in these investigations was to use 
real time PCR analysis to facilitate a quantitative comparison o f the levels o f these 
three markers in Tera2.cl.SP12 cells grown in suspension or adherent conditions in 
the presence of retinoic acid or retinoic acid and W n t l . Figure 5.3A demonstrates that 
there is a clear expression o f nestin as would be expected when using embryonal 
carcinoma cells, and the levels at which this marker is present vary little between the 
condifions. Figure 5.3B indicates that Soxl is present at higher levels in the adherent 
cultures, the lower levels present in the suspension cultures though may be favourable 
in the context o f there being an advantage in applying Sonic hedgehog and Fibroblast 
growth factor 8 prior to or before a threshold o f Soxl expression as described by Yan 
et al., 2005. This was therefore an interesting result as it offered the prospect that 
suspension culture may be advantageous i f pursuing the acquisition o f a dopaminergic 
phenotype using a method involving Sonic hedgehog and Fibroblast growth factor 8 
administration. There appeared however to be little difference in relation to the use of 
Wnt l in conjuncfion with retinoic acid. In contrast Figure 5.3C shows that the 
combined use o f suspension culture and Wnt l plus retinoic acid may give more 
neuronal cultures. Interestingly W n t l in concert wi th retinoic acid does not have the 
same effect as observed previously in Chapter 4 on adherent cultures. Why Wnt l 
may have had an effect in one set o f experiments in Chapter 4 but seemingly does not 
in an identical set here is unknown, as it appears to exert an effect in the suspension 
cultures and this is o f a similar scale to that previously observed. It may be that the 
aberrant nature o f the cell culture model has caused this difference as i f one passage 
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of cells used was more abnormal or flawed than is usual, then they could have been 
subsequently passaged (a number o f times) and used for setting up each of the 3 
repeats for which samples for analysis were collected. I t could also be the W n t l used 
lost its activity, although this may be less likely given that the same batch was used 
for the suspension culture samples where it appears to have had a positive effect. 
However the effect observed may not be due to the application o f exogenous 
compounds at all. I t may be the W n t l did lose its activity or was unable to exert any 
action on this occasion in either adherent or suspension cultures. The differences 
observed in these initial investigations may actually arise f rom differences in gene 
expression profiles that come about f rom the growth o f the embryonal carcinoma cells 
in suspension rather than adherent conditions in a similar manner to that found with 
embryonic stem cells. Indeed the specific method o f suspension culture o f mouse 
embryoid bodies (hanging drop versus static suspension culture) can itself affect the 
gene expression profile observed (Mogi et al, 2009). This too may be the case in the 
embryonal carcinoma cell system and may account for some of the differences 
recorded. 
Figures 5.4A, B and C show a similar pattern to that for Beta I I I tubulin for the 
dopaminergic markers, tyrosine hydroxylase and dopamine receptor 2, as well as the 
ventral midbrain marker Nkx6-1 . The trend though is promising in that dopaminergic 
marker expression is highest in the W n t l plus retinoic acid suspension cultures. 
Figure 5.5A and C show that for L m x l a and neurogenin2 the same trend is apparent; 
however there is little difference between the retinoic acid and retinoic acid plus W n t l 
conditions in relation to M s x l expression. This possible component of the 
dopaminergic specification pathway is though up regulated in suspension cultures. 
Therefore given that both neuronal and dopaminergic phenotypic markers are up 
regulated in the W n t l plus retinoic acid suspension cultures, as are some o f the factors 
( L m x l a and neurogenin2) that may help specify a dopaminergic fate, it would appear 
this is the optimal condition. Although the inclusion o f W n t l does not appear to 
affect Soxl or M s x l levels to any real extent, the use o f suspension culture may give 
favourable levels o f these two markers. The Wnt l plus retinoic acid suspension 
culture condition or possibly even just its retinoic acid only suspension culture 
counterpart are as such likely to enhance the possibility of producing an enriched 
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population o f dopaminergic neurons. Figure 5.6A demonstrates that the mRNA for 
the transporter protein that allows ascorbic acid into cells is present in such cultures, 
as is the receptor for Sonic hedgehog (Figure 5.6B), as is the receptor for Fibroblast 
growth factor 8 (Figure 5.6C), although the mRNA levels for this have declined to a 
statistically significant level from those in the starting material. In an ideal scenario 
the expression o f the Fibroblast growth factor 8 receptor would be studied at the 
protein level as fall ing quantities o f mRNA may be present but the receptor may still 
be expressed and be functional at this stage. Likewise it would be more complete to 
confirm the presence o f the other receptor and transporter protein at this level. 
However the indication is that all three molecules ascorbic acid, Sonic hedgehog and 
Fibroblast grov\^h factor 8 may be able to exert an effect and thus hopefully promote 
the formation o f potential neurons displaying dopaminergic characteristics. Indeed 
the system may be priming itself for a response to ascorbic acid and given the falling 
expression o f the Fibroblast growth factor 8 receptor may be at a point where 
Fibroblast growth factor 8 application is necessary for it to have an effect, or its 
maximum effect on dopaminergic differentiation. 
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Figure 5.3; Nestin, Soxl & Beta I I I tubul in expression in suspension & adherent 
cultures 
A. 
> 20 
RA Day7 Mtierent Wntl + RA Day? Mtlerent RA Day? Suspension 
Sampla 
Wntl • R A Day? 
Suspension 
B. 
R A D a y ? >VJherent Wntl * R A Day7 Adhereni R A D a y ? S u s p e n s i o n VWitl + R A D a y ? 
S u s p e n s i o n 
c. 
R.A Day? Mherent Wiitl + R A Day? Mherent R.A Day? Suspension 
Sample 
Wntl + R.A Day? 
Suspension 
Figure 5.3A: Relative expression of Nestin mRNA in Tera2.cl.SP12 cultures and their derivatives 
grown in the presence of lO\iM retinoic acid alone or in combination with 2ng/ml Wntl for 7 days 
as either adherent monolayers or free floating aggregates in suspension. B: Relative expression of 
Soxl mRNA in the same conditions outlined above. C: Relative expression of Beta I I I tubulin 
mRNA again in the conditions outlined in part A. Error bars = S.D. of mean. In all experiments 
n=3. 
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Figure 5.4: T H , D2 & Nkx 6-1 expression in suspension «& adherent cultures 
A . 
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C. 
R.A. Day? 
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Adherent 
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Wnti • R.A. Day? 
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Figure 5.4A: Relative expression of TH mRNA in Tera2.cl.SP12 cultures and their derivatives 
grown in the presence of lOuM retinoic acid alone or in combination with 2ng/ml Wnti for 7 days 
as either adherent monolayers or free floating aggregates in suspension. B: Relative expression of 
D2 mRNA in the same conditions outlined above. C: Relative expression of Nkx 6-1 mRNA again 
in the conditions outlined in part A. Error bars = S.D. of mean. In all experiments n=3. 
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Figure 5.5: L m x l a , M s x l & Ngn2 expression in suspension & adherent cultures 
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Figure 5.5A: Relative expression of Lmxla mRNA in Tera2.cl.SP12 cultures and their derivatives 
grown in the presence of lO^iM retinoic acid alone or in combination with 2ng/ml Wntl for 7 days as 
either adherent monolayers or free floating aggregates in suspension. B: Relative expression of Msxl 
mRNA in the same conditions outlined above. C: Relative expression of Ngn2 mRNA again in the 
conditions outlined in part A. Error bars = S.D. of mean, in all experiments n=3. 
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Figure 5.6: Transporter/receptor expression in suspension & adherent cultures 
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Figure 5.6A: Relative expression of SLC23AI mRNA in Tera2.cl.SP12 cultures and their derivatives grown in 
the presence of 10|iM retinoic acid alone or in combination with 2ng/ml Wntl for 7 days as either adherent 
monolayers or free floating aggregates in suspension. B: Relative expression of Patched 1 mRNA in the same 
conditions outlined above. C: Relative expression of FGFR4 mRNA again in the conditions outlined in part A. 
Error bars = S.D. of mean. In all experiments n=3. A one way anova with accompanying Tukey post hoc 
analysis was performed to elucidate the significant differences highlighted in red. 
The 7 day refinoic acid and Wnt l plus retinoic acid treated suspension cultures were 
taken forward as they appeared to offer the greatest chance o f facilitating the 
formation o f potential dopaminergic neurons. In addition the presence and absence of 
Wnt l in the initial step gave rise to the opportunity to assess i f W n t l application prior 
to Sonic hedgehog/Fibroblast growl:h factor 8 usage had any beneficial effects which 
could give support to the concept that it creates a permissive environment in which 
such inductive signals can act (Burbach & Smidt, 2006). When cells are grown in 
suspension and then plated out into adherent conditions as per Figure 5.1 they appear 
from the stage o f entering adherent culture at 7 days more neuronal in appearance. 
Figure 5.7 shows morphological images o f such cells after 1 day o f Sonic 
hedgehog/Fibroblast growth factor 8/retinoic acid application and at the final 17 day 
time point. The cells appear to show more process like structures in the final 10 days 
of differentiation and differ considerably in morphology f rom the vehicle controls. 
Phase images though are not particularly conclusive so some immunocytochemistry 
was carried out to assess expression of the neuronal marker Beta I I I tubulin. Figure 
5.8 shows both control and test cultures stain strongly for Beta I I I tubulin. Despite 
mechanical disruption o f the neurospheres prior to seeding out into adherent culture 
plastic ware there are still some cell aggregates or sections o f cells that remain in 
close proximity to each other. It is as such di f f icul t to make a quantitative assessment 
of the number o f neuronal cells. 
Figure 5.7: Morphological Images of ceils growing in the presence o f a combination of Shh /FGF8 /R.A. & A . A . 
D a y s Day 17 Day 17 Cont ro l 
R.A. Only 
Pre 
T rea tment 
R.A. + Wnt i 
P r e 
T rea tment 
Figure 5,7: Phase images o f cell morphology in cultures o f Tera2.cl.SP12 cells pre treated for 7 days when grown in 
suspension with lOpM retinoic acid alone or in combination with 2ng/ml W n t i that were then seeded out into adherent 
cell culture plastic ware for the remaining 10 days o f differentiation. Day 8 reflects the cultures following 1 day in 
adherent culture at this stage they were exposed to 200ng/ml Shh, lOOng/ml FGF8 and lO^iM retinoic acid. Day 17 
represents the cultures at the end o f the differentiation protocol outlined in Figure 5.1. Day 17 control reflects the 
morphology o f cultures that received the pre treatments outlined above for 7 days in suspension but that were then left in 
just media with the vehicles used to make the Shh, FGF8 and for the final 6 days A . A . up in prior to application. Scale 
bars represent 100pm. 
Figure 5.8: Beta I I I tubulin immunostaining of Shh/FGF8/R.A. & A.A. treated Tera2.cl.SP12 cultures at 17 davs 
17 Day Treated Sample 17 Day Vehicle Control Sample 
Negative Control Negative Control 
Figure 5.8: Beta III tubulin immunostaining of Tera2.cl.SP12 cells cultured for 7 days in suspension with lOfiM retinoic acid and 2ng/ml Wntl prior to seeding out into 
24 well plates where they were exposed to 200ng/ml Shh, lOOng/ml FGF8 & lO^M R.A. for 10 days with 200nM A.A. also being added to this cocktail for the final 6 
days of differentiation. Vehicle controls were treated identically for the first 7 days but upon seeding out received only the vehicle solutions that the Shh/FGF8 and for 
the final 6 days A.A. were prepared in. Images were merged in Adobe Photoshop, Hoescht stained nuclei are blue, Beta III tubulin positive cells are represented by 
green (FITC) detection. Neuronal type processes and possible cell bodies are seen and as such this staining is viewed as a positive indicator that potentially neuronal 
cells have been produced. Due to the nature of the cultures it was very difficult to discern individual cells for cell counting but both cultures appeared clearly Beta III 
tubulin immunopositive, some of this clarity was lost upon merging the images due to the strong blue background. Scale bars represent lOOnm. One representative 
image of n=3 biological repeats is shown. 
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Real time PCR was subsequently carried out to try and gain a relative estimate o f how 
neuronal the cultures were based on the expression o f the marker Beta I I I tubulin. 
Samples were taken at both 11 days and 17 days to attempt to gauge whether there 
was any pattern o f neuronal induction. A 3 week retinoic acid treated adherent culture 
sample was also included as a comparative in an effort to relate this study to earlier 
work. First o f all Figure 5.9 indicates that the treated samples vary f rom the vehicle 
controls suggesting the application o f this cocktail o f molecules has an effect. There 
is in addition a clear induction in Beta I I I tubulin expression f rom the untreated 
embryonal carcinoma cells to the 11 day and subsequently the 17 day samples. It is 
interesting that the W n t l plus retinoic acid pre treated samples at 11 days show on 
average almost double the expression o f their retinoic acid only pre treated 
counterparts. This is in support o f the concept that W n t l may create a permissive 
environment for Sonic hedgehog and Fibroblast growth factor 8 to act as inductive 
cues that drive the formation o f dopaminergic neurons. The effect is still present but 
to a lesser degree after 17 days. The 3 week retinoic acid treated sample does not 
differ to a statistically significant level f rom the embryonal carcinoma cell sample, 
however the 17 day (retinoic acid plus W n t l ) sample does. This sample though does 
not differ to a statistically relevant level from the 3 week retinoic acid treated sample. 
The Sig. value o f 0.062 is quite close to reaching a statistically significant value o f < 
0.05 and given the variability which is undoubtedly seen when using embryonal 
carcinoma cell cultures, could be taken as a positive indicator, as often one passage of 
the three used is out o f line with the other two, making it more dif f icul t to observe a 
statistical effect even though the data are indicative o f a strong trend, in this case 
towards a much more neuronal culture. This result is as such a promising start; a 
panel o f dopaminergic markers were then screened to investigate i f they displayed a 
similar expression pattern. Both phenotypic markers and factors that could be 
involved in specifying a dopaminergic fate were investigated. 
In stark contrast to Beta I I I tubulin expression, Figure 5.10 demonstrates that tyrosine 
hydroxylase m R N A levels are down regulated by 17 days to a point below the basal 
expression in the starting material. The 11 and 17 day (retinoic acid) samples show 
slightly higher expression than their retinoic acid plus W n t l pre treated counterparts 
at the equivalent time points, with the effect being less apparent at 17 days. This is 
essentially almost the opposite o f the trend seen for Beta I I I tubulin, posing the 
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question o f how are these molecules that normally drive dopaminergic differentiation 
having a seemingly negative effect? One possible answer is that the presence o f 
retinoic acid may be inhibitory to their function. This was tested subsequently. 
Another alternative is that the presence o f retinoic acid is promoting acquisition of an 
alternative neurotransmitter phenotype. It may also be that the expected peak in 
tyrosine hydroxylase expression has passed and that a lower level o f mRNA 
expression is not necessarily a negative indicator. 
Figure 5.11 shows that for dopa decarboxylase there is an analogous expression 
pattern to that for tyrosine hydroxylase, although in both cases there is no statistically 
significant difference between the embryonal carcinoma cells starting material, 17 day 
((retinoic acid plus W n t l ) most neuronal) sample and the 3 week retinoic acid treated 
comparative. However as is seen for dopamine receptor 1 in Figure 5.12 the 
embryonal carcinoma and 17 day (retinoic acid plus W n t l ) samples differ 
significantly f rom the 3 week comparative, supporting the trend that expression o f a 
range o f markers o f a dopaminergic phenotype is relatively low in the 17 day (retinoic 
acid plus W n t l ) treated samples, despite them appearing highly neuronal in nature 
(assessed by the expression o f Beta I I I tubulin). Figure 5.13 indicates that the trend is 
comparable for dopamine receptor 2, but that there is little difference between the 
mRNA levels observed at 11 and 17 days. 
Figure 5.9: Beta I I I Tubulin mRNA expression in Tera2.cl.SP12 cultures treated with a combination of Shh. F G F 8 . R . A . & A.A. 
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Figure 5.9: Relafive expression o f Beta I I I Tubulin mRNA in Tera2.cI.SP12 cells grown as in Figure 5.1; treated samples were collected at 
11 and 17 days, controls at just the latter time point. The EC cell sample reflects the undifferentiated Tera2.cI.SP12 cells and the 3W R.A. 
sample reflects such cells fol lowing 3 weeks o f retinoic acid induced differentiation in adherent condifions. This 3W R.A. set o f samples 
was included for comparison purposes to try and help relate this work to previous findings. The one way anova output indicates that there is 
a significant difference between the EC and 17 Day (R.A. + W n t l ) samples. Error bars = S.D. o f mean. In all experiments n=3. 
Figure 5.10: T H mRNA expression in Tera2.cLSP12 cultures treated with a combination of Shh. FGF8. R.A. i& A.A. 
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Figure 5,10: Relative expression of TH mRNA in Tera2.cl.SP12 cells grown as in Figure 5.1; treated samples were collected at 11 and 17 days, 
controls at just the latter time point. The EC cell sample reflects the undifferentiated Tera2.cl.SP12 cells and the 3W R.A. sample reflects such 
cells following 3 weeks of retinoic acid induced differentiation in adherent conditions. This 3W R.A. set of samples was included for 
comparison purposes to try and help relate this work to previous findings. The one way anova output indicates that there are no significant 
differences between the EC, 3W R.A. and 17 Day (R.A. + Wntl) samples. Error bars = S.D. of mean. In all experiments n=3. 
Figure 5.11: AADC mRNA expression in Tera2.cLSP12 cultures treated with a combination of Shh. FGF8. R.A. & A.A. 
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Figure 5.11: Relative expression of Dopa decarboxylase mRNA in Tera2.cl.SP12 cells grown as in Figure 5.1; treated samples were collected 
at 11 and 17 days, controls at just the latter time point. The EC cell sample reflects the undifferentiated Tera2.cl.SP12 cells and the 3W R.A. 
sample reflects such cells following 3 weeks of retinoic acid induced differentiation in adherent conditions. This 3W R.A. set of samples was 
included for comparison purposes to try and help relate this work to previous findings. The one way anova output indicates that there are no 
significant differences between the EC, 3W R.A. and 17 Day (R.A. + Wntl) samples. Error bars = S.D. of mean. In all experiments n=3. 
Figure 5.12: D l mRNA expression in Tera2.cl.SP12 cultures treated with a combination of Shh. FGF8. R A . <& A.A. 
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Figure 5.12: Relative expression o f D l m R N A in Tera2.cl.SP12 cells grown as in Figure 5.1; treated samples were collected at 11 and 17 days, controls 
at just the latter time point. The EC ceil sample reflects the undifferentiated Tera2.cl.SPI2 cells and the 3W R.A. sample reflects such cells fo l lowing 3 
weeks o f retinoic acid induced differentiation in adherent conditions. This 3W R.A. set o f samples was included for comparison purposes to try and 
help relate this work to previous findings. The one way anova output indicates that the 3W R.A. samples vary to a statistically significant level f rom 
both the EC and 17 Day (R.A. + W n t i ) samples (not shown on graph). Error bars = S.D. o f mean. In all experiments n=3. 
Figure 5.13: D2 mRNA expression in Tera2.cl.SP12 cultures treated with a combination of Shh. FGF8. R.A. & A.A. 
Sig. < 0.05 
11 Day (R A. ) 11 Day (R A. 
W n t i ) 
17 Day (R.A.) 17 Day (R A + Control 17 Day Control 17 Day 
W n t i ) (R.A ) (R.A. + W n t i ) 
S a m p l e 
Figure 5.13: Relative expression of D2 mRNA in Tera2.cl.SP12 cells grown as in Figure 5.1; treated samples were collected at 11 and 17 days, 
controls at just the latter time point. The EC cell sample reflects the undifferentiated Tera2.cl.SP12 cells and the 3W R.A. sample reflects such 
cells following 3 weeks of retinoic acid induced differentiation in adherent conditions. This 3W R.A. set of samples was included for 
comparison purposes to try and help relate this work to previous findings. The one way anova output highlights the significant difference 
between the EC and 3W R.A. samples. Error bars = S.D. of mean. In all experiments n=3. 
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When factors that may be involved in specifying a dopaminergic fate as per Figure 4.2 
were studied, at first as seen in Figure 5.14, Lmxla within the context of the 
experimental error displayed a similar expression pattern to that observed for the 
markers of a dopaminergic phenotype. The 17 day (retinoic acid plus Wnti) and 
embryonal carcinoma cell starting material differed to a statistically significant degree 
(p < 0.05) from the 3 week comparative supporting the notion that the expression of 
mRNA for the dopaminergic markers tested was low at this time point under the 
treatment conditions used. 
However Figure 5.15 shows that for Msxl the downstream target of Lmxla the 
expression profile is somewhat different. In this instance the 3 week retinoic acid 
treated comparative and 17 day (retinoic acid plus Wnti) sample hardly differ at all, 
but both although not to a statistically significant level display a clear induction above 
the levels observed in the Tera2.cl.SP12 starting material. In fact Msxl expression is 
raised from 11 to 17 days particulariy in the 17 day (retinoic acid plus Wntl) samples 
which appear the most neuronal. It is interesting that the vehicle control samples 
display a particularly high level of Msxl expression in a similar fashion to some other 
markers in these conditions such as Lmxla and Beta I I I tubulin. This may suggest 
that given a pre treatment with retinoic acid alone or in combination with Wntl , that 
Tera2.cl.SP12 cultures are capable of controlled up regulafion of dopaminergic and 
neuronal markers, or they may show a continued response to the earlier treatment with 
such factors. However even though they demonstrate this seemingly favourable 
ability to up regulate indicators of a dopaminergic or neuronal phenotype which is 
promising, it would need to be harnessed in a more controlled manner to potentially 
derive the greatest possible benefit from it. That is i f such high levels of such markers 
are required at all, the process may be more subtle with lower levels being adequate to 
exert more delicate effects. There may even be an interaction between certain key 
dopaminergic inducing factors and metabolites such as dopamine itself; that make the 
process more intricate and mean that merely observing elevated levels of 
dopaminergic markers is not sufficient to produce the desired outcome of an enriched 
population of functional dopaminergic neurons. 
There is though seemingly in the test conditions a difference in the regulation of Msxl 
mRNA levels. Msxl is postulated to act positively on neurogenin2 and to suppress 
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Nkx 6-1. Figure 5.16 shows that although neurogenin2 expression is not as great in 
17 day (retinoic acid plus Wnti) samples as it is in the 3 week retinoic acid treated 
comparatives, it does rise in its expression from 11 to 17 days when retinoic acid and 
Wnti are used in the initial 7 days. When just retinoic acid is used in this preliminary 
stage there is no real difference between the 11 and 17 day samples. This raises the 
possibility that Msxl is at least in the Wnti plus retinoic acid pre treated samples 
having an effect on the up regulation of neurogenin2 from 11 to 17 days, although 
much more thorough investigation would be needed to make any firm conclusion as to 
the viability of this fledgling idea. Of interest though as can be seen in Figure 5.17 is 
that Nkx 6-1 levels drop off from 11 to 17 days, with the lowest expression being in 
the 17 day (retinoic acid plus Wnti) samples, where Msxl levels are relatively high. 
This raises the possibility that Msxl may as expected be exerting an inhibitory effect 
on Nkx 6-1 expression. Nkx 6-1 is induced to a statistically significant level in the 3 
week retinoic acid treated comparative samples in relation to the embryonal 
carcinoma stem cell starting material. Msxl although not to a level of statistical 
relevance is induced in such samples in a comparable manner. Therefore the 
statistically significant difference in expression between 3 week retinoic acid treated 
and 17 day (retinoic acid plus Wnti) samples is interesting not only in that the 17 day 
(retinoic acid plus Wnti) samples express Nkx 6-1 more weakly than in the starting 
material, suggesting something within the system under investigation is having an 
effect, but this is seen when a known suppressor of Nkx 6-1, namely Msxl is in 
relafive terms showing an induction in its levels. Again this possible correlation 
would require further investigation but it does appear that components of the pathway 
described in Figure 4.2 thought to be influenced by Sonic hedgehog are seemingly 
regulated in a predictable fashion in its presence. 
Figure 5.14: Lmxla mRNA expression in Tera2.cl.SP12 cultures treated with a combination of Shh. FGF8. R.A. & A.A. 
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Figure 5.14: Relative expression of Lmxla mRNA in Tera2.cl.SP12 cells grown as in Figure 5.1; treated samples were collected at 11 and 
17 days, controls at just the latter time point. The EC cell sample refiects the undifferentiated Tera2.cl.SP12 cells and the 3W R.A. sample 
refiects such cells following 3 weeks of retinoic acid induced differenfiation in adherent conditions. This 3W R.A. set of samples was 
included for comparison purposes to try and help relate this work to previous findings. The one way anova output indicates that the 3W 
R.A. samples vary to a statistically significant level from both the EC and 17 Day (R.A. + Wntl) samples (not shown on graph). Error 
bars = S.D. of mean. In all experiments n=3. 
Figure 5.15: Msxl mRNA expression in Tera2,ci,SP12 cultures treated with a combination of Shh. FGF8. R,A. & A.A. 
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Figure 5.15: Relafive expression of Msxl mRNA in Tera2.cl.SP12 cells grown as in Figure 5.1; treated samples were collected at 11 and 17 
days, controls at just the latter fime point. The EC cell sample reflects the undifferenfiated Tera2.cl.SP12 cells and the 3W R.A. sample 
reflects such cells following 3 weeks of retinoic acid induced differentiation in adherent conditions. This 3W R.A. set of samples was 
included for comparison purposes to try and help relate this work to previous findings. The one way anova output indicates that there a 
significant differences between the EC, 3W R.A. and 17 Day (R.A. + Wntl) samples. Error bars = S.D. of mean. In all experiments n=3. 
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Figure 5.16: Ngn2 mRNA expression in Tera2.cl.SP12 cultures treated with a combination of Shh, FGF8. R.A. & A.A. 
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Figure 5.16: Relative expression of Ngn2 mRNA in Tera2.cl.SP12 cells grown as in Figure 5.1; treated samples were collected at 11 and 17 
days, controls at just the latter time point. The EC cell sample reflects the undifferentiated Tera2.cl.SP12 cells and the 3W R.A. sample reflects 
such cells following 3 weeks of retinoic acid induced differentiation in adherent conditions. This 3W R.A. set of samples was included for 
comparison purposes to try and help relate this work to previous findings. The one way anova output highlights the significant difference 
between the EC and 3W R.A. samples. Error bars = S.D. of mean. In all experiments n=3. 
Figure 5.17; Nkx 6-1 mRNA expression in Tera2.cl.SP12 cultures treated witii a combination of Shh. FGF8. R.A. & A.A. 
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Figure 5.17: Relative expression o f Nkx 6-1 m R N A in Tera2.c!.SP12 cells grown as in Figure 5.1; treated samples were collected at 11 and 17 days, controls 
at just the latter time point. The EC cell sample reflects the undifferentiated Tera2.cl.SP12 cells and the 3W R.A. sample reflects such cells fo l lowing 3 
weeks o f retinoic acid induced differentiation in adherent conditions. This 3W R.A. set o f samples was included for comparison purposes to try and help 
relate this work to previous findings. The one way anova output indicates that the 3W R.A. samples vary to a statistically significant level f rom both the EC 
and 17 Day (R.A. + W n t l ) samples (the EC to 3W R.A. difference is indicated on the graph, the other difference is not as it is probably o f lesser relevance). 
Error bars = S.D. o f mean. In all experiments n=3. 
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The question though still remains as to why the phenotypic markers appear to be 
relatively down regulated, especially given the suggestion that the pathway for 
dopaminergic specification thought to be influenced by Sonic hedgehog may well be 
active in the presence of this molecule within the context of this experimental 
strategy. One possible reason for this is that retinoic acid was included in the final 10 
days of the differentiation protocol; feasibly this may have an inhibitory effect on 
dopaminergic differentiation or promote the acquisition of other neurotransmitter 
phenotypes. Therefore to address i f this is likely to be the case retinoic acid was 
omitted for the final differentiation stages so as to replicate this part of the method of 
Cho et al., 2008. The cells were grown as per the scheme in Figure 5.2 with the most 
neuronal (as assessed by real time PCR) condition being selected for the initial stage. 
This was the 7 day retinoic acid plus Wntl suspension culture pre treatment followed 
by the 10 day protocol of Cho et al., 2008 termed the minus condition, which was then 
compared to the plus retinoic acid condition (that had previously been identified as the 
most neuronal) as defined in Figure 5.2. The comparison also included samples from 
the embryonal carcinoma cell starting material, the 3 week retinoic acid treated 
comparafive and a 17 day vehicle control, as well as a MG63 sample that was not 
expected to show any dopaminergic or neuronal marker expression and as such this 
would act as a control to check in a non neural cell type that there was not a 
background expression of such markers. 
Figure 5.18 shows that for dopa decarboxylase and dopamine receptor 2 there is 
hardly any difference between the plus and minus retinoic acid condifions. The trends 
are similar to those found previously for the other samples too, suggesting some 
consistency in the results obtained. A similar scenario is found for tyrosine 
hydroxylase and Beta I I I tubulin (Figure 5.19), there does appear to be a higher 
expression of tyrosine hydroxylase in the minus retinoic acid samples but this 
difference is not statistically significant. Figures 5.20 and 5.21 show the situation is 
analogous for the components of the pathway that Sonic hedgehog may affect to 
promote the acquisition of a dopaminergic phenotype. 
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Figure 5.18: AADC & D2 expression in the plus and minus R.A. conditions 
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Figure 5.18A: Relative expression of Dopa decarboxylase mRNA in Tera2.cl.SP12 cultures treated as 
per the conditions defined in Figure 5.2, harvested at the terminus o f the 17 day differentiation protocol. 
The EC cell sample reflects the undifferentiated Tera2.cl.SP12 cells and the 3W R.A. sample reflects 
such cells following 3 weeks of retinoic acid induced differentiation in adherent conditions. The MG63 
condition was included as a control to assess i f dopaminergic markers were expressed in a non neural cell 
line. B: Relative expression of D2 mRNA in identical conditions to those described in part A. Error bars 
= S.D. o f mean. In all experiments n=3. Student's T-test was used to assess i f there was a statistically 
significant difference between the plus and minus R.A. conditions, there was not in either instance. 
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Figure 5.19: T H & Beta III tubulin expression in the plus and minus R.A. 
conditions 
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Figure 5.19A: Relative expression o f TH mRNA in Tera2.cl.SP12 cultures treated as per the conditions defined in 
Figure 5.2, harvested at the terminus o f the 17 day differentiation protocol. The EC cell sample reflects the 
undifferentiated Tera2.cl.SP12 cells and the 3W R.A. sample reflects such cells following 3 weeks o f retinoic acid 
induced differentiation in adherent conditions. The MG63 condition was included as a control to assess i f 
dopaminergic/neuronal markers were expressed in a non neural cell line. B: Relative expression o f Beta I I I tubulin 
mRNA in identical conditions to those described in part A. Error bars = S.D. o f mean. In all experiments n=3. 
Student's T-test was used to assess i f there was a statistically significant difference between the plus and minus R.A. 
conditions, there was not in either instance. 
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Figure 5.20: Lmxla & Msxl expression in the plus and minus R.A. conditions 
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Figure 5.20A: Relative expression of Lmxla mRNA in Tera2.ci.SP12 cultures treated as per the conditions 
defined in Figure 5.2, harvested at the terminus of the 17 day differentiation protocol. The EC cell sample 
reflects the undifferenfiated Tera2.cl.SP12 cells and the 3W R.A. sample reflects such cells following 3 
weeks of refinoic acid induced differentiation in adherent conditions. The MG63 condition was included as 
a control to assess i f dopaminergic markers were expressed in a non neural cell line. B: Relative 
expression of Msxl mRNA in identical condifions to those described in part A . Error bars = S.D. of mean, 
in all experiments n=3. Student's T-test was used to assess i f there was a stafisfically significant difference 
between the plus and minus R.A. conditions, there was not in either instance. 
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Figure 5.21: Ngn2 & Nkx 6-1 expression in the plus and minus R.A. conditions 
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Figure 5.21A: Relative expression of Ngn2 mRNA in Tera2.cl.SP12 cultures treated as per the conditions 
defined in Figure 5.2, harvested at the terminus of the 17 day differentiation protocol. The EC cell sample 
reflects the undifferentiated Tera2.cl.SP12 cells and the 3W R.A. sample reflects such cells following 3 
weeks o f retinoic acid induced differentiation in adherent conditions. The MG63 condition was included as 
a control to assess i f dopaminergic markers were expressed in a non neural cell line. B: Relative 
expression of Nkx 6-1 mRNA in identical conditions to those described in part A. Error bars = S.D. of 
mean. In all experiments n=3. Student's T-test was used to assess i f there was a statistically significant 
difference between the plus and minus R.A. conditions, there was not in either instance. 
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It is also of interest that dopa decarboxylase, tyrosine hydroxylase, Lmxla and 
neurogenin2 are not detectable as would be expected in the non neural MG63 
samples. However dopamine receptor 2, Beta I I I tubulin, Msxl and Nkx 6-1 
expression were detected in such samples. Although dopamine receptor 2 and Msxl 
are relatively only moderately expressed and as is the case for Beta III tubulin and 
Nkx6-1 the variability in their expression is quite high. This may be due to the fact 
that the house keeping gene GAPDH used to normalise the expression data showed a 
highly different expression pattern in these MG63 samples in relation to their 
embryonal carcinoma cell derived counterparts. The raw cycle threshold data 
indicated it took usually around 25-26 cycles for detecfion of GAPDH in the MG63 
cell samples, where as usually only 19-21 cycles were required for the embryonal 
carcinoma cell based samples. This is indicative of weaker expression of GAPDH in 
the MG63 cell samples which in turn could make any detectable expression in the test 
samples (for example Beta II I tubulin) appear greater than it really is in relative terms 
to the expression in embryonal carcinoma cell derived material. Beta-actin the other 
house keeping gene used in this analysis was also expressed differently in MG63 
samples in comparison to embryonal carcinoma cell based samples. The cycle 
threshold values for beta-actin were around 18-20 for embryonal carcinoma cell based 
specimens but ranged from 26-29 for MG63 cell samples. This highlights that even 
when using more than one house keeping gene disparities may arise due to variable 
expression of both the house keeping genes used, giving support to the concept that as 
wide a range as possible of house keeping genes should be utilised. It may however 
be that the data indicate false positives being recorded. For dopamine receptor 2 this 
is highly unlikely as detection occurs at between 36-39 cycles (out of 40). Such weak 
detection at so late a stage in the process is likely to only reflect the presence of a few 
transcripts or even a hint of contamination i f the RNase treatment has not removed all 
the contaminating DNA that may be present. Given this in combination with the 
differences in house keeping gene expression it is possible but highly unlikely that 
false positives are being obtained that would have any effect on the data (this 
argument runs for Msxl (detected at around 33-36 cycles) and Nkx6-1 (detected 
around 37-39 cycles)). There is also the possibility that as MG63 cells are cancerous 
that they may possess a low level aberrant expression of certain markers that would 
not be expected to be detected. 
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In the case o f Beta I I I tubulin it would appear that although the house keeping gene 
issue may be o f some relevance, that there is some detection. This may indicate the 
real time PGR results earlier in this Chapter and in Chapter 4 could be a result of false 
positives. This may be the case but this argument is not well supported by the 
immunostaining in this and the previous Chapter, that indicates cells are present that 
display the morphology expected o f a potential neuron in culture. The variability in 
the level o f expression seen also indicates that a broad false positive detection is less 
likely as more uniformity might be expected amongst the results i f this was the case. 
The neurogenin2 real time PCR data in this Chapter also add support to the notion that 
there is an up regulation o f neuronal marker expression and neurogenin2 was not 
detectable at all in the MG63 cell samples. It may be given their cancerous origins 
that MG63 cells express Beta I I I tubulin even though this may not be predicted. 
Alternatively the possibility o f this seemingly false positive may arise more as a result 
o f Beta I I I tubulin not being a solely neuronal marker, as a member o f the tubulin 
family o f proteins it may be that it is expressed more broadly and that it is not an ideal 
marker o f a neuronal phenotype. In any future work it would be advisable to use a 
panel o f neuronal markers such as microtubule associated protein 2, neurofilament 
200 and Beta I I I tubulin in an analogous manner to the panel o f dopaminergic markers 
tested. Alternatively another cell line expected to be negative for Beta I I I tubulin 
expression could be tested and i f found to be negative could then be used as a 
negative control. I f another cell line was tested and found to be negative in a 
predictable manner it would though raise the question o f what is and isn't suitable for 
use as a negative control and also given the MG63 results just how specific a marker 
is Beta I I I tubulin? This would indicate the need for a panel o f suspected neuronal 
markers to add validity to any further work. 
Flow cytometry was subsequently carried out to try and assess further i f the MG63 
cell line was negative for the expression o f the markers tested using immunological 
reagents. Figure 5.22 shows that for the neuroprogenitor/neuronal and dopaminergic 
markers tested in previous chapters, there is little to no expression in MG63 cells. 
The mean fluorescence intensity values for nestin, Nur r l and tyrosine hydroxylase are 
equivalent to those for secondary only controls; there is a low level o f Beta I I I tubulin 
expression but it is not as high as it would appear to be in the real time PCR analysis 
when related to mean fluorescence data for retinoic acid treated embryonal ceircinoma 
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cells in Chapter 3. Also Beta I I I tubulin as a member o f the tubulin family o f 
cytoskeletal proteins may feasibly be present in other non neuronal cell types, so this 
is not a completely unsurprising result. On balance therefore it would appear that 
dopaminergic markers are not just expressed in any cell type but that they are actually 
able to be induced and regulated in a relatively controlled manner in the 
Tera2.cl.SP12 model under different conditions. 
The finding that there is though some detection in a large number of cells of Beta I I I 
tubulin and a detection o f tyrosine hydroxylase in particular and N u r r l in a smaller 
but noticeable percentage o f cells reinforces the concept discussed earlier that there 
may be some non specific binding o f the antibodies used. The variability in 
expression and morphological features highlighted earlier are therefore critical 
features as they suggest that although there may be broad background detection, some 
specific clear predictable detection is still possible. 
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Figure 5.22: Flow cytometry analysis of MG63 cells 
A. 120 
" 80 
Nestin Nurr1 TH Tuj1 
B. 
Nestin Nurr1 TH Tuj1 
216 
c. 
1(jO 10' 10^ 10* 
FL4-H 
Figure 5.22A: The percentage of MG63 cells positive for expression of Nestin, Nurrl, TH and 
Beta III tubulin. The observed readings for Nestin, Nurrl and TH are generally low in 
comparison to those for the retinoic acid treated derivatives of Tera2.cl.SP12 cells detailed in 
Chapters 3 & 4. B: The intensity of Nestin, Nurrl, TH and Beta III tubulin expression in MG63 
cells. For the first 3 markers these values vary little from secondary only controls. For Beta III 
tubulin they reflect a relatively low but detectable level of expression akin to that observed for 
Tera2.cl.SP12 cells in Chapter 3. Error bars = S.D. of mean. In all experiments n=3. C: Flow 
cytometry traces showing how from the secondary only control sample where close to all cells 
were gated out as negative (left hand image) there is a shift to the right of the single peak for the 
test sample (right hand image). This detection of non neural MG63 cells positive for Beta III 
tubulin that is associated with a relatively weak (akin to that for EC cells recorded in Chapter 3 as 
mentioned above) but measurable intensity may reflect non specific binding of the antibody. 
However given that by other means detection in EC cells (which show comparable results to 
MG63 samples) of Beta III tubulin is weak it may be that this is not reflective of a strong 
expression of this marker but one that is detectable partly as a result of the sensitivity of the 
technique. It is though possible that Beta III tubulin is expressed in the non neural MG63 cells as 
it may be that it is not a totally neural specific marker, as neural markers have been found to be 
expressed by non neural cell types (stromal cells) such as in Deng et al, 2006. 
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The question though given that there appears to be little difference in expression at 17 
days between the plus and minus retinoic acid conditions remains as to why there is a 
relatively low amount o f m R N A present for a range o f dopaminergic markers, when 
the embryonal carcinoma cells have been treated with a cocktail o f molecules thought 
to drive dopaminergic differentiation. To probe deeper and change the point o f 
comparison. Western blotting was used to try and gauge i f the expression o f neuronal 
and dopaminergic marker proteins reflected the trends seen in terms o f the mRNA 
levels at the 17 day time point in the plus and minus retinoic acid conditions. Figure 
5.23 shows that tyrosine hydroxylase protein is up regulated in both the plus and 
minus retinoic acid conditions, relative to the Tera2.cl.SP12 starting material. The 
test samples also display greater expression than in the 17 day vehicle control sample, 
supporting the concept that the more controlled approach is the superior method. As 
is the case for the m R N A data there appears to be a slightly greater expression in the 
minus retinoic acid condition. There is however very little correlation between the 
mRNA and protein data, as at the mRNA level tyrosine hydroxylase expression in the 
embryonal carcinoma cells is comparable to that in the vehicle control and plus 
retinoic acid conditions, with slightly more of it present in the minus retinoic acid 
samples. This is clearly not the case in terms o f tyrosine hydroxylase protein 
expression. The minus retinoic acid condition may show a slightly greater induction 
than the vehicle control and plus retinoic acid samples, but in all three cases there is a 
marked inducfion o f tyrosine hydroxylase protein relative to the Tera2.cl.SP12 
starting material. Figure 5.23 also shows that for Beta I I I tubulin there is a slight but 
less tangible induction. This may be due to the fact that embryonal carcinoma stem 
cells show a propensity for neural differentiation and perhaps do express the slightly 
more generic marker Beta I I I tubulin at a basal detectable level. It may however be 
due to a general non specific binding o f the antibody used. Although treatment using 
the protocols outlined in Figure 5.2 may enhance the neuronal nature o f the cultures as 
observed in the real time PCR analyses it may also be the case that there is a 
remodelling o f the Beta I I I tubulin present i n such cultures, along with some 
induction. Further analysis using flow cytometry or the immunostaining shown 
previously (Figure 5.8) may give a better indication o f the changing patterns o f Beta 
I I I tubulin expression in this model system. 
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Figure 5.23: Beta I I I tubulin & T H protein expression in the plus & minus R.A. 
conditions 
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Figure 5.23: A representative Western blot image demonstrating TH and Beta III tubulin protein 
expression in samples harvested at the 17 day terminus of the differentiation protocol defined in 
Figure 5.2. The EC cell sample represents samples derived from cultures of undifferentiated 
Tera2.cl.SP12 embryonal carcinoma stem cells. 20|ug of protein were loaded for each sample (n=3). 
Beta-actin was used as a loading control, as indicated the main bands for each antibody were of the 
predicted size. There is a faint additional band above the band of interest in the Beta 111 tubulin blot 
supporting the concept that there may be some non specific binding of this antibody. This is in 
keeping with the detection of this neural marker in the non neural MG63 cell line by flow cytometry, 
which may be due to non specific binding of the antibody or as a result of Beta 111 tubulin not being a 
totally specific marker of a neuronal phenotype. 
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It is clear though that mRNA and protein levels for markers o f a dopaminergic 
phenotype are not regulated in a simple linear fashion. Figure 5.24 presents one 
possible model o f how mRNA and protein expression for markers o f a dopaminergic 
phenotype such as tyrosine hydroxylase may vary over time based on the data 
obtained. In an ideal scenzirio further protein based analysis using a panel of 
dopaminergic markers would be carried out as the presence of tyrosine hydroxylase 
may indicate the presence of adrenergic or noradrenergic neurons and as such this 
may account for the down regulation of other dopaminergic markers at the mRNA 
level, as indicators o f other phenotypes may be up regulated. This though may not be 
that likely a scenario as tyrosine hydroxylase mRNA is down regulated in a 
comparable fashion to other dopaminergic markers, suggesting a conserved effect, i f it 
was present as an indicator o f another phenotype then it may feasibly be expected to 
be controlled in a different fashion. Further additional work could focus on assessing 
expression o f alternative markers indicative o f other neuronal phenotypes. Overall 
though there is some case to believe that under the conditions tested, in particular the 
minus retinoic acid condition that Tera2.cl.SP12 cells can respond to and be driven 
towards acquisition o f a dopaminergic phenotype using this Sonic 
hedgehog/Fibroblast growth factor 8 based approach. 
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Figure 5.24: A summary of the trends in mRNA & protein expression in E C cells treated with a dopaminergic differentiation cocktail 
A possible model of the trends in mRNA and protein expression for 
dopaminergic markers such as tyrosine hydroxylase in Tera2.cl.SP12 human 
embryonal carcinoma stem cells treated as per the scheme outlined 
Note: Not to 
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Figure 5.24: A possible model of the trends in mRNA and protein expression for dopaminergic markers such as tyrosine hydroxylase based upon the 
findings in this study. Neuronal marker expression is also shown as broadly increasing over the course of differentiation. There doesn't appear to be a direct 
correlation between mRNA and protein expression under the conditions tested, and there may well be a lag period where there is a rise in levels of protein as 
the mRNA levels start to decline. Both the plus and minus R.A. conditions are postulated to behave in a comparable manner throughout the entire process 
based upon the observation that there is little or no difference between the conditions at the end point of the differentiation protocol. This though would need 
to be verified experimentally if this work were to be extended. 
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5.4 Discussion 
The first hypothesis to be addressed in this Chapter was whether suspension culture o f 
the Tera2.cl.SP12 cell line could offer any advantages in the pursuit o f the production 
o f potential dopaminergic neurons relative to the use o f standard adherent conditions. 
In the presence o f retinoic acid alone and particularly in combination wi th W n t l 
suspension culture appears to offer some benefits. First o f all neurospheres formed 
from Tera2.cl.SP12 cells treated with refinoic acid (Horrocks et al, 2003), or this 
molecule and W n t l for 7 days expressed nestin, Soxl and Beta I I I tubulin in a 
comparable fashion to the spherical neural masses formed f rom human embryonic 
stem cells in the work o f Cho et al., 2008. The spherical neural masses were then 
utilised to obtain a high yield o f dopaminergic neurons, so given that the embryonal 
carcinoma cell derived neurospheres displayed a similar pattern o f marker expression 
there was the prospect that they may be an adequate and representative substitute for 
the spherical neural masses when using the Tera2.cl.SP12 model. In addition 
suspension cultures tended to increase Beta I I I tubulin mRNA expression and lowered 
the levels o f Soxl mRNA present. In the light o f the findings o f Yan et al., 2005 that 
suggested when using human embryonic stem cells Sonic hedgehog and Fibroblast 
growth factor 8 should be applied early prior to or at a threshold o f Soxl expression, 
the lower levels o f it in suspension cultures may be favourable in the context o f 
integrating the effective 10 day Sonic hedgehog/Fibroblast growth factor 8 based 
differentiation protocol o f Cho et al., 2008. It would be o f interest in fixture studies to 
assess i f Soxl protein expression reflects the pattern seen for its mRNA. Suspension 
culture also appears to promote broadly neuronal differentiation as seen by elevated 
amounts o f Beta I I I tubulin mRNA. However dopaminergic marker expression at 7 
days appears to be affected less by suspension culture and more by the presence o f 
W n t l as observed in Chapter 4. Some indicators such as M s x l that is thought to be 
involved in the specification o f a dopaminergic fate do though show an up reguladon 
due to the use o f suspension culture. A broader screen at different fime points might 
help to extend this work to see i f at other stages similar effects on factors associated 
with a dopaminergic phenotype are detectable. There is though seemingly promise in 
the use o f suspension culture as part o f the strategy to drive the dopaminergic 
differenfiation o f the Tera2.cl.SP12 cell line, as mentioned in the results this could be 
222 
via changes in gene expression profiles in a comparable manner to that found in 
mouse embryonic stem cells. This notion is also broadly in keeping wi th the work o f 
Ravindran & Rao, 2006, who used an alternative embryonal carcinoma cell line, 
Ntera2 to produce dopaminergic neurons using a method involving embryoid body 
formation and the application o f Sonic hedgehog/Fibroblast growth factor 8 in a 
similar fashion to the protocol pioneered by Lee et al., 2000 using mouse embryonic 
stem cells. 
One anomaly that arose in these initial investigations though was the lack o f an effect 
due to the presence of W n t l in combination with retinoic acid in adherent conditions. 
Wnt l had previously been shown in Chapter 4 to up regulate dopaminergic marker 
mRNA expression at 7 days in relation to cultures treated with only retinoic acid. In 
suspension cultures at 7 days a comparable trend was seen, indicating that this 
molecule was able to exert an effect. However in the adherent samples tested in this 
chapter i t emerges as having little or no influence on dopaminergic marker 
expression. In the light o f the same stock o f W n t l being used and the observable 
effects on suspension cultures this is unusual as the exogenous Wnt l appears to only 
be inactive in the adherent set o f cultures. This may be due to some flaw in the 
embryonal carcinoma cells used for these particular experiments as i f one bad batch 
was split for use and passaged with a view to subsequent use any abnormality could 
be passed on to each set o f cells utilised to provide the 3 biological repeats. The 
unpredictable, aberrant nature o f the embryonal carcinoma cells makes this a 
possibility and could l imit their use in the context o f them not always providing 
reproducible results. There may be other reasons such as some mRNA may be 
degraded during storage, especially i f for example the storage vessel temperature 
drops, although this may be expected to affect all samples it is possible it may have 
more impact on some than others, the duration o f storage may more realistically have 
an effect. There are a myriad o f other potential reasons but the unpredictable nature 
of the embryonal carcinoma cells is one o f them and is an important consideration 
when contemplating their prospective use. 
The next question was, can Sonic hedgehog and Fibroblast growth factor 8 alone and 
in conjunction with ascorbic acid influence the dopaminergic differentiation of 
Tera2.cl.SP12 embryonal carcinoma stem cells? In the Ntera2 cell line Stull & 
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lacovitti, 2001 made the suggestion that Sonic hedgehog and Fibroblast growth factor 
8 were not alone sufficient to drive the dopaminergic differentiation o f such cultures 
(although here retinoic treated derivatives o f the Ntera2 cells were used as previously 
discussed). However Ravindran & Rao, 2006 presented data indicating that in the 
absence o f retinoic acid these molecules could be used to help form dopaminergic 
neurons f rom the Ntera2 cell line. Sonic hedgehog is thought to act via the 
mechanism outlined in Figure 4.2 and in the Tera2.cl.SP12 system it appears that 
Sonic hedgehog may up regulate the amount o f M s x l mRNA, whilst in turn Nkx 6-1 
is repressed and neurogenin2 levels are slightly elevated. This would be expected i f 
Sonic hedgehog was up regulating M s x l and thus enabling it to act on its downstream 
signalling components. A greater effect may be expected to be seen on L m x l a 
mRNA levels but as the first part o f the signalling cascade perhaps i f there is a peak in 
the expression o f this factor it has already passed prior to the sampling points chosen. 
Further analysis starting with an assessment o f the pattern o f protein expression for 
these key transcription factors would be o f benefit. Also i f more time points could be 
included this would be o f use to give a deeper understanding o f the patterns o f 
regulation o f mRNA and protein for dopaminergic markers when applying Sonic 
hedgehog, Fibroblast growth factor 8 and ascorbic acid to the Tera2.cl.SP12 
embryonal carcinoma stem cell system. 
It is o f interest that M s x l is relatively up regulated and that it may influence 
neurogenin2 m R N A levels as this factor is thought to have broadly pro neural 
properties (Abeliovich & Hammond, 2007). This might be a part o f the reason for the 
enhanced levels o f the neuronal marker Beta I I I tubulin that are observed. The 
induction o f the m R N A for Beta I I I tubulin f rom 11 to 17 days also indicates that the 
ascorbic acid in conjunction with the Sonic hedgehog and Fibroblast grov^h factor 8 
may be having an effect on maturation of the cultures. It is also worthy o f note that 
the Wnt l plus retinoic acid pre treatment followed by 4 days o f Sonic hedgehog and 
Fibroblast growth factor 8 application leads to almost twice the amount o f Beta I I I 
tubulin m R N A expression relative to samples treated with only retinoic acid for the 
first 7 days. This may suggest that Wnt l is creating a permissive environment for 
Sonic hedgehog and Fibroblast growth factor 8 to subsequently act in as inductive 
signals, to drive the dopaminergic differentiation process. Further work would be 
needed to address this in more detail, as it may be that the difference is in part or 
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wholly due to the fact that the W n t l plus retinoic acid combined cultures show higher 
levels o f Beta I I I tubulin expression at 7 days and this may be carried forward to 11 
days. It does though still indicate that there could be a positive synergy in the 
combined use o f all three molecules. 
Therefore given that the pathway thought to be induced by Sonic hedgehog is to some 
degree seemingly influenced by it at the mRNA level and the apparent ability o f this 
molecule in concert wi th Fibroblast growth factor 8 and ascorbic acid to enhance the 
expression o f the neuronal marker Beta I I I tubulin. I t is a little surprising to find that 
a range o f markers o f a dopaminergic phenotype are relatively weakly expressed and 
in fact generally down regulated in terms o f the level o f their mRNA present at the 
terminus o f the 17 day differentiation protocol. There was the possibility that this was 
due to the presence o f retinoic acid, however the minus retinoic acid condition that 
replicates the method o f Cho et al., 2008 shows no difference to its plus retinoic acid 
counterpart. This raises the question as to whether retinoic acid should be omitted i f 
possible f rom the entire process as in Ravindran & Rao, 2006. It also offers the 
opportunity for further investigations into alternatives to retinoic acid, for example 
ascorbic acid which has been shown to enhance the yield o f dopaminergic neurons 
from rat midbrain precursor cultures (Yan et al., 2001). There are also two other clear 
possibilities for this unexpected effect, the first is that false positives are arising when 
detecting Beta I I I tubulin expression giving a false impression o f how neuronal the 
sample cultures are. This as discussed in the results is somewhat debateable 
especially given that neurogenin2 is up regulated and this marker is seen by some as 
broadly neuronal. However it is not impossible that cells reflective o f a neuronal 
phenotype are not being formed at all or certainly to a lesser degree than might appear 
to be the case, in turn explaining the lack o f dopaminergic marker expression. 
Alternatively it may be excess Sonic hedgehog is being applied possibly at a sub 
optimal temporal window in the differentiation process. Too much Sonic hedgehog 
may have an inhibitory effect and lead to fewer neurons o f a potentially dopaminergic 
phenotype (Fasano & Studer, 2009; Joksimovic et al, 2009), giving an alternative 
explanafion o f the findings. 
Another possible reason for the relatively negative effect on dopaminergic marker 
expression may be related to the drop in the levels o f the mRNA for the receptor for 
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Fibroblast growth factor 8. Although the mRNA is present and the protein may be too 
perhaps a shorter period o f neurosphere formation would be beneficial or earlier 
Fibroblast growth factor 8 application alongside W n t l and retinoic acid may be 
advantageous. 
It may also be that low levels o f mRNA do not correlate directly with the amount o f 
protein present. This was found to be the case for tyrosine hydroxylase and it would 
be o f use to expand this comparison to other markers in future investigations to try 
and lend support to the model whereby the peak in dopaminergic marker mRNA 
expression has passed prior to the sampling points. Markers o f other phenotypes 
could be assessed for their expression to try and identify i f an alternative neuronal 
population is being formed. 
The MG63 cell control though highlights that such expression profi l ing approaches 
although valid need to be thorough, especially when considering more generic 
markers such as Beta I I I tubulin. On balance it appears that MG63 cells do not 
express dopaminergic markers in a regulated manner, but transcription factors such as 
Msx l can be detected in samples from these cells. It may be the case that certain 
elements associated with a particular phenotype in one cell or tissue play a totally 
different role in another cell or tissue type and this may account for the observation 
that some dopaminergic markers are detected in the non neural MG63 cell samples. 
This though underpins the absolute need i f possible to assess a panel o f markers for 
the phenotype o f interest. I f these can also be identified to be regulated in a 
predictable fashion this is an added bonus, as it helps put any findings into a specific 
context. In an ideal scenario both mRNA and protein data would be obtained because 
as the results in this chapter highlight there is seemingly not always a clear correlation 
between mRNA and protein expression. 
The limitations o f assessing marker expression also point to the need for functional 
testing. A clear development to this work would be to assess dopamine release using 
high performance liquid chromatography. I f there was a clear evoked dopamine 
release in test conditions relative to controls upon treatment wi th potassium ions it 
would suggest that there were dopaminergic neurons present. This would i f it were 
the case correlate wi th the protein data for tyrosine hydroxylase. Proteins are the 
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functional components o f a cell and as such their expression may be viewed as more 
critical than that o f the corresponding mRNA. I f this work was investigated to a 
functional level it could be o f great benefit. In addition i f the Tera2.cl.SP12 cell line 
is to be used such testing is essential as any candidate neurons derived f rom it would 
need to show functional properties i f they were to be utilised in pharmacological 
screening. The assessment o f the electrophysiological properties and possibly even 
the transplantation o f the cells derived in vitro into a Parkinsonian animal model such 
as a 6-hydroxydopamine treated mouse could also be o f value, as they would give a 
fiirther insight into the fianctional potential of embryonal carcinoma stem cell derived 
neurons. 
Although it was hoped that some assessment could be made o f the potential for 
applied usage of the Tera2.cl.SP12 model, the current data are not sufficient to base 
any conclusive decisions on, they do suggest that the 17 day approach could offer the 
prospect o f an enhanced yield o f dopaminergic neurons but further protein expression 
data are needed prior to at least some form of functional test such as a dopamine 
release assay. It appears that there may be idiosyncrasies in such cultures that dictate 
that the patterns o f m R N A and protein expression vary differentially wi th time in the 
complex process o f attempting to achieve dopaminergic differentiation but currently 
the data are still too open to interpretation to really make a judgement on the potential 
o f the Tera2.cl.SP12 cell line as a model to study dopaminergic neurogenesis. 
Therefore to try and gain a better insight into the suitability o f this model system for 
this purpose, it was decided to make a direct comparison o f it relative to the Ntera2 
cell line that has been utilised in the desired context in the available literature, using 
another well established method, that o f co-culture with PA6 cells; this forms the 
basis o f Chapter 6. 
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Chapter 6 
The use of a mesodermal 
cell co-culture method to 
make a comparison of the 
dopaminergic 
differentiation potential of 
the Human E C cell 
systems Tera2.cLSP12 and 
Ntera2.Dl 
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6.1 Introduction 
The primary purpose o f this final results Chapter is to compare the Tera2.cl.SP12 
embryonal carcinoma cell line to a suitable counterpart that has been used in the 
published literature to study dopaminergic neurogenesis. The Ntera2 cell line was 
chosen to make the comparison against for a number o f reasons. First o f all, it is an 
embryonal carcinoma cell line so suffers f rom the same generic drawbacks o f being of 
cancerous origin, secondly it is f rom the same species, this purports the use of the 
same primers, antibodies and other reagents used for the Tera2.cl.SP12 cell line is 
feasible; f inally it has been used to produce neurons representative of a dopaminergic 
phenotype using a range o f established methods. For example Ravindran & Rao, 
2006, utilised a Sonic hedgehog based protocol and Schwartz et al., 2005, were able 
to demonstrate dopaminergic differentiation o f this cell line using a PA6 based co-
culture methodology. However Stull & lacovitti, 2001, had questioned the ability o f 
Sonic hedgehog and Fibroblast growth factor 8 to drive the dopaminergic 
differentiation o f the Ntera2 cell line, this though may be due to the use of these 
molecules on Ntera2 cells that had already received a lengthy retinoic acid induction. 
Still this poses some unanswered questions as to the potential o f this cell line i f using 
a Sonic hedgehog based approach, especially when this earlier work is 
compared/contrasted to the findings of Ravindran & Rao, 2006. In addition in 
Chapter 5 the ability of Tera2.cl.SP12 cells to respond to these molecules is 
observable but the means by which they regulate differentiation o f such cells is still 
open to interpretation. Therefore as a result the PA6 based co-culture method was 
chosen as it offered a technically straight forward, reasonably rapid means o f 
comparing the Ntera2 system to the Tera2.cl.SP12 model; that had worked previously 
using the Ntera2 cell line (Schwartz et al., 2005). PA6 co-culture has also been 
shown to influence the dopaminergic differentiation o f mouse (Kawasaki et al., 2000), 
primate (Kawasaki et al., 2002) and human (Zeng et al., 2004, Vazin et al., 2008) 
embryonic stem cells, so would appear to possess a stromal derived inducing activity 
that is sufficiently conserved to have an effect on a range of cells f rom different 
species and sources. Further support for choosing this particular method comes from 
the work o f Hayashi et al., 2008 where Wnt5a was highlighted as a key part of the 
dopaminergic neuron inducing activity o f PA6 cells. In the light of the positive 
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findings in Chapter 4 using W n t l to direct the differentiation o f the Tera2.cl.SP12 cell 
Hne there is a strong possibility that another member o f the Wnt family, namely 
WntSa may be able to exert an effect in this cell system. 
There is the concept that the stromal derived inducing activity o f PA6 cells may 
contain two components one related to the cell surface and the other a soluble element 
(Kawasaki et al., 2000). Vazin et al., 2008, extended this idea suggesting that the cell 
surface activity may account for the neural inducing effect o f PA6 cells on human 
embryonic stem cells, whilst the soluble component is responsible for the specific 
dopaminergic neuron inducing activity (Vazin et al., 2008). Therefore although 
various strategies have been tried for example using PA6 conditioned medium or filter 
membranes to separate the PA6 cells from those under investigation (Kawasaki et al., 
2000), the decision was made to utilise the method of directly co-culturing the PA6 
cells with the embryonal carcinoma stem cells as it offered the greatest number o f 
potential avenues to achieve dopaminergic differentiation. 
To try and eliminate stress on the Ntera2 cells, Schwartz et al., 2005 tested the ability 
o f mitomycin C treated, mitotically inactivated PA6 cells to drive the dopaminergic 
differentiation o f this embryonal carcinoma cell line. Such treatment o f the PA6 cells 
did not detract to any significant degree from the potency o f them to promote 
acquisition o f a dopaminergic phenotype, and helped prevent over crowding, in turn 
reducing the burden on the culture media (Schwartz et al., 2005). The embryonal 
carcinoma cells though are the more highly proliferative cell type, and as such steps to 
control their proliferation and differentiation may be an alternative means by which to 
prevent over grown co-cultures. In Chapter 3 after just 1 day retinoic acid was shown 
to cause a statistically significant increase in expression of the neuronal marker Beta 
I I I tubulin. Therefore although the main focus o f this work is to compare the 
Tera2.cI.SP12 model to its Ntera2 counterpart, an additional hypothesis to investigate 
is whether a short pre treatment o f the Tera2.cl.SP12 cells with retinoic acid has any 
benefits when such cells are subsequently co-cultured with PA6 cells. 
In the light o f work by Perrier et al., 2004, who demonstrated that other stromal cells 
such as the MS5 line could be used in strategies aimed at the production o f 
dopaminergic neurons and given the availability o f primary stromal cells in the 
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laboratory, one final hypothesis was put under scrutiny. This was can rat 
mesenchymal stem cells (otherwise known as bone marrow stromal cells) be used to 
drive the dopaminergic differentiation o f embryonal carcinoma stem cells (or their 
retinoic acid induced derivatives)? 
Mesenchymal stem cells have been reported as a potential source o f material f rom 
which dopaminergic neurons can be derived directly in vitro (Trzaska et al., 2007). 
These cells displayed expression o f dopaminergic markers and were able to secrete 
dopamine (Trzaska et al., 2007). This work was supported by that o f Barzilay et al., 
2008 who were able to demonstrate dopaminergic marker expression and dopamine 
secretion upon depolarisation. Further work where REl - silencing factor, a known 
suppressor o f mature neuronal genes in neuronal progenitors, was artificially reduced 
in mesenchymal stem cells facilitated the production o f more functionally mature 
neurons (Trzaska et al., 2008). This work though promising is based on the premise 
that mesenchymal stem cells can trans-differentiate across the germ layer boundary to 
form cells o f different lineages (normally mesenchymal stem cells would form cells o f 
mesodermal origin such as fat, cartilage and bone, not those o f ectodermal origin such 
as neurons). As such this is an area surrounded by much controversy with a body o f 
evidence being presented that suggests cytoskeletal collapse may be a mechanism by 
which mesenchymal stem cells acquire neuronal morphologies (Hardy et al., 2008). 
There is also work that indicates mesenchymal stem cells may express neural proteins 
in standard culture (Deng et al., 2006). In addition the time course o f neuronal 
differentiation could be brought into question as i t might not be expected that 
production o f dopaminergic neurons is possible in 4-6 days as observed in Barzilay et 
al., 2008, especially given that cells have to cross the germ layer boundary and 
neurogenesis is usually not a particularly rapid process even in neural cell types or 
those cell lines with a propensity for this differentiation pathway. On balance though 
it is not inconceivable that 6 days may be adequate i f the correct inductive cocktail is 
supplied, given that a cell in vitro is highly unlikely to mirror in a precise fashion 
events in vivo, as exemplified by the unexpectedly rapid nature o f PA6 driven 
dopaminergic differentiation in primate embryonic stem cell cultures (Kawasaki et al., 
2002). The functional ability o f cells representative o f a dopaminergic phenotype 
derived f rom mesenchymal stem cells clouds the picture further creating greater 
uncertainty. 
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However one aspect o f the potential o f mesenchymal stem cells for use that can more 
readily be agreed upon appears to be their capacity to provide trophic factors that may 
influence neural and more specifically neuronal development (Hardy et al., 2008). 
Bone marrow stromal cells f rom adult mice were used in conjunction with Sonic 
hedgehog and Fibroblast growth factor 8 to help generate neurons characteristic of a 
dopaminergic phenotype f rom embryonic stem cells (Shintani et al., 2008). Therefore 
to add another dimension to this work, the effects o f primary rat mesenchymal stem 
cells in co-culture on the dopaminergic differentiation potential o f embryonal 
carcinoma cells were decided upon as an area for investigation. The fact the cells are 
of rat origin also opens up the possibility o f at least being able to make an inference as 
to whether highly conserved factors play a role in dopaminergic differentiation across 
a number o f species. In addition i f the mesenchymal stem cells in co-culture can exert 
an effect on the embryonal carcinoma cells they offer an additional means by which to 
compare the dopaminergic differentiation capability o f the two cell lines Ntera2 and 
Tera2.cl.SP12 under investigation, which is the principle focus o f this Chapter. 
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6.2 Cell Culture Methods 
Maintenance of mouse PA6 Stromal Cells 
PA6 cells f rom the Riken Bioresource Centre Japan 
(http://www.brc.riken.go.jp/inf/en/index.shtml) were maintained and grown in alpha-
Minimal Essential Medium ( a M E M ; Invitrogen) supplemented with 10% (v/v) fetal 
calf serum (Sigma), and lOOU/ml penicillin/streptomycin (Gibco) in T25 culture 
flasks (Nunc) at 37°C in a 5% CO2 incubator (Sanyo) prior to use. 0.25% (w/v) 
Trypsin/ 0 .1% (w/v) EDTA (in HBSS) (Cambrex) was used to passage cells 1:4 once 
they had grown to a confluent state, on a weekly basis as per the instructions provided 
upon purchase o f the cell line. Passages U+8 to U+12 cells were used as passage U+8 
cells were provided f rom Riken Bioresource centre and subsequent passaging lead to 
the choice o f passages used. 
Maintenance of Primary Rat Mesenchymal Stem Cells 
Primary rat MSCs (all passage 1) were kindly provided by Steven Allan Hardy o f the 
Przyborski Lab, Durham University. They were maintained in Dulbecco's modified 
Eagle's medium ( D M E M ; PAA) supplemented with 10% (v/v) fetal calf serum 
(Sigma), 2 m M L-glutamine (Cambrex), 1 OOU/ml penicillin/streptomycin (Gibco) and 
I x non essential amino acids (Invitrogen) in T75 culture flasks (Nunc) at 37°C in a 
5% CO2 incubator (Sanyo) prior to use. 
Co-culture Differentiation 
PA6 cells or primary rat MSCs were grown to confluency under the conditions 
outlined above, the media aspirated from them, before being washed with Ix PBS, 
prior to treatment for 5 minutes with 0.25% (w/v) Trypsin/ 0 .1% (w/v) EDTA (in 
HBSS) (Cambrex), to release the cells f rom the surface o f the culture flask. The 
Trypsin was then neutralized by addition o f 4ml o f D M E M F G for MSC cultures or 
a M E M supplemented as described above for PA6 cultures and any cells remaining 
loosely bound washed o f f the surface o f the flask by pipetting the D M E M F G or 
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aMEM/Trypsin-EDTA mix against the side o f the flask where cell attachment occurs. 
A further wash with I x PBS was carried out to optimize the retrieval of cells for use. 
The cell containing mix was then transferred to a 15ml Falcon tube and spun in a 
centrifuge (Eppendorf 581 OR (swing bucket rotor A-4-62)) at lOOOrpm, 4°C, for 3 
minutes for PA6 cells or 250g, 4°C, for 5 minutes for the MSCs. The excess fluid was 
removed to leave a cell pellet. This was resuspended in Glasgow minimum essential 
medium ( G M E M ) (Invitrogen) supplemented with 10% (v/v) Knockout Serum 
Replacement (Invitrogen), O.lx non essential amino acids (Invitrogen), I m M sodium 
pyruvate (Invitrogen) and 0.1 m M P-Mercaptoethanol (Invitrogen) as appropriate and 
cell number was obtained by using a haemocytometer. 
Once cell number was known MSCs or PA6 cells were plated out at a density o f 
5000-10000 cells/cm^ (Schwartz et al., 2005) in 6 or 12 well plates (Nunc) in 
Glasgow minimum essential medium (Invitrogen) supplemented with 10% (v/v) 
Knockout Serum Replacement (Invitrogen), O.lx non essential amino acids 
(Invitrogen), I m M sodium pyruvate (Invitrogen) and O. lmM P-Mercaptoethanol 
(Invitrogen). The cells were allowed to settle whilst the EC cells were prepared for 
use as follows. 
Cultures o f Tera2.cl.SP12 or Ntera2.Dl EC cells were grown to confluency, the 
media aspirated f rom them, before being washed with I x PBS, prior to treatment for 5 
minutes with 0.25% (w/v) Trypsin/ 0 .1% (w/v) EDTA (in HBSS) (Cambrex), to 
release the cells f rom the surface o f the culture flask. The Trypsin was then 
neutralized by addition o f 4ml o f D M E M F G and any cells remaining loosely bound 
washed o f f the surface o f the flask by pipetting the DMEMFG/Trypsin-EDTA mix 
against the side o f the flask where cell attachment occurs. A further wash with Ix 
PBS was carried out to optimize the retrieval o f EC cells for use. The cell containing 
mix was then transferred to a 15ml Falcon tube and spun in a centrifuge (Eppendorf 
581 OR (swing bucket rotor A-4-62)) at SOOrpm, 4°C, for 2 minutes. The excess fluid 
was removed to leave an EC cell pellet. This was resuspended in G M E M 
supplemented as outlined above and cell number was determined using a 
haemocytometer. 
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Once cell number was known Tera2.cl.SP12 or Ntera2.Dl EC cells in G M E M 
supplemented as described above were added at a density o f 2000 cells/cm^ (Schwartz 
et al., 2005) into the wells containing MSCs or PA6 cells. The co-cultures were then 
topped up with media to a final volume of 3-5ml. Media was changed after the first 4 
days and every day thereafter up to 17 days which had previously been shown to be 
sufficient time to achieve robust tyrosine hydroxylase expression (Schwartz et al., 
2005). A l l cultures were maintained at 37°C in a 5% CO2 incubator (Sanyo). 
Retinoic acid pre treatment of Tera2.cl.SP12 cells 
Cultures o f Tera2.cl.SP12 EC cells were grown to confluency, the media aspirated 
from them, before being washed with I x PBS, prior to treatment for 5 minutes with 
0.25% (w/v) Trypsin/ 0 .1% (w/v) EDTA (in HBSS) (Cambrex), to release the cells 
from the surface o f the culture flask. The Trypsin was then neutralized by addition o f 
4ml o f D M E M F G and any cells remaining loosely bound washed o f f the surface o f 
the flask by pipetting the DMEMFG/Trypsin-EDTA mix against the side o f the flask 
where cell attachment occurs. A further wash with Ix PBS was carried out to 
optimize the retrieval o f EC cells for use. The cell containing mix was then 
transferred to a 15ml Falcon tube and spun in a centrifuge (Eppendorf 581 OR (swing 
bucket rotor A-4-62)) at SOOrpm, 4°C, for 2 minutes. The excess fluid was removed 
to leave an EC cell pellet. This was resuspended in D M E M F G and cell number was 
obtained by using a haemocytometer. Once the cell number was known the EC cells 
were seeded out in D M E M F G at 0.5x10^ cells per T25 flask (Nunc). After seeding 
out cells were induced to differentiate by exposure to a final concentration o f l O j i M 
all trans retinoic acid (Sigma) for 3 days. Cells were grown in a standard 37°C, 5% 
CO2 incubator (Sanyo). 
After 3 days cells were seeded out into co-cultures in an identical fashion to their 
untreated embryonal carcinoma cell counterparts (as described previously in the co-
culture differentiation section). Figure 6.1 illustrates the two different approaches. 
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Figure 6.1; Schematic of co-culture studies 
Summary of co-culture differentiation methods 
3 day R.A. 
induction 
treated 
EC cell 
17 days of co-culture 
with PA6 cells or MSCs 
17 days of co-culture 
with PA6 cells or MSCs 
Differentiated 
Cell? 
Differentiated 
Cell ? 
Similar or 
Different? 
Note: Not to Scale 
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6.3 Results 
The initial comparison o f the Tera2.cl.SP12 model to the Ntera2 system was made by 
using real time PCR to compare the relative levels o f mRNA for neuronal and 
dopaminergic markers in samples f rom the two embryonal carcinoma cell lines grown 
in co-culture with PA6 cells or mesenchymal stem cells. Figure 6.2A shows that 
dopamine receptor 2 m R N A is most up regulated in its expression in Tera2.cl.SP12 
samples co-cultured with PA6 cells. However the induction due to PA6 cell co-
culture is not statistically significant as there is substantial variation in the results 
obtained. I t is though regardless o f this on average markedly up regulated relative to 
the other conditions. In contrast mesenchymal stem cell or PA6 co-culture o f the 
Ntera2 line for 17 days causes a statistically significant increase in dopamine receptor 
2 mRNA levels, reflecting a difference between the starting material and test samples, 
which show much less variation and as such facilitate the statistical effect. These 
samples though in raw terms are on average displaying an induction that is smaller in 
magnitude than that seen with the Tera2.cl.SP12 cell line co-cultured in the presence 
of PA6 cells. Figure 6.2B shows for dopa decarboxylase there is a large variation in 
its expression in most o f the samples and as such little can be taken from this result. It 
may though suggest given that such co-cultures appear by eye to be very over grown 
that there is insufficient regulation o f the differentiation o f the embryonal carcinoma 
cells. 
Tyrosine hydroxylase expression was also examined in such samples and as can be 
seen in Figure 6.3A the trend is comparable to that for dopamine receptor 2 in that 
PA6 cells in co-culture with the Tera2.cl.SP12 cell line show the greatest average 
induction. However once more the Ntera2 co-culture samples display relatively lower 
mean levels o f mRNA for the marker o f interest but the induction observed is 
statistically significant. Again this is most probably due to less variation between test 
samples. Figure 6.3B demonstrates that for the neuronal marker Beta I I I tubulin the 
trend is comparable to that for indicators o f a dopaminergic phenotype with 
PA6/Tera2.cl.SP12 co-culture offering the greatest increase in mRNA expression. On 
this occasion there is a statistically significant induction from the Tera2.cl.SP12 
starting material to the 17 day PA6/Tera2.cl.SP12 co-culture samples, which in 
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addition display a statistically significant increase in expression relative to the 
PA6/Ntera2 condition. This gives some support to the trend observed that suggests 
PA6/Tera2.cl.SP12 co-culture is producing the most neuronal and possibly more 
specifically dopaminergic cultures, i f higher levels o f marker expression are viewed 
as a positive gauge, which in this relatively simple system is probably the most 
appropriate measure. 
When markers associated with the acquisition o f a dopaminergic phenotype were 
assessed a comparable trend was discovered once again. Figure 6.4A shows that 
L m x l a mRNA is most up regulated in PA6/Tera2.cl.SP12 co-cultures and this 
increase relative to the starting material is in this instance significant. Both Ntera2 co-
culture samples show statistically relevant inductions but much lower mean levels 
relative to the PA6 /Tera2.cl.SP12 co-culture condition. Figure 6.4B demonstrates 
that M s x l is up regulated to a statistically significant degree in all co-culture samples 
relative to the appropriate starting material. The trend though once more points to 
PA6/Tera2.cl.SP12 co-culture offering the greatest opportunity to derive a substantial 
average increase in marker expression. Figure 6.5A indicates that for neurogenin2 the 
same trend o f a strong increase in PA6/Tera2.cl.SP12 co-culture samples holds true. 
Although there is a statistically significant increase in expression in MSC/Ntera2 co-
cultures in relation to the Ntera2 starting material this is probably o f little biological 
relevance in the context o f the broader trends. Likewise Figure 6.5B shows that on 
average PA6/Tera2.cl.SP12 co-culture provides the greatest up regulation in marker 
expression (for Nkx 6-1), yet again it is the Ntera2 co-culture samples that differ 
significantly f rom their respective starting material. One question though to arise 
fi-om this analysis o f Nkx 6-1 mRNA expression is i f Msx l levels are up regulated in 
PA6/Tera2.cl.SP12 co-culture samples and this factor is a suppressor o f Nkx 6-1, then 
why and also how is Nkx 6-1 up regulated as well? One possible explanation is that it 
could be due to different cells within the cultures expressing the two different markers 
independently. This is feasible given that Tera2.cl.SP12 cells have been shown to be 
able to produce a mixture o f cell types (Stewart et al, 2003). 
One other factor to be considered when carrying out co-culture experiments is that the 
interaction between the cell types may operate in both directions. That is to say 
stromal cells may influence the differentiation o f embryonal carcinoma cells but these 
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cells themselves may exert an effect on their stromal cell counterparts. Although the 
dopamine receptor 2 and tyrosine hydroxylase primers are to the best o f our 
knowledge human specific, there is the possibility that for these and the other probes 
that detection o f transcripts for the markers tested may arise f rom the expression o f 
them in the PA6 cells or mesenchymal stem cells that have been potentially activated 
by the presence o f the embryonal carcinoma stem cells in co-culture. In practice this 
may or may not be the case and both stromal cell types appear negative for the 
markers tested when grown in isolation but the prospect o f this two way interaction is 
nonetheless worthy o f consideration. Given that the tyrosine hydroxylase antibody 
used in Figure 6.6 that is able to detect both human and mouse tyrosine hydroxylase 
protein, does so in PA6 cells and it is generally accepted that mRNA needs to be 
present to form protein, then given that no tyrosine hydroxylase transcript is found in 
the stromal cells it is reasonable to think at least for this marker that any result is due 
to stromal cell induction o f the embryonal carcinoma cells (and not the reverse 
scenario). The observation that the trends for tyrosine hydroxylase are seen for other 
markers o f a dopaminergic phenotype lends support to the notion that in this system it 
is the stromal cells primarily exerting an effect on the embryonal carcinoma cells and 
not the reciprocal interaction taking place. The human specific nestin 
immunostaining in Figure 6.13 is also indicative that there are few i f any stromal cells 
present at the point o f harvesting the samples for analysis due to the highly 
proliferative embryonal carcinoma cells dominating the co-cultures. Therefore it 
would not be expected that induction o f markers in the stromal cells due to embryonal 
carcinoma cell co-culture would be likely to occur, but it is still valid to think that this 
is theoretically possible. One way to alleviate this issue in future work would be to 
use conditioned media f rom stromal cell cultures to try and drive the differentiation o f 
the embryonal carcinoma stem cells. 
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Figure 6.2: D2 «& AADC mRNA expression in EC/Stromal cell co-cultures 
A. 
"S 80 
L I 
Tera2,cl.SP12 NTena2.Dl PA6 MSG * NTera2 MSC » PAS • NTera2 PA6 * 
Tera2.cl.SP12 Tera2.cl.SP12 
S a m p i s 
B. 
Rat M S G MSC •^ NTera2 PA6 -1- NTera2 
TBra2.cl SP12 Tora2.cl.SP12 
Tera2.cl.SP12 NTena2.D1 
Sample 
Figure 6.2A: Relative expression of human D2 mRNA in samples from two human EC cell lines 
(Tera2.cl.SP12 & Ntera2), rat MSCs & murine PA6 cells, as well as 17 day old co-cultures of the EC and 
stromal cell types. Statistically significant differences between samples calculated using a one way anova 
with accompanying Tukey post hoc analysis are indicated by black bars where appropriate and indicate a 
significance < 0.05. B: As above but for human dopa decarboxylase (and there are no statistically relevant 
differences). In all cases error bars represent the standard deviation of the mean; n=3. 
240 
Figure 6.3: T H & Beta III tubulin mRNA expression in EC/Stromal cell co-
cultures 
A. 
Tera2.cl.SP12 PA6 MSC f NTora2 MSC • PA6 * NTena2 PA6 * 
Tera2.CI.SP12 Tora2.cl.SP12 
SampI* 
rera2.cl-SP12 
Tena2.cl.SP12 NTora2.D1 Rat MSC 
Figure 6.3A: Relative expression of human TH mRNA in samples from two human EC cell lines (Tera2.cl.SP12 & 
Ntera2), rat MSCs & murine PA6 cells, as well as 17 day old co-cultures of the EC and stromal cell types. 
Statistically significant differences between samples calculated using a one way anova with accompanying Tukey 
post hoc analysis are indicated by black bars where appropriate and indicate a significance < 0.05. B: As above but 
for human Beta I I I tubulin, the purple bars indicate a significant difference between the untreated Tera2.cl.SP12 cells 
and their 17 day PA6 co-cultured counterparts worked out using a one way anova with Tukey post hoc analysis (sig 
< 0.05). Green bars indicate a statistically significant difference between Ntera2 and Tera2.cl.SPI2 samples co-
cultured with PA6 cells for 17 days, defined using Student's T-test (sig < 0.05). In all cases error bars represent the 
standard deviation of the mean; n=3. 
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Figure 6.4; Lmxla & Msxl mRNA expression in EC/Stromal cell co-cultures 
^Ae MSG + NTera2 MSG + PA6 -»• NTera2 PAe + 
Tera2.cl,SP12 Tora2.cl.SP12 
Tera2.cl.SP12 NTora2.D1 Rat MSG 
SampI* 
B. 
m „i_J 
Tena2.cl.SP12 NTerai2.D1 PA6 MSG * NTera2 MSG * PA6 * NTera2 PA6 * 
Tera2.cl.SP12 Tera2.cl.SP12 
S a m p I * 
Figure 6.4A: Relative expression of human Lmxla mRNA in samples from two human EC cell lines 
(Tera2.cl.SP12 & Ntera2), rat MSCs & murine PA6 cells, as well as 17 day old co-cultures of the EC and 
stromal cell types. Statistically significant differences calculated using a one way anova with 
accompanying Tukey post hoc analysis are indicated by black bars for Ntera2 based samples and purple 
bars for Tera2.cl.SP12 based samples where appropriate and indicate a significance < 0.05. B: As above 
but for human Msxl . In all cases error bars represent the standard deviation of the mean; n=3. 
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Figure 6.5: Ngn2 & Nkx 6-1 mRNA expression in EC/Stromal cell co-cultures 
A. 
Tera2.cl.SP12 NTera2.D1 Rat MSC PA6 MSC * NTeraZ MSC * PAS NTera2 PAS + 
Tera2.cl.SP12 TetB2.cl.SP12 
Sample 
B. 
Tef32,cl,SP12 NTera2 01 MSC + NTera2 MSC + 
Tera2.cl.SP12 
PA6 •<- NTera2 PA6 * 
Tera2-Cl.SP12 
Figure 6.5A: Relative expression of human Ngn2 mRNA in samples from two human EC cell lines 
(Tera2.cl.SP12 & Ntera2), rat MSCs & murine PA6 cells, as well as 17 day old co-cultures of the EC 
and stromal cell types. Statistically significant differences between samples calculated using a one way 
anova with accompanying Tukey post hoc analysis are indicated by black bars where appropriate and 
indicate a significance < 0.05. B: As above but for human Nkx 6-1. In all cases error bars represent the 
standard deviation of the mean; n=3. 
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Overall therefore it appears feasible these results may indicate that there is a lack of 
control in the co-culture system with the up regulation observed occurring in a hap 
hazard or less well ordered fashion than is desirable, possibly due to a lack of retinoic 
acid to drive the initial differentiation of the embryonal carcinoma cells. One other 
more basic observation that can be made from all the real time PGR analyses is that 
the primers used were human specific in their detection, as there was no amplification 
in any of the murine PA6 or rat mesenchymal stem cell samples for any of the 
markers investigated. Although this would need to be checked more thoroughly by 
testing the primers on rat or mouse sources known to be positive for the phenotypic 
indicators investigated. Also to check that a comparable quantity of cDNA was used, 
the amount of it in rat, mouse and a representative human sample was quantified. 
Table 6.1 shows a similar amount of cDNA was present for each species supporting 
the concept that the lack of detection was probably due to the primers only being 
suitable for amplification from human sources. 
Table 6.1: Quantification of cDNA 
Sample (n=3) Mean Quantity of cDNA 
(ng/^L) 
Standard Deviation of Mean 
(ng/^L) 
Human (Ntera2) 263.62 8.03 
Mouse (PA6) 247.19 14.53 
Rat (MSC) 247.14 9.63 
To try and build on this initial real time PGR data that suggested Tera2.cl.SP12 cells 
could show a comparable or greater up regulation of dopaminergic marker mRNA 
relative to their Ntera2 counterparts when co-cultured with PA6 cells or mesenchymal 
stem cells, Western blotting was employed to extend the comparison to the level of 
protein expression. Figure 6.6 indicates that there is little difference in Beta I I I 
tubulin protein expression between any of the test co-culture conditions and the two 
types of embryonal carcinoma cell under investigation. There is only a weak to no 
real detection of this marker though in the PA6 or mesenchymal stem cell samples. 
On top of this tyrosine hydroxylase protein expression is not observed in either 
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embryonal carcinoma cell line or the non neural MG63 cell samples as might be 
predicted. However it is only weakly detected in the PA6/Tera2.cl.SP12 co-culture 
samples and is absent in any o f the other co-cuUure conditions. It does appear to be 
detectable in the PA6 cells and may be very weeikly present in the mesenchymal stem 
cells. This observation is not totally unsurprising as stromal cell types have been 
shown previously to express neural markers (Deng et al, 2006). The disparity 
between detection o f tyrosine hydroxylase protein in Figure 6.6 and the lack o f 
detection o f its m R N A in Figure 6.3 most probably arises f rom the antibody used 
being able to detect tyrosine hydroxylase in a range of species including both human 
and mouse, where as the primers supplied for tyrosine hydroxylase are thought on 
reliable grounds to be human specific The observation that the detection o f tyrosine 
hydroxylase is stronger in the PA6 cell only than in the PA6/Ntera2 and PA6 
/Tera2.cl.SP12 co-culture samples would suggest few i f any PA6 cells are left at 17 
days and that the embryonal carcinoma cells comprise close to or the entire culture. 
This is supported further by the human specific nestin staining in Figure 6.13 that 
indicates few i f any non human cells remain at the point o f harvesting the samples for 
analysis and is also consistent with the appearance o f such cultures prior to 
harvesting. This protein data may also support the notion that there is a lack of 
control over the differentiation process as although mRNA levels are up regulated this 
increase is not observable at the protein level. The only trend that could be picked out 
is that tyrosine hydroxylase protein is detectable in the PA6/Tera2.cl.SP12 co-culture 
samples, which show the greatest mean induction o f this and other markers in terms o f 
mRNA expression. Thus it would appear that Tera2.cl.SP12 cells again compare 
favourably to their Ntera2 counterparts, although the conditions for investigation 
could be improved upon. 
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Figure 6.6: T H & Beta I I I tubul in protein expression in EC/Stromal cell co-
cultures 
A. 
TH (62 kDa) — 
Beta III Tubulin 
(55 kDa) -
^' iV' <S' 
B. 
<^ 
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Figure 6.6A: TH protein expression assessed by Western blotting in samples from two human 
EC cell lines (Tera2.cl.SP12 & Ntera2), rat MSCs & murine PA6 cells, as well as 17 day old co-
cultures of the EC and stromal cell types. "Non neural MG63 samples were also included as a 
control. 20^L of protein were loaded for each sample. B: As for A. above but this blot 
indicates expression of Beta III tubulin not TH. C: A blot showing beta-actin expression in 
comparable samples to those in A. and B. above, beta-actin was used as a loading control. 
Representative images from n=3 repeats using biologically independent samples are shown. 
The detection of Beta III tubulin in the MG63 cell samples is consistent with the flow cytometry 
analysis in Chapter 5 and may reflect non specific binding of the antibody. An alternative 
theory is that it may be possible to detect neural markers (that are perhaps not totally specific for 
a particular phenotype) in non neural cell types in a similar manner to the detection of neural 
markers in stromal cells in Deng et al, 2006. This would also help explain the detection of TH 
in the stromal PA6 cells. 
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Prior to changing the experimental conditions one final assessment o f the two 
embryonal carcinoma cell lines in co-culture wi th PA6 cells or mesenchymal stem 
cells was made using immunocytochemistry. This facilitated the possibility of 
observing neuronal cell morphology and also the detection o f tyrosine hydroxylase in 
more than just one test condition as a small area o f tyrosine hydroxylase positive cells 
could possibly be detected that may not be sufficient in number to provide a clear 
band on a Western blot. First o f all though the Ntera2, PA6 and mesenchymal stem 
cells had to be screened for their expression o f tyrosine hydroxylase and Beta I I I 
tubulin the two markers that were to be studied in test samples. Figure 6.7 
demonstrates that Ntera2 cells give a diffuse faint stain for Beta I I I tubulin that is 
barely detectable and are essentially negative in their staining for tyrosine 
hydroxylase. Mesenchymal stem cells and PA6 cells showed no real detectable 
staining for tyrosine hydroxylase or Beta I I I tubulin (data not shown). Therefore any 
staining observed is likely to be due to the presence of these markers in embryonal 
carcinoma cell derivatives fol lowing their co-culture driven differentiation. One point 
the lack o f tyrosine hydroxylase staining o f stromal cell cultures highlights though is 
that the strength o f expression and sensitivity o f detection are key factors when 
considering expression data. Tyrosine hydroxylase is detectable given the amount of 
sample loaded in the Western blot analysis in Figure 6.6, however it is not detectable 
by immunostaining. This disparity may arise f rom the differences between the protein 
being detectable and situations where it is truly present in a manner that is 
meaningfiil. I f tyrosine hydroxylase was found in process like structures indicative o f 
a neuronal morphology it may be deemed an indicator o f a dopaminergic phenotype, 
but in stromal cells this is unlikely to be the case and it may be more an artefact o f 
culture and the sensitivity o f detection offered by molecular expression analyses. In 
addition some immunological reagents may perform more effectively for one 
technique such as Western blotting than another such as immunostaining, as a 
cytosolic protein, tyrosine hydroxylase may by its very nature also not lend itself to 
detection by immunocytochemistry. Figure 6.8 shows that Beta I I I tubulin staining is 
detectable in all co-culture conditions. There are some neuronal type cells but there 
are not long clear processes as seen in Chapter 4 when Wnt l was used in conjunction 
with retinoic acid for 3 weeks. In addition only fairly small areas o f the entire culture 
show positive staining, although most areas are extremely confluent wi th cells as can 
be seen from the amount o f Hoescht stained nuclei and phase images. Figure 6.9 
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indicates the same pattern is true for tyrosine hydroxylase staining. It is detectable in 
all co-culture samples but only in very rare patches and the positive cells are a tiny 
proportion o f the entire cultures. It may be these small areas are stromal cells (as 
tyrosine hydroxylase was detected in PA6 cells by Western blot) but given the 
associated morphologies that are more characteristic o f a potential neurite in culture 
along with the nestin staining in Figure 6.13, this is unlikely. Therefore it would 
appear that although the method for co-culturing the cells could be improved upon the 
Tera2.cl.SP12 cell line is seemingly as or more potent than the Ntera2 cell line in 
terms o f its ability to express markers o f a dopaminergic phenotype. It also seems to 
be the case that PA6 cells are more able inducers o f dopaminergic marker expression 
in relation to mesenchymal stem cells, although these cells may possess some 
potential to do this in more refined culture conditions. 
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Figure 6.7: Staining o f Ntera2 EC ceils f o r T H & Beta I I I tubul in 
Beta III tubulin 
Secondary only control Secondary only control 
Phase x10 
Figure 6.7: Immunostaining of the Ntera2 cell line for Beta III tubulin and TH. There is no real 
detection of tyrosine hydroxylase and a faint diffuse background level of detection for Beta 111 tubulin. 
This is very hard to detect in the merged image produced in Adobe Photoshop. The secondary only 
control conditions were not treated with any primary antibody just the vehicle in which antibodies were 
diluted (SBP), prior to treatment with the appropriate secondary antibody for either TH or Beta HI 
tubulin. As expected there is an absence of any detection in the secondary only controls which are 
merged with the corresponding Hoescht images to confirm the presence of cells by staining their nuclei. 
The phase image displays the morphology of the cells after fixation and the staining process. Scale bars 
are approximately equal to 100p.m. Representative images of n=3 repeats are shown. Given that the TH 
and Beta III tubulin staining are so weak it is probably safe to conclude that there is no true detection. 
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Figure 6.8: Beta I I I tubul in staining in EC/Stromal cell co-cultures 
Beta III tubulin 
(MSC/NT2) 
Secondary only control 
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Figure 6.8: Merged images (produced in Adobe Photoshop) of Beta III tubulin immunostaining (FITC) against a background of Hoescht stained nuclei in 17 
day old co-cultures of stromal and embryonal carcinoma cells. The conditions represent Ntera2 (NT2) cells in co-culture with MSCs or PA6 cells and 
Tera2.cl.SP12 (SP12) cells in comparable co- culture conditions. The secondary only control conditions were not treated with any primary antibody just the 
vehicle in which antibodies were diluted (SBP), prior to treatment with the appropriate secondary antibody for Beta III tubulin, these images were also 
merged with the corresponding Hoescht image to show cells were detectable. As expected there is an absence of any FITC detection in the secondary only 
controls. The phase images show the confluent nature of the cultures at the point of fixation and staining. Scale bars are approximately equal to 100|im. 
Representative sample images of n=3 biological repeats are shown. The merged images highlight that the cultures are very confluent and that only some 
areas of the cultures imaged were positive for Beta III tubulin expression. 
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Figure 6.9: T H staining i n EC/Strotnal cell co-cultures 
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To try and overcome the problem o f the embryonal carcinoma cells predominating in 
the co-cultures, retinoic acid was used to try and direct their differentiation for 3 days, 
prior to subsequent co-culture for 17 days. In these experiments only the 
Tera2.cl.SP12 cell line was used to make the comparison as it had shown in broad 
terms the greatest capacity to up regulate marker expression and as such seemed the 
most promising vehicle to identify any differences that retinoic acid pre treatment o f 
the embryonal carcinoma cells may bring about. Figure 6.10 displays phase images 
that reveal the co-cultures o f retinoic acid pre treated embryonal carcinoma cells with 
PA6 or mesenchymal stem cells are not heavily overgrown. This is not observed 
when using untreated embryonal carcinoma cells which produce very cluttered 
cultures. However in the mesenchymal stem cell cultures at 7 days there are signs o f 
floating, probably dead, cells. Even at day I the mesenchymal stem cells do not show 
the expected morphology and as such may be undergoing a stress response, prior to 
possible death. This is unsurprising given that the protocol has previously been 
used/refined for use with PA6 cells which respond seemingly more favourably to it. 
Although this may be the case even when using PA6 cells with retinoic acid pre 
treated embryonal carcinoma cells, one passage of such cells produced very confluent 
cultures, so their proliferative nature had not in 3 days been fu l ly brought under 
control, the result being one sample that appeared over grown in some areas, with 
clear signs o f dead cells floating in the media. 
Immunocytochemistry was again used to assess Beta I I I tubulin and tyrosine 
hydroxylase expression in co-culture samples. Retinoic acid treated embryonal 
carcinoma cells fol lowing co-culture with PA6 cells or mesenchymal stem cells show 
Beta I I I tubulin expression (Figure 6.11) and a faint but detectable level o f tyrosine 
hydroxylase (Figure 6.12). There appear to be no real differences in these samples 
relative to comparable untreated embryonal carcinoma cell co-cultures. The number 
o f tyrosine hydroxylase positive cells is a tiny proportion o f the entire culture, wi th 
more cells being broadly neuronal (Beta I I I tubulin positive) as might be expected and 
as was found previously. The same technique was also employed to address the 
question as to whether the co-cultures contained any stromal cells at 17 days. A 
human specific nestin antibody was used that would identify the vast 
majority/possibly the whole embryonal carcinoma cell based population. Figure 6.13 
and supporting Appendix E show that the bulk o f the co-cultures were heavily nestin 
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positive (indicated by the upper heavy condition images), where as in less confluent 
areas there appeared in PA6/Tera2.cl.SP12 co-cultures to be nestin negative cells, 
indicated by the presence o f positive Hoescht stained nuclei but a lack o f nestin 
staining that morphologically in the phase images are disparate f rom what one would 
expect for an embryonal carcinoma cell or a derivative o f it. Mesenchymal stem cell 
co-cultures though even in the less confluent areas show nestin staining that correlates 
with the presence o f Hoescht stained nuclei, the supporting phase image also shows 
the samples to have observable characteristic embryonal carcinoma cell type 
morphologies. Therefore it would appear there may be a small number o f stromal 
cells left in the co-cultures at 17 days or possibly particularly in the case of the 
mesenchymal stem cells none at all. Even with the retinoic acid pre treatment the 
embryonal carcinoma cells still seem to predominate to the detriment of the stromal 
cell types. 
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Figure 6.10: The morphology of R.A. treated EC/Stromal cell co-cultures 
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Figure 6.10: Phase images of Tera2.cl.SP12 cells (pre treated for 3 days with lOfiM retinoic 
acid) in co-culture with either murine PA6 or rat mesenchymal stem cells at different time 
points. The bright clumps of cells/debris clearly present at 7 days in MSC/Tera2.cl.SP12 
may represent dead cells. When retinoic acid is used the co-cultures appear far less 
confluent than when it is omitted from the differentiation strategy. Scale bars are 
approximately equal to 10O^m. 
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Figure 6.11: Beta I I I tubul in staining in R.A. treated EC/Stromal cell co-cultures 
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Figure 6.11: Merged FITC/Hoescht images (produced in Adobe Photoshop) showing Beta III 
tubulin immunostaining in Tera2.cl.SP12 cells (pre treated for 3 days with 10|iM retinoic acid) 
then co-cultured with either murine PA6 or rat mesenchymal stem cells for 17 days. The 
secondary only control conditions were not treated with any primary antibody just the vehicle in 
which antibodies were diluted (SBP), prior to treatment with the appropriate secondary antibody 
for Beta III tubulin. As expected there is an absence of any detection in the secondary only 
controls, the merge with the corresponding Hoescht image confirms the presence of cells by 
staining their nuclei. Scale bars are approximately equal to lOOjim. Representative sample 
images of n=3 biological repeats are shown. It is clear that only some of the total cellular 
population are positive for Beta III tubulin, areas were imaged that were relatively sparsely 
populated to try and alleviate the problem of the Hoescht background drowning out the FITC 
detection when the images were merged. 
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Figure 6.12: T H staining in R.A. treated EC/Stromal cell co-cultures 
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Figure 6.13: Nestin staining in R.A. treated EC/Stromal cell co-cultures 
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One final real time PCR screen was carried out to compare mRNA levels of neuronal 
and dopaminergic markers in untreated and 3 day retinoic acid pre treated 
Tera2.cl.SP12 cells co-cultured for 17 days with PA6 cells or mesenchymal stem 
cells. A comparison was also made to Tera2.cl.SP12 embryonal carcinoma cells left 
to grow for 17 days in the medium used for the co-culture step. Figure 6.14A shows 
that for tyrosine hydroxylase there is no real difference between retinoic acid pre 
treated or untreated embryonal carcinoma cells following the co-culture step. The 
mesenchymal stem cell co-cultures appear almost identical to the 17 day embryonal 
carcinoma control suggesting that the mesenchymal stem cells may well be under 
stress and as such exert less o f an effect prior to potentially dying off. Figure 6.14B 
shows that for Beta I I I tubulin the 17 day embryonal carcinoma control samples 
actually display the highest level o f mRNA expression for this neuronal marker, 
though there is a noticeable variation in the results probably due to the total absence 
o f any control over the differentiation process. Within the context of the experimental 
error there is no real difference between the co-culture samples, regardless o f whether 
or not the embryonal carcinoma stem cells are given a retinoic acid pre treatment. 
Figure 6.15A shows that in terms o f dopamine receptor 2 m R N A expression, retinoic 
acid pre treatment o f the embryonal carcinoma cells has no real effect in comparison 
to using their untreated counterparts. In this instance expression in the control is 
greater than in the mesenchymal stem cell co-culture conditions supporting the 
concept that the conditions are sub optimal for using this cell type. Figure 6.15B 
demonstrates similar trends for L m x l a , suggesting once again that retinoic acid pre 
treatment offers no real advantages and that mesenchymal stem cell co-culture o f 
embryonal carcinoma cells is not adequately facilitated using the methods followed in 
this work. Overall therefore exposing the Tera2.cl.SP12 cell line to retinoic acid prior 
to co-culturing it with PA6 cells or mesenchymal stem cells for 17 days using the 
protocol outlined appears to offer no advantages in driving it towards the acquisition 
of a dopaminergic phenotype. 
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Figure 6.14: T H & Beta I I I tubul in expression in R.A. treated EC/Stromal cell 
co-cultures 
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Figure 6.14A: Relative expression of human TH mRNA in either undifferentiated or 3 day lO i^M retinoic acid 
pre treated Tera2.cI.SP12 ceils co-cultured with rat MSCs or murine PA6 cells for 17 days. The 17 day E C 
control samples represent Tera2.cl.SP12 cells left to grow for this duration in just the media used for the co-
culture step in the absence of any other cell type. The Tera2.cl.SP12 condition represents the E C cell starting 
material. Although by eye there appears to be the possibility of statistically significant differences between the 
starting material and the test conditions in particular the PA6 + Tera2.cl.SP12 samples this is not the case. B: As 
above but for human Beta III tubulin. In all cases error bars represent the standard deviation of the mean; n=3. 
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Figure 6.15: D2 <& Lmxla expression in R.A. treated EC/Stromal cell co-cultures 
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Figure 6.15A: Relative expression o f iiuman D2 m R N A in either undifferentiated or 3 day \0\iM retinoic acid 
pre treated Tera2.cl.SPI2 cells co-cultured wi th rat MSCs or murine PA6 cells for 17 days. The 17 day EC 
control samples represent Tera2.cl.SP12 cells left to grow for this duration in just the media used for the co-
culture step in the absence o f any other cell type. The Tera2.cl.SP12 condition represents the EC cell starting 
material. B: As above but for human L m x l a . In all cases error bars represent the standard deviation o f the 
mean; n=3. Again although by eye there appear to be some conditions which show variations which could be 
viewed as potentially significant no statistically relevant differences were found. 
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6.4 Discussion 
The main focus of this Chapter was to compare and contrast the Tera2.cl.SP12 cell 
line to its Ntera2 counterpart to try and gauge its potential for dopaminergic 
differentiation; given that the Ntera2 system has been used previously in the published 
literature in the context of studying dopaminergic neurogenesis via a number of 
established protocols such as those used in Ravindran & Rao, 2006, and Schwartz et 
al., 2005. A PA6 co-culture approach similar to that of Schwartz et al., 2005 was 
adopted for use and in the initial investigations, a number of markers associated with a 
neuronal or dopaminergic phenotype displayed an apparent mean up regulation in 
their expression that was particularly marked in PA6/Tera2.c!.SP12 co-cultures, 
however only Beta I I I tubulin, Lmxla and Msxl showed a statistically significant 
increase in their mRNA expression relative to the starting material. In contrast 
PA6/Ntera2 co-cultures displayed statistically significant increases in tyrosine 
hydroxylase, dopamine receptor 2, Lmxla, Msxl and Nkx 6-1 mRNA expression 
relative to the Ntera2 starting material. These samples though, on average, showed a 
relatively low expression of these markers in contrast to their Tera2.cl.SP12 
counterparts. Therefore it would appear that although these may be statistically 
relevant differences in some cases they might not represent biologically meaningful 
variations. It does though suggest that the Ntera2 cells offer a more reproducible 
system that may give more results to which a statistical degree of significance can be 
attributed. In contrast the Tera2.cl.SP12 cells appear to offer a system that shows 
slightly less reproducibility but in absolute terms a greater ability to up regulate 
dopaminergic markers. In essence the two cell lines are probably both suitable for use 
but offer different advantages and disadvantages. 
The Tera2.cl.SP12 cells appear more able to up regulate Beta III tubulin mRNA 
showing a statistically significant difference in this initial screen (Figure 6.3B) to both 
their Ntera2 counterparts when the two cell lines are co-cultured with PA6 cells and to 
the Tera2.cl.SP12 starting material. However in a later screen (Figure 6.14B) 
comparable samples of PA6 co-cultured Tera2.cl.SP12 cells do not differ to such a 
degree in relation to the starting material. This highlights neatly the problem of 
reproducibility found when using the Tera2.cl.SP12 system. This is not dissimilar to 
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the scenario seen in earlier work where in Chapter 4 Wntl in the presence of retinoic 
acid had an effect on dopaminergic and neuronal marker expression at 7 days in 
adherent cultures, whilst in Chapter 5 it exerted little or no impact in comparable 
conditions for no apparent reason. Despite this though, it is not possible to ignore the 
often strong trends seen when using Tera2.cl.SP12 cells and ultimately i f up 
regulation of markers is a positive which it may well be in a simple differentiation 
model then such cells are well suited to this purpose. In comparison it would appear 
that Ntera2 embryonal carcinoma stem cells offer a more reproducible system for the 
purpose investigated, but they are seemingly less able to produce such striking 
differences in relation to those seen for the Tera2.cl.SPl2 cells. 
Primary rat stromal cells were also tested for their ability in co-culture to induce 
dopaminergic marker expression. Only Msxl was up regulated to a statistically 
significant degree in Tera2.cl.SP12 co-cultures, but 6 markers were up regulated to 
such an extent in Ntera2 co-cultures. Subsequent data make it questionable i f any of 
these differences were of biological importance but the statistics do reinforce the 
concept that the Ntera2 system is more measured, controlled and possibly less 
aberrant than the Tera2.cl.SP12 cell line as Ntera2 samples consistently give rise to 
more reproducible results that allow statistical relevance to be more often attributed. 
To some extent this could be an advantage but it is also a risk in that it may give some 
results that are biologically of little value a statistical meaning and this should be 
guarded against. 
In this regard the most interesting observations from the initial real time PCR data are 
the concomitant rises in Msxl and Nkx 6-1 mRNA expression levels. Msxl is 
thought to be a suppressor of Nkx 6-1 (Abeliovich & Hammond, 2007) so i f Msxl is 
up regulated to a statistically significant degree, one would predict Nkx 6-1 levels 
would show a reduction, but this is not the case. This suggests that different cells 
within the culture are up regulating the markers independently or there is a lack of 
control over the system. This concept (of a lack of control) is supported by the total 
lack of tyrosine hydroxylase protein expression and the lack of induction (which 
might be expected) of Beta I I I tubulin at this level. Ultimately i f protein expression is 
not correctly monitored then as proteins are the functional components of a cell, it is 
highly unlikely that the expected behaviour of the cells under investigation wil l occur. 
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In the context of the Msxl observation i f the mRNA for Msxl is not translated into 
protein (as appears to be the scenario for tyrosine hydroxylase) then Nkx 6-1 levels 
are unlikely to be repressed at any level and up regulation of mRNA for markers can 
take place at wil l . To extend this notion it appears that especially in relation to 17 day 
embryonal carcinoma cell only controls that markers are being up regulated over time 
and not in a controlled fashion due to the co-culture. This is not true in all cases but it 
is clear from the amount of nestin expression and seemingly total absence or at best 
minimal presence of stromal cells at 17 days that there is insufficient control over the 
embryonal carcinoma cells. It would appear that given that using retinoic acid to try 
and gain control over the embryonal carcinoma cells helps very little, evidenced by 
the slight drop in marker expression, that perhaps the mitotic inactivation of a 
confluent monolayer of PA6 cells as in Schwartz et al., 2005, is the best way forward, 
to achieve control over the co-culture system. Alternatively as in Hayashi et al., 2008 
key components such as WntSa that constitute the stromal derived inducing activity 
need to be defined and then i f possible applied in an exogenous fashion in a controlled 
way, in an analogous manner to that by which Sonic hedgehog and Fibroblast growth 
factor 8 are often effectively used for example in Yan et al., 2005. Co-culture could 
also be carried out in the presence of Fibroblast growth factor 20 as in Correia et al., 
2008, application of this molecule increased the percentage of tyrosine hydroxylase 
positive neurons obtained from human embryonic stem cells five fold from 3 to 15%. 
The somewhat cluttered nature of the co-cultures at 17 days also detracts from the 
immunocytochemical results, because the presence of Beta III tubulin and tyrosine 
hydroxylase although detectable is only observed in discrete areas, there is no 
consistency or uniformity to the cultures. As such any comparison between 
conditions is difficult to make especially for the more sparsely detectable tyrosine 
hydroxylase. The only real observation that can be made is that there are neuronal 
like structures with cell bodies extending thin neuritic processes that stain positively 
for Beta II I tubulin and tyrosine hydroxylase, this at least supports the concept that the 
PA6 cells and mesenchymal stem cells can secrete neurotrophic factors that may 
cause some differentiation amongst the melee of proliferating embryonal carcinoma 
cells. In addition the high level of nestin expression in the co-cultures is indicative of 
the presence of relatively immature neural cells and as such supports the idea that 
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more stromal cells are necessary to drive the process of embryonal carcinoma cell 
differentiation, this would be a necessity in future work. 
Other aspects to consider in any additional studies building on this Chapter would be 
is the effect of treating the cells with retinoic acid for 3 days undone or undermined 
by disrupting them when seeding them out a second time for the co-culture step? It 
may be better to treat the embryonal carcinoma cells with retinoic acid (possibly for 
longer than 3 days) then seed the stromal cells into the vessel in which the retinoic 
acid treated embryonal carcinoma cells already reside. In addition the protocol used 
is refined for use with the PA6 cells, it may well be the mesenchymal stem cells are 
dying off in the conditions used. Therefore i f extending this work, it would be 
advisable to try and define more optimal conditions in which to grow the 
mesenchymal stem cells in conjunction with the embryonal carcinoma cells. Both 
mesenchymal stem cells and embryonal carcinoma stem cells grow in DMEM but 
when seeded out together in this medium (supplemented as it would be for 
mesenchymal stem cells) neither cell type showed any sign of adhering. This was just 
a small test study and the problem may have been with the plastic ware. Alternatively 
it may be the two cell types do not directly interact well or that one or both cell types 
have a negative effect on each other via the factors they may secrete. Under the 
conditions tested here though it is quite clear that the mesenchymal stem cell co-
cultures are seemingly sub optimal not just for use as a means to try and produce 
dopaminergic neurons but also as a means to study the process. The PA6 based co-
cultures are less sub optimal but the method needs further refinements to try and 
produce more conclusive results. It may be that co-culture methods involving 
mesenchymal stem cells or PA6 cells are best combined with the use of other 
dopaminergic inducing agents such as Sonic hedgehog and Fibroblast growth factor 8 
as in the work of Shintani et al., 2008 using mesenchymal stem cells, or even the use 
of such molecules in conjunction with ascorbic acid application and Nurrl over 
expression as in the work of Kim et al., 2006, using PA6 cells. In the light of the fact 
embryonal carcinoma cells are highly proliferative they may also be viewed as not 
well suited to co-culture based approaches that in themselves by combining the use of 
two cell types potentially create a greater burden on the culture media and possibly a 
more stressful cellular environment. The use of conditioned media may help in this 
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regard and would also eliminate the possibility of embryonal carcinoma cells having 
inductive effects on their stromal cell counterparts. 
In summary it is not possible to make any inference as to whether highly conserved 
factors between species can drive the dopaminergic differentiation of human 
embryonal carcinoma cells as the range of molecules that could be secreted by the two 
stromal cell types is too vast and the method employed in this study too sub optimal 
especially when using the mesenchymal stem cells. In turn it is hard to make any 
conclusive remarks as to whether mesenchymal stem cells can direct the 
dopaminergic differentiation of human embryonal carcinoma stem cells in the 
conditions tested as the mesenchymal stem cells are clearly not behaving in a 
characteristic fashion, exemplified by the observation that they do not show an 
expected morphology even after just 1 day of co-culture. PA6 cells as would be 
expected do seem to be able to cause an induction of dopaminergic markers, 
especially in Tera2.cl.SP12 cells at least at the level of the mRNA. Retinoic acid pre 
treatment of such embryonal carcinoma cells prior to co-culture appears to offer no 
advantage in terms of inducing dopaminergic or neuronal marker expression relative 
to the use of untreated Tera2.cl.SP12 cultures as the starting material. Therefore it 
would appear that the most balanced view of this work is that mesenchymal stem cells 
in more optimised conditions may be able to show positive effects on the 
dopaminergic differentiation of embryonal carcinoma cells, although they appear to 
exert a minimal effect in the conditions tested here. PA6 cells are perhaps more able 
to function in the context of the experimental protocol used but they could possibly 
have a greater effect i f more of them were used. In addition it would appear that 
using the method outlined earlier in this chapter that Tera2.cl.SP12 embryonal 
carcinoma stem cells are as viable and potent a model for the study of dopaminergic 
neurogenesis as the Ntera2 cell line. 
267 
Chapter 7 
Final Discussion 
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The investigations undertaken in this thesis have attempted to assess the capacity for 
dopaminergic differentiation of the human embryonal carcinoma cell line 
Tera2.cl.SP12. The findings presented offer an insight into the potential of this model 
as a research tool but further work is required to give a broader perspective. 
To begin with it would appear that when treated with retinoic acid the Tera2.cl.SP12 
cell line is able to up regulate the expression of markers associated with a 
dopaminergic phenotype over time. However the dopaminergic differentiation of the 
system is seemingly unaffected by the use of more physiologically relevant oxygen 
pressures, in contrast to work in rat mesencephalic precursor cultures (Studer et al., 
2000). This is most probably due to embryonal carcinoma cells not being derived 
from the brain and as such in vivo mimicry of the environment in this organ is less 
likely to exert an effect on them in comparison to that seen with cells of midbrain 
origin. There is also the possibility that 5% oxygen is not a low enough pressure to 
produce a clear effect as there may be a threshold level above which no tangible 
difference is observed. I f such a situation exists and the 5% oxygen condition lies 
above the critical point for an effect to be detectable then this may explain these 
observations. Alternatively it may be that certain technologies such as lowered 
oxygen culture are more optimal in their usage where they offer the opportunity for 
recapitulation of the in vivo environment, rather than being looked upon as a means to 
induce a dopaminergic phenotype. The finding that when using embryonic stem cells 
3.5% oxygen culture exhibited only a small but positive effect on dopaminergic 
differentiation (Kim et al., 2008) adds support to this concept. It may be that the main 
purpose of physiological oxygen culture is to reduce the oxidative stress that standard 
(21%) oxygen culture may engender. This though would still be of value if a 
relatively pure population of dopaminergic neurons could be generated. 
In the pursuit of an enriched population of potential neurons displaying this particular 
neurotransmitter phenotype one molecule that may be of use is Wntl . Although 
additional experiments to elucidate the mechanism by which it acts in synergy with 
retinoic acid are required, the findings in Chapter 4 are consistent with it having a 
positive effect on the production of Beta II I tubulin positive cells that are potentially 
neurons. In addition it appears to possess the ability to up regulate dopaminergic 
marker expression after a relatively short period of exposure to it in conjunction with 
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retinoic acid in the Tera2.cl.SP12 cell line. Both of these elements are of appeal, in 
that, in an in vitro system where there are mixtures of cell types, the ability to first and 
foremost increase the neuronal population offers a starting point from which further 
more specific differentiation strategies can be focussed. Also in the context of 
creating screening assays, protocols are required that provide temporal efficiency; 
Wntl by displaying an early mode of action may help meet this requirement. 
It could have been postulated that Wntl may have influenced Nurrl expression 
(Castelo-Branco et al., 2003). In Chapter 3 retinoic acid was seen to have positive 
effects on the up regulation of the mRNA for this marker after just one day of 
differentiation, in a similar manner to that seen in Misiuta et al., 2006 for Nurrl 
protein. Therefore one area for advancement of this study would be to over express 
Nurrl to attempt to efficiently produce more neuronal cultures in a manner analogous 
to that in Hara et al., 2007. I f this could be combined with the use of Wntl then 
potentially a very large number of potential neurons could be generated. 
It has also been proposed that Wntl creates a permissive environment for inductive 
signals such as Sonic hedgehog and Fibroblast growth factor 8 to act (Burbach & 
Smidt, 2006). These molecules may offer the ability to produce seemingly highly 
neuronal cultures derived from the Tera2.cl.SP12 cell line, as demonstrated by 
immunostaining and a clear induction of Beta II I tubulin mRNA. However Western 
blotting displays a less apparent induction, in contrast to the situation for 
dopaminergic markers which appear to be down regulated at the mRNA level by the 
terminus of the 17 day differentiation protocols outlined in Chapter 5, despite 
expression of tyrosine hydroxylase protein being clearly induced. The results 
obtained are therefore of interest as they indicate not only the need for further 
experimentation including functional testing but also that there is a complex series of 
interactions that lead to the specification of particular cellular fates that cannot simply 
be recognised or understood via the assessment of rising or falling levels of certain 
phenotypic indicators. Standard reverse transcription PGR is often used to display the 
induction of dopaminergic markers but this relatively simple on/off or at best weak to 
strong based expression analysis is a limiting factor in furthering our knowledge and 
understanding of the process of dopaminergic neurogenesis in vitro, as it does not 
account for the clear idiosyncrasies observed when using real time reverse 
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transcription PCR. The more widespread use of this technology could potentially be 
of benefit in broadening our grasp of how the process of generating dopaminergic 
neurons in vitro is regulated by certain molecules. It may be though in the work 
presented in Chapter 5 that the unexpected and varying observations arise from the 
production of other neuronal subtypes. 
The situation is complicated still further in that the high level expression of a 
particular mRNA may reflect a high rate of turnover of the associated protein, which 
might correlate with less protein being detected in relative terms at the point when the 
sample is collected. A cellular system is essentially like a living organism in that it is 
in a state of constant flux. Therefore as such methods that just detect mRNA or 
protein levels for a particular marker are only of value as a starting point. In many 
respects techniques such as immunocytochemistry that can demonstrate the 
distribution of a given protein of interest are of more value, as they at least give an 
insight into the morphology of a culture. Methods that assess overall expression of a 
protein, for example Western blotting are perhaps more prone to error in the 
interpretation of the results they produce. This is exemplified by embryonal 
carcinoma cells appearing to express Beta II I tubulin; it may be that the sensitivity of 
detection is so high that i f a cell line with a propensity for neural differentiation is 
used then any more generic marker can be detected. This may also be influenced by 
loading volume with an excess of protein essentially causing saturation and a signal 
that gives an output of bands on the blot that are essentially indistinguishable. Great 
care therefore is required when putting expression data into context and whenever 
possible some aspect of functional testing is desirable. 
The co-culture study in Chapter 6 reinforces this concept as clearly there is a lack of 
control over the Tera2.cl.SP12 cell line when using this differentiation strategy. This 
is evidenced by the concomitant rise in expression of mRNA for both Msxl and Nkx 
6-1. It would be expected from the model presented in Figure 4.2 that Nkx 6-1 would 
be repressed with rising levels of Msxl ; that is of course i f Msxl mRNA is translated 
into functional protein. The rise in levels of Msxl mRNA does not correlate with a 
fall or even low levels of Nkx 6-1 mRNA. In addition the rise in mRNA levels for 
dopaminergic markers like Msxl and tyrosine hydroxylase is not reflected at least for 
tyrosine hydroxylase at the protein level. I f Msxl protein is similarly not present then 
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normal development cannot occur. Therefore at a number of stages the dopaminergic 
differentiation observed in the Tera2.cl.SP12 cell line using this method is not just 
uncontrolled but unrepresentative of what would be expected in the course of the 
regular development of this neuronal subtype as it is currently understood. The use of 
retinoic acid to try and gain control over this process also exhibits no positive effects. 
Indeed its usage appears to have negative implications for the dopaminergic 
differentiation of the Tera2.cl.SP12 cell line in co-culture with PA6 stromal cells, in a 
similar fashion to that reported for mouse embryonic stem cells in Kawasaki et al., 
2000 though this data was not shown, merely given mention. 
The main question to arise therefore is can a cancerous cell line be used as a 
developmental model? I f cancer is seen simply as the result of an abnormality or 
abnormalities in development then ultimately the answer is no. There is no means to 
justify studying developmental processes in a system that is aberrant in its regulation 
of at least some of them. However the situation is not so simple in the broader 
context. Culture of cells in vitro may result in them evolving genetic and possibly 
other, for example morphological abnormalities. I f animal models are used even 
though certain pathways may be conserved there could be species specific differences. 
Therefore in the light of the alternatives, cell lines like Tera2.cl.SP12 offer a human 
system, that although flawed, i f used in conjunction with other models and in a 
suitably selective manner may be of some value. This is seen in the work that 
combines the use of Wntl and retinoic acid that could perhaps be translated into 
embryonic stem cells for which embryonal carcinoma cells are seen as a model. To 
this end, perhaps embryonal carcinoma cells would be better viewed in the context of 
dopaminergic differentiation strategies as a cell line with a propensity for neural 
differentiation as it is this feature that is being put to use not their more pluripotent 
stem cell like characteristics. In addition any model is essentially, even i f only in a 
very minor way incorrect; an embryonic stem cell in vitro is a model of development 
for such a cell in vivo, and i f an embryonal carcinoma cell is viewed as a model of an 
embryonic stem cell then it is essentially becoming a model of a model. Given the 
cancerous origins of an embryonal carcinoma cell it is unlikely to compensate for the 
flaws in the in vitro embryonic stem cell model and as such would occupy a very 
restricted and questionable niche, which would short sell such cells as they are robust, 
inexpensive to culture and can display quite rapid differentiation. Also dopaminergic 
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differentiation in vitro rarely takes place on the time scales seen in vivo, demonstrated 
in the work of Kawasaki et al., 2002 using primate embryonic stem cells. It would 
thus appear that although idealistic positions are in theory desirable, in practice the 
reality is very different and a compromise is required that encompasses balanced 
experimentation across a range of systems. 
In the light of this the Tera2.cl.SP12 cell line is from the findings presented here most 
effectively utilised in approaches that are more highly controlled and make use of 
exogenously applied molecules such as Wntl , Sonic hedgehog. Fibroblast growth 
factor 8 and ascorbic acid. Any further work in this system may well try to expand on 
the methods tested here, for example ascorbic acid could be investigated as an agent 
to induce differentiation and i f viable for this task could be a replacement for retinoic 
acid. The effect of varying the concentrations of such agents is an additional 
approach not assessed here that could also be beneficial in deepening our 
understanding of the process. There is also the possibility that over expression of key 
determinants of a dopaminergic phenotype such as Lmxla and Msxl could help 
provide the foundations for producing a highly enriched population of dopaminergic 
neurons. I f this is possible, functional testing is required as the current findings are 
not sufficient to make any judgement on the ability of this cell line to act as a source 
of cells for application in screening assays. In the light of the variability sometimes 
seen and the lack of reproducibility observed with the Tera2.cl.SP12 cell line, it may 
be that rather than act as a model for embryonic stem cells, embryonal carcinoma cells 
provide a system that is complimentary to the development of strategies for the 
dopaminergic differentiation of embryonic stem cells. 
Indeed i f the transplantation of dopaminergic neurons derived in vitro is seen as 
desirable in the context of trying to remedy the loss of such cells in Parkinson's 
disease patients, then in keeping with the concept that the implantation of cells from a 
cancerous source is now deemed too precarious to contemplate, it is safe to say that 
embryonal carcinoma cells are never going to be a source of material for use in such 
treatment approaches. It may also be viewed as unlikely that they could provide a 
robust enough system in terms of producing suitably consistent results i f used in 
screening assays, although as part of a range of assays, and given an awareness of 
their inherent limitations, the use of embryonal carcinoma cells in this setting is not so 
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far removed. It may well be that other cellular models are just as variable but this 
could only be assessed i f in fiiture a direct comparison was made. I f this was 
unfavourable with respect to embryonal carcinoma cells then they may be limited to 
basic investigations. At the level of a fundamental research tool though they compare 
reasonably well against another embryonal carcinoma cell line Ntera2 that features in 
the literature and from the findings in this thesis may be a suitable means to 
investigate new and refine current methods aimed at the in vitro generation of 
dopaminergic neurons. I f embryonal carcinoma cells are put to use in this manner and 
i f any findings from their utilisation can be translated into embryonic stem cell or 
other model systems that are then used in an application that may help improve 
current therapies for Parkinson's disease then they are of undoubted value. Figure 7.1 
summarises the potential advantages and disadvantages of the Tera2.cl.SP12 cell line 
as a means to study dopaminergic differentiation in vitro. 
Figure 7.1: The advantages and disadvantages of the Tera2.cl.SP12 cell line as a 
model to study dopaminergic differentiation in vitro 
Advantaqes 
Robust and easy Inexpensive (as few costly 
media supplements to culture 
required) Able to be 
expanded rapidly 
to give large 
numbers of cells 
Responsive to Abie to grow 
dopaminergic as monolayers 
inducing agents or in 
such as Wnt1 The Tera2.cl.SP12 cell line suspension 
as a means to study 
dopaminergic 
Difficult to control 
differentiation in vitro 
especially in the Difficult/Impossible to 
absence of retinoic Variability between define developmental 
acid sample repeats can be stage of starting 
substantial material 
Cancerous origin means Effects observed 
any findings of are not always High maintenance, 
developmental significance reproducible regular media 
require validation 
Disadvantages 
changes required 
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Summary of key findings 
• Retinoic acid treatment of Tera2.cl.SP12 cultures can induce expression of a 
range of dopaminergic markers over time. 
• Lowered oxygen culture appears to have little detectable effect on the ability 
of the Tera2.cl.SP12 cell line to acquire a dopaminergic phenotype. 
• Expression of Otx2 a potential determinant of a dopaminergic fate is down 
regulated rapidly by exposure of embryonal carcinoma cells to retinoic acid. 
• Wntl shows a minimal ability to rescue the drop in Otx2 expression caused by 
retinoic acid. 
• The application of Wntl can approximately double the number of Beta I I I 
tubulin positive cells obtained from Tera2.cl.SP12 cultures exposed to retinoic 
acid. It may also augment dopaminergic differentiation as well. 
• Suspension culture of embryonal carcinoma cells may offer advantages when 
trying to promote the acquisition of a neuronal cell fate. 
• Sonic hedgehog may be able to induce dopaminergic marker expression via a 
mechanism congruous with that observed in other experimental systems. 
• The application of retinoic acid, Sonic hedgehog. Fibroblast growth factor 8 
and ascorbic acid to embryonal carcinoma cell derived neurospheres treated 
with retinoic acid and Wntl appears to facilitate the production of cultures that 
are highly positive for the potential neuronal marker Beta I I I tubulin. 
• The use of this cocktail of signalling molecules causes differential regulation 
of the mRNA and protein for dopaminergic markers such as tyrosine 
hydroxylase. 
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PA6 co-culture can induce detectable expression of neuronal and 
dopaminergic markers in embryonal carcinoma cells. 
Co-culture driven differentiation of embryonal carcinoma stem cells does not 
appear to occur in a highly regulated or predictable fashion. 
Pre treatment of Tera2.cl.SP12 cultures with retinoic acid does not appear to 
increase their potential for subsequent co-culture induced dopaminergic 
differentiation. 
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Appendix A 
Buffer compositions for Western blot analysis 
• lOx TBS - 6.1g Tris base (Fisher Scientific) and 43.8g Sodium Chloride 
(BDH Biosciences), dissolved in 500ml of distilled water, (adjust pH to 7.5 
and autoclave). 
• Ix TBS - dilute 100ml of TBS (lOx) with 900ml of distilled water. 
• 1X TBS-T - TBS (1 x) with 0.2% Tween 20 (Sigma). 
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Relative expression (linear scale) of DAerg markers on EC cells (5% oxygen) 
Expression of dopaminergic markers on human EC cells 
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Appendix B: Dopaminergic marker expression in Tera2.ci.SP12 cells cultured for 4 weeks 
in the presence of 1 O^M retinoic acid in a 5% oxygen incubator. 
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Relative expression (linear scale) of DAerg markers on EC cells (21% oxygen) 
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Appendix B: Dopaminergic marker expression in Tera2.cl.SP12 cells cultured for 4 weeks 
in the presence of lOuM retinoic acid in a 21% (atmospheric) oxygen incubator. 
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Appendix B: A schematic summary of the trends in dopaminergic marker expression for 
Tera2.cl.SP12 cells treated with lOuM retinoic acid for varying periods up to 4 weeks. Most 
markers are barely detectable or absent in the starting material and are induced by increasing the 
duration of retinoic acid exposure. Some markers such as DAT and Dl are more weakly expressed 
and are detected at higher Ct values than those such as D2 and TH that are more strongly detectable. 
Therefore the line position is only a guide as to the trend and will vary for each specific marker 
investigated. 
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Appendix C 
Western Blot - Nurrl Positive Control 
Rat Brain Material 
(positive control) 
Diffuse Nurrl 
Band 
Discrete 
Beta-actin 
Band 
Appendix C: Post natal adult rat brain material (courtesy of the lab of Dr. P. Chazot, 
Durham University) thought to be positive for expression of Nurrl was used as a 
positive control to test the Nurrl antibody (obtained from Cambridge Bioscience) used 
in the investigations outlined in this thesis. 
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Appendix D 
Cell count merged images 
Retinoic acid only Retinoic acid plus Wnt1 
A Hoescht stained 
nucleus (blue) for 
counting purposes 
A beta III tubulin positive 
cell (green) for counting 
purposes 
Appendix D: A merge of FITC and Hoescht images performed using Adobe 
Photoshop to show the expression of Beta II I tubuhn (FITC detection - green in the 
images above) in some cells against a background of total cell number (defined by 
the presence of Hoescht stained cell nuclei (blue in the images above)). The cell 
count data in Figures 4.28 and 4.29 were based on such immunocytochemical 
observations. The intensity of staining was generally greater in the Wntl plus 
retinoic acid condition, this is refiected in these images but some of the difference 
arises from a stronger background on the Wntl plus reUnoic acid image shown here, 
the difference although apparent was not observed to be this striking in practice and 
may in part arise from the merging process. 
Appendix E : Nestin staining in R.A. treated EC/Stromal cell co-cultures 
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Appendix E: Human specific nestin immunostaining in Tera2.cl.SP12 cells (pre treated for 3 days with 10|iM retinoic acid) then co-cultured with either murine PA6 or rat 
mesenchymal stem cells for 17 days. The upper two rows of images (termed Heavy) display the strong nestin expression seen in the bulk of most cultures, that are highly 
confluent as seen in the corresponding Hoescht and phase images. The two lower rows of images (termed Light) are representative of less confluent areas of such cultures. 
In the case of the PA6/Tera2.ci.SP12 condition it would appear that there are cells (evidenced by their Hoescht stained nuclei) present that are not EC cell like in 
morphology that are nestin negative and as such may well be PA6 cells confirming that some stromal cells are still present in these co-cultures at the terminus of the 
differentiation protocol. However even in the less confluent areas of MSC/Tera2.cl.SP12 co-cultures all the cells appear to be nestin positive and morphologically 
characteristic of EC cells, suggesting few i f any of the original stromal cell population remain at this point. Scale bars are approximately equal to lOO^m. 
